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ABSTRACT
Each eukaryotic cell is exquisitely divided into organellar compartments whose functions
are uniquely defined by the set of proteins they possess. For each individual protein, precise
targeting to a specific sub-cellular location and trafficking between compartments are often key
to its proper function. In fact, many human diseases are linked to mutations that cause mis-
targeting and/or defective trafficking. This thesis describes the development of enzyme-based
reporters for measuring protein localization and trafficking. We employ two complementary
approaches: a top-down approach, involving proteomics, to simultaneously acquire the sub-
cellular localization information for hundreds of proteins; and a bottom-up approach, involving
fluorescence imaging, to record detailed spatial information for proteins on an individual basis.
This thesis is therefore divided into the following two parts.
Part A describes a promiscuous protein labeling technique for proteomic mapping of
organelles. This method capitalizes on peroxidase as a source of free radical generator.
Compared to traditional sub-cellular fractionation methods, this novel approach obviates the
need of organelle purification, thereby not only eliminating the potential artifacts associated with
purification, but also greatly improving the temporal resolution of the proteomic mapping.
Applying this technique to study the proteome of mitochondrial matrix and endoplasmic
reticulum lumen has led to the discovery of several mitochondrial proteins whose localizations
have previously been unknown or ambiguous.
Part B discusses the development and application of site-specific protein labeling
methods for studying receptor trafficking mechanisms. Building upon previous work in our lab,
we utilized the Escherichia coli biotin ligase BirA and its acceptor peptide to site-specifically
label the low-density lipoprotein receptor and studied its internalization and trafficking both at
the ensemble imaging and single-molecule level. We discovered that this receptor internalizes as
an oligomer into cells.
Thesis Supervisor: Alice Y. Ting
Title: Ellen Swallow Richards Associate Professor of Chemistry
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1.1 Introduction -
An important feature of eukaryotic cells is the exquisite division of cellular space into
organellar compartments that vary both in shape and in molecular composition. Because the lipid
membrane of these compartments presents a barrier to the diffusion of hydrophilic molecules,
functionally distinct aqueous environments can be created within the cell. The biochemical
properties of these environments differ considerably. While the cytosolic space is abound with
reducing agents, the secretory pathway comprising of the endoplasmic reticulum (ER) and the
Golgi apparatus has highly oxidizing redox potential (1). Whereas most compartments have
nearly neutral pH, the late endosome and lysosome have highly acidic luminal space (2,3).
Compartmentalization allows precise control of biochemical reactions within the cell.
This is exemplified by the creation of concentration gradients across the membranes that are
useful for many physiological processes. The proton gradient across the mitochondrial inner
membrane is established by the action of electron transport chain and ultimately drives the
synthesis of adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic
phosphate (4,5). Calcium ion is largely sequestered within the endoplasmic reticulum, and in
response to signaling, it can be released into the cytosol to trigger a variety of physiological
processes, ranging from muscle contraction to apoptosis (6, 7). Another advantage of cellular
compartmentalization is to dramatically increase the surface area of lipid membrane, which is
home to many essential membrane-bound metabolic enzymes. For example, many enzymes
involved in lipid metabolism are located on the mitochondrial inner and outer membranes (8),
and both oxidative phosphorylation and photosynthesis require membrane protein complexes to
produce the proton gradient necessary for ATP synthesis (9,10).
The function of each organelle is uniquely defined by the set of proteins that it contains.
In order to understand how an organelle is engaged in biological pathways, it is often desirable to
know its complete molecular inventory. Since the discovery of signal peptides (11), it has also
become possible to predict the sub-cellular localization of proteins based on their amino acid
sequences (12). However, predicted localization ultimately needs to be experimentally validated.
Currently, two complementary approaches have been employed to verify protein localizations.
On the one hand, the top-down approach, involving purification of an organelle of interest and
subsequent proteomic analysis, aims to identify the sub-cellular localization information for
hundreds of proteins in parallel; on the other hand, the bottom-up approach, involving specific
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protein labeling and fluorescence imaging, reports detailed spatial information for proteins on an
individual basis. In this chapter, we review the currently available techniques for purification and
identification of the sub-cellular proteome. Existing techniques for protein labeling and
fluorescence microscopy will be reviewed in Chapter 4.
1.2 Existing methods for sub-cellular fractionation
Purification of organelles was traditionally done with sub-cellular fractionation and
differential centrifugation. In the first step, cells are homogenized in isotonic buffer solution to
disrupt the plasma membrane. Homogenization could be achieved with osmotic shock, freeze-
thaw cycle, shearing, grinding, or ultra-sonication. The homogenate then undergoes repeated
centrifugation steps to separate organelles based on their sizes and densities. Whereas intact
mitochondria can be purified via sub-cellular fractionation approach, the endoplasmic reticulum
is too delicate to survive the purification process. Rather, the endoplasmic reticulum is always
fragmented into vesicles known as the microsomes, which can be isolated from other cellular
components in the fractionation process. Here we summarize our current knowledge about the
purification and proteomic analysis of these two compartments.
Sub-cellular fractionation of mitochondria
In one of the earliest studies on mitochondrial proteome, classical cell fractionation of
placental tissue was employed to isolate mitochondria (13). The mitochondrial suspension was
subsequently lysed in denaturing condition, and its protein contents separated by 2-dimensional
gel electrophoresis. Gel pieces containing protein spots were excised and analyzed with either
protein sequencing or in-gel trypsin digestion followed by mass spectrometry (MS) analysis. Due
to limited sensitivity of the method, merely 46 proteins were identified. Another issue with this
method is contamination by proteins from other cell components, such as abundant secreted
protein (choriomammotropin) in secretion granules whose density matches that of mitochondria,
and cytoskeletal proteins (Rho protein and actin) at the mitochondrion-cytosol interface. In
addition, bovine serum albumin (BSA) introduced at the initial purification stages were also
retained as a contaminant (13).
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The same strategy of cell fractionation has been employed in all subsequent proteomics
studies of mitochondria. As liquid chromatography-tandem mass spectrometry (LC-MS/MS)
became a standard tool for protein identification, the coverage has greatly improved due to
increased sensitivity. In 2003, Taylor et al. identified 615 mitochondrial proteins of human heart
using sucrose density gradient centrifugation to purify intact protein complexes (14). Mootha et
al. identified 591 mitochondrial proteins from four mouse tissues based on combined
information from proteomics survey and existing genomics annotation. Notably, 163 proteins in
this list had not been associated with mitochondria in previous research (15).
While it is relatively easy to purify the intact mitochondria, it is challenging to obtain
sub-mitochondrial fragments. For instance, the mitochondrial matrix proteome has previously
been studied using hypotonic shock to remove the outer membrane from purified rat liver
mitochondria (16), but only 37 matrix proteins were identified, perhaps due to the harshness of
the procedure. Da Cruz et al. combined sub-cellular fractionation and membrane extraction with
organic acid to selectively purify inner mitochondrial membrane (IMM) proteins from mouse
liver (17). A total of 182 proteins were identified, including 20 unknown mitochondrial proteins.
Zahedi et al. isolated outer membrane vesicles from highly purified yeast mitochondria (18).
Subsequent MS analysis revealed 112 proteins, achieving coverage of about 85% of known outer
mitochondrial membrane (OMM) proteins.
Even more challenging is to selectively identify proteins located in the mitochondrial
inter-membrane space (IMS). Recently, Vbgtle et al. presented the first study on yeast IMS
proteome (19). This experimental design is based on the conserved mechanism of Bax-induced
mitochondrial outer membrane permeabilization, which releases IMS proteins into the cytosol.
When combined with stable isotope labeling, this approach allows for the specific identification
of released IMS proteins. A total of 51 proteins were identified, among which 20 novel IMS
protein candidates were discovered. Remarkably, 10 protein candidates have never been
associated with mitochondria in previous research.
Sub-cellular fractionation of endoplasmic reticulum
Endoplasmic reticulum forms an extended network of tubules and sheets (20). The
lumenal space is continuous throughout the endoplasmic reticulum and is connected with the
nuclear envelope. The endoplasmic reticulum is morphologically and functionally divided into
rough and smooth endoplasmic reticulum subdomains. The rough endoplasmic reticulum is
decorated with membrane-bound ribosomes and is the entry point of the secretory pathway. The
smooth endoplasmic reticulum, on the other hand, lacks ribosome on the surface and is involved
in lipid synthesis and calcium storage.
Due to structural complexity, the endoplasmic reticulum is too delicate to be purified
directly. Instead, previous purification schemes disrupted the endoplasmic reticulum into small
membrane-bound vesicles called microsomes. Rough and smooth endoplasmic reticulum
generates rough and smooth microsomes, respectively. In general, microsomes remain in
suspension at low speed centrifugation (10,000 x g for 20 min) but are pelleted at high speed
(100,000 x g for 1 hour) (21). Sucrose gradient density centrifugation is capable of
differentiating between these two types of microsomes (22). Rough microsomes can be further
purified by removing surface-attached ribosomes with high salt concentration and addition of
puromycin (23-25). In addition, in order to enrich for integral membrane proteins, peripheral
membrane proteins can be removed via treatment with sodium carbonate at basic pH (6).
Using this approach, Gilchrist et al. compiled a list of over 1,400 proteins in the rat liver
secretory pathway including 345 proteins that have previously unknown functions (22). Among
these, 832 proteins are unique to the endoplasmic reticulum, 193 proteins are unique to the Golgi,
and 405 are in both the endoplasmic reticulum and the Golgi. More recently, Song et al.
performed quantitative proteomic survey of mouse liver and identified 903 proteins in the rough
endoplasmic reticulum and 1042 proteins in the smooth endoplasmic reticulum (26). However,
comparison between these two proteomics studies showed that merely 662 proteins were found
in common. Even considering that these endoplasmic reticulum proteomes are derived from
different animals, this poor overlap still suggests lack of reliability in extracting the endoplasmic
reticulum proteome.
Limitations of sub-cellular fractionation
Density centrifugation of organelles is often plagued by artifacts. On the one hand, false
positive hits arise because of incomplete purification or contaminants introduced into the sample;
on the other hand, if the purification condition is too harsh, then loosely interacting proteins
could be lost, resulting in false negatives. Protein correlation profiling has been employed to
battle against contaminating proteins in sub-cellular fractionation (27). This strategy utilizes
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known protein markers for the protein complexes or organelles that are being purified, and reject
proteins whose abundance distribution profiles are different from that of the markers.
Another drawback of organelle purification processes is the requirement of intensive
labor and extensive period of time. During hours of purification, the physiology of organelles
could change significantly. Furthermore, many regions of interest in the cell - such as the
synaptic cleft or the contact site between mitochondria and the endoplasmic reticulum - simply
cannot be purified using conventional methods and therefore their proteomes are largely
unknown.
1.3 Proximity-dependent promiscuous protein labeling
*-XH
= biotin labeled not
protein labeled
add
0
Figure 1-1. Scheme of proximity-dependent promiscuous protein labeling.
The green packman represents the labeling source, which in our case is an engineered enzyme. It
catalyzes the conversion of a stable compound into a highly reactive intermediate which then diffuses
away from the active site and forms a covalent bond with nearby proteins. Ideally, such intermediate is
short lived, so that it does not diffuse far from the source before getting inactivated. Therefore, inside a
living cell, chemical labeling occurs in a proximity-dependent manner.
We sought to develop new methods for proteomic mapping that preserves spatial
information yet circumvents the many drawbacks of traditional cellular lysis and purification. In
this alternative approach, the proteome of interest is tagged with a chemical handle such as biotin
while the cell is still alive, with all cellular membranes, macromolecular complexes, and spatial
arrangements preserved. Ideally, the yield of such chemical reactions should be strictly
dependent on the proximity between the labeling source and endogenous protein targets, and it
should be able to label any proteins, regardless of their amino acid sequence, three-dimensional
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structure and physicochemical properties such as size, charge, and hydrophobicity. The scheme
of such proximity-dependent promiscuous labeling reaction is outlined in Figure 1-1. This
strategy has been employed in previous research, using various labeling sources to generate
reactive intermediates. These are reviewed below.
Promiscuous biotin ligase
One candidate promiscuous protein labeling source is engineered biotin ligase. The
Cronan group discovered that the R 118G mutant form of Escherichia coli biotin ligase BirA is
capable of catalyzing the formation of biotin-adenylate ester (biotin-AMP) and subsequently
releasing it from the active site (28). Roux et al. further developed this method by expressing
BirA RI 18G mutant protein in living mammalian cells. Due to its high reactivity toward
nucleophilic groups such as the side chain of lysine residue, biotin-AMP reacts with proteins
proximal to the enzyme, resulting in covalent modification of these proteins with biotin. These
biotinylated proteins could then be selectively recovered with streptavidin-based affinity
purification, and subsequently analyzed by Western blot or identified by mass spectrometry. This
labeling technique was termed BiolD (proximity-dependent biotin identification) (29).
BioLD has been demonstrated to be useful for analyzing the proteome of nuclear lamina.
In this study, promiscuous BirA was fused to lamin A, a component of the nuclear lamina, and
expressed in a human cell line (29). MS identified about 100 protein candidates, including both
known protein components of the nuclear lamina and several uncharacterized proteins. SLAP75
belongs to the latter group, and follow-up immunofluorescence study confirmed its localization
to the nuclear envelope.
However, BiolD suffers from slow labeling kinetics and poor spatial resolution. It
requires at least 6 hours of labeling (29). This prolonged incubation could cause biological
perturbation, because artificially modifying proteins with biotin could interfere with protein
functions such as blocking protein-protein interactions. Promiscuous covalent modification of
thousands of proteins in a living cell could therefore alter the physiology of the organelle under
investigation or even be toxic to cells. In addition, the poor temporal resolution of this method
makes it impossible to analyze any rapid changes in the organellar proteome, such as acute
response to drug treatment. Furthermore, the proposed mechanism of promiscuous labeling with
biotin-AMP implies a long half-life and hence a large labeling radius (28). The authors claimed
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that the labeling radius is within 20 nm, based on the examination of proteomics data. However,
it contradicts with our knowledge of the stability of acyl-adenylate. For example, the hydrolysis
rate constant of glutaminyl-adenylate in buffered aqueous solution was measured to be merely
0.7 x I0-3 s-', corresponding to a half-life of about 103 sec (30). Such long life time would allow
the intermediate to diffuse across the entire cell. It might be still useful for mapping organelle
proteomes, because the adenylate is membrane-impermeant due to its negative charges. However,
it would be implausible to map non-membrane-bound sub-cellular regions or protein complexes.
Finally, the selectivity toward primary amines poses another limitation of BiolD, because this
creates a bias toward proteins with more surface-accessible lysine residues. The labeling reaction
yield would also be lower at acidic environments as fewer lysine amino groups are deprotonated.
Enzyme-mediated activation of radical source
Horseradish peroxidase (HRP)-catalyzed generation of nitrene from aryl azide is another
candidate. It is well-known that aryl azide can be photo-activated into a highly reactive and
short-lived nitrene radical, which can form covalent bond with nearby biomolecules via insertion
reactions (31). Recently, Honke et al. reported that in addition to ultraviolet (UV) light, HRP is
also capable of activating arylazide into nitrene (32). By tethering aryl azide to biotin and
targeting HRP to a specific cellular location via antibody, it is now possible to label the
surrounding proteins with an affinity tag. Thereafter, these labeled proteins can be enriched and
identified using streptavidin-based affinity purification. This technique was termed EMARS
(enzyme-mediated activation of radical source).
To demonstrate the power of EMARS labeling, HRP was targeted via antibody to various
cell surface proteins including growth factor receptors and integrin. EMARS labeling and
subsequent analysis by antibody array and MS identified proteins co-clustering with these
markers on the cell surface (32-34). HRP has also been targeted to lipid raft markers such as
gangliosides GMI and GD3, and fluorescein-conjugated aryl azide was used to fluorescently
labeling cell surface molecules within the lipid raft. Enrichment with anti-fluorescein antibody-
coated resins and MS analysis identified membrane proteins and secreted proteins as candidates
in the lipid raft microdomain (35,36).
Electron microscopy showed that the labeled proteins are positioned within 200 - 300 nm
of the HRP enzyme (32). This small radius is consistent with the short lifetime of the nitrene
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radical. It is noteworthy that the EMARS approach bears resemblance to the commercial
"tyramide signal amplification" method (37), which uses antibody-targeted HRP to generate
fluorophore-tyramide deposits on fixed cells for imaging. This method is also known to preserve
the spatial information of labeling, with minimal diffusion of fluorophore-tyramide signal
beyond the location of HRP enzyme. One limitation of this method is that HRP is inactive when
expressed in the mammalian cytosol (38). Therefore, all the applications so far have been on cell
surface protein clusters, and it is not possible to extend this technique to labeling cytosolic
proteins.
Direct crosslinking to endogenous proteins
A special case of proximity-dependent labeling is protein crosslinking, in which a protein
of interest is introduced into cells as bait. In order to discover its endogenous interaction partners
(preys), a crosslinking reagent was added to covalently conjugate the bait to nearby proteins.
Affinity purification of the bait also pulls down the crosslinked preys, which are subsequently
identified. In this scheme, the bait protein itself serves as the label.
A variety of reagents have been used for protein crosslinking experiments. Formaldehyde,
N-hydroxysuccinimidyl esters and carbodiimides are reactive toward primary amines, and are
therefore useful for crosslinking proteins via the side chain of lysine residues or the N-termini.
Photocrosslinkers such as benzophenone (39,40), aryl azide (41), and diazirines (42,43) have
been incorporated into proteins in living cells through unnatural amino acid mutagenesis.
Subsequent UV irradiation generates highly reactive intermediates (triplet-state benzophenone,
nitrene, or carbene, respectively) that enable crosslinking of proteins of interest to other
endogenous targets. The main concern regarding photocrosslinking is the low yield, which
necessitates long exposure time.
A variation of the photocrosslinker strategy is the development of targeted releasable
affinity probe, in which a benzophenone probe is targeted to the bait via a tetra-cysteine motif
(44). After photo-induced crosslinking to endogenous proteins, this group can be dissociated
from the bait with treatment of excess dithiols. The preys are therefore released from the bait and
left with a covalent modification that can be used for affinity purification. This technique has
been applied to cultured mammalian cells and it revealed the interaction between the membrane
protein phospholamban and the extracellular matrix protein fibronectin (16). The ability to
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release the prey from the bait reduces sample complexity, which facilitates MS analysis.
However, the caveat of using the tetra-cysteine motif is the oxidation and palmitoylation of
cysteine residues that could block probe binding (45).
Transition metal-mediated oxidative protein crosslinking is another possibility (46).
Pioneered by Kodadek et al., this technique capitalizes on the oxidizing power of high-valence
transition metal complexes and primarily targets electron-rich residues such as tyrosine,
tryptophan and cysteine (47,48). In the case of tyrosine, one-electron oxidation generates a
tyrosyl radical which rapidly couples to an adjacent protein, often with another tyrosine residue
(49,50).
Various transition metal complexes have been employed for oxidative crosslinking
reactions. Highly reactive high-valence metal complexes are often prepared from stable, low-
valence complexes through either chemical oxidation or photo-oxidation. One prominent
example of chemical oxidation is the nickel-peptide complex. In the presence of magnesium
monoperoxyphthalate or potassium peroxomonosulfate as the stoichiometric oxidant, Ni(II)
complexed with a tripeptide Gly-Gly-His (51) or a hexapeptide His 6 (52,53) is oxidized into
Ni(III) oxo, which is highly reactive and mediates crosslinking. In addition, by introducing these
Ni(II)-binding peptides to proteins through genetic fusion, it is possible to target redox active
nickel complexes in recombinant proteins (23,26,27,54). This method has been applied to study
the interaction between actin and myosin (55).
In the case of photo-oxidation, Ru(II)-tris(bipyridine) (21) and Pd(II)-tetrakis-(4-
methylpyridyl) porphyrin (56) have been utilized. In the presence of electron acceptors such as
ammonium persulfate or Co(IlI)(NH 3)5 Cl 2*, light irradiation excites an HOMO electron in the
metal complex to a LUMO state which is then captured by the electron acceptor. The resulting
high-valence metal complex then mediates the crosslinking process by taking an electron from
tyrosine residues, in the same way as oxidized nickel-peptide complexes. Photo-induced
crosslinking has been used in the proteomic study of the 20S proteasome (57), and the covalent
labeling of G-protein coupled receptors with their ligands on the cell surface (58).
The crosslinking yield needs to be carefully optimized. While too little crosslinking fails
to capture weak and transient interactions, over-crosslinking could generate insoluble protein
precipitate and/or block epitope tag recognition.
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1.4 Existing mass spectrometry techniques for proteomics
Mass spectrometry (MS) is an analytical tool for measuring the mass-to-charge ratio of
ions. In history, the most primitive model was built by physicist Wien in 1898, when he applied
electric and magnetic fields to deflect a stream of ionized gas that later came to be known as the
proton (59). This technique was further developed in the early 1900s by Thomson and his student
Aston, who designed the first mass spectrograph to discover different isotopes of neon (60,61),
and Dempster, who introduced both the magnetic sector field mass spectrometer and electron
impact ionization source (62). In the following decades, various mass analyzers have been
developed, and MS has become a powerful tool for both physicists and chemists. However, the
application of MS to analyzing proteins and nucleic acids had been limited, mainly because
traditional ionization sources were too harsh for these biomolecules.
The introduction of soft ionization techniques such as electrospray ionization (ESI) (63)
and matrix-assisted laser desorption/ionization (MALDI) (64,65) has revolutionized the field of
bioanalytical chemistry. In ESI, highly charged droplets containing the analyte are generated by
passing the liquid phase through the tip of a capillary tube that is held at high voltage. The
droplets are subsequently evaporated, leading to the formation of ionized analyte in the gas phase.
In MALDI, the analyte is first dispersed in a solid matrix containing UV light-absorbing
molecules. Subsequent UV laser irradiation causes ablation of the matrix surface and generates a
plume of ionized analyte. Both ESI and MALDI are compatible with large biomolecules such as
proteins and nucleic acids, to the extent that they could even preserve non-covalent interactions
during ionization (66,67).
Over the past decades, MS has gained increasing popularity as a major tool for
proteomics studies. Recent developments in mass analyzers such as the Orbitrap technology have
achieved unprecedented sensitivity, accuracy (1 - 2 ppm), and mass resolution (200,000) (68,69).
At the same time, various liquid chromatography techniques have been improved to efficiently
couple with MS analysis. Tandem MS allows simultaneous detection of the parent ion and
deduction of its sequence. This section reviews the basics of mass spectrometry in proteomic
experiments, with a focus on quantitative MS approaches.
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Protein identification by mass spectrometry
Modem liquid chromatography-tandem MS (LC-MS/MS) is highly efficient in detecting
peptide fragments within a complex sample. Proteins are generally too large for this analysis, and
therefore need to be broken down to peptides first. Enzymatic digestion is a favored approach to
break down proteins, because the fragment length is optimal for LC-MS/MS and the cleavage
site is often predictable. For example, trypsin has been routinely used to cleave proteins at the C-
termini of basic amino acid residues lysine and arginine. In this way, peptides are identified first,
and protein identifications are then deduced based on peptide sequences. Availability of genome
information of the organism under investigation could help map peptide fragments onto known
open-reading frames, thereby greatly facilitating the protein identification process. This approach
is termed "bottom-up proteomics" (70,71).
Protease digestion can be performed directly in the solution of protein sample.
Alternatively, proteins can be first separated by gel electrophoresis, in either one dimension or
two dimensions. Thereafter, gel spots containing proteins can be sliced out and treated
individually with protease. After this in-gel digestion, the resulting peptides can be recovered
through extraction. Although in-gel digestion is more time-consuming than the in-solution form,
its main advantage is the reduction of sample complexity, which helps improve the coverage of
proteomics study. A hybrid method utilizing micro-reactors has been employed to combine the
resolving power of in-gel approach and the speed of in-solution approach. In this method, trypsin
is immobilized within a solid matrix so that enzymatic digestion can be performed on-line to the
liquid chromatography (72-74). The main limitation of this approach is the requirement of
sophisticated instrumentation.
Digested peptides are separated by liquid chromatography (LC), usually on a reverse
phase column. The LC is directly coupled to tandem mass spectrometer. The first stage mass
spectrometer measures the mass-to-charge ratio of ionized peptides, and then transports peptides
of interest to the second stage mass spectrometer. These selected peptide ions are mixed in the
gas phase with inert gas molecules, and collision-induced dissociation causes peptide ions to
fragment, most frequently at the peptide bond. Because dissociation can occur at different sites, a
series of fragment ions are generated and analyzed. Sequence information of each parent peptide
ion can thus be deduced from this measurement.
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Quantitative mass spectrometry
While extremely powerful for identifying proteins, traditional MS is not inherently good
at quantifying proteins in a complex sample. The MS peak intensity is affected by many
parameters other than protein or peptide abundance. These parameters include size, charge state,
and hydrophobicity of proteins or peptides. Internal standards can be added to the sample to
calibrate the MS instrument, but this has to be done on an individual peptide basis, and it is
challenging to extend this on a proteomic level. Recently, using stable isotope labels, various MS
methods have been developed to allow quantitation of relative protein abundance between
multiple samples. Proteins labeled with different isotope tags are pre-mixed before any sample
processing occurs. Because these proteins differ only in the isotope that they carry, their physical
and chemical properties are identical, so that they are affected in exactly the same manner in
subsequent biochemical (protein enrichment, protease digestion, peptide extraction, etc.) and
instrumental (chromatographic separation, ionization, MS response) analyses. This effectively
minimizes quantitation errors. MS analysis resolves multiplet peaks, with each corresponding to
a unique monoisotopic species.
In cultured cell lines, it is often convenient to metabolically incorporate isotope labels
into proteins. Stable isotope labeling with amino acids in cell culture, or SILAC, has been widely
used for this purpose (75). Among 20 standard amino acids, arginine and lysine are favored
candidates for isotope labeling for two reasons: 1) trypsin digestion is specific to the arginine and
lysine residues; and 2) lysine (an essential amino acid) and arginine do not easily convert to other
standard amino acids during metabolism (excess arginine can be converted to proline via the
arginase catabolism pathway (76), but this can be prevented by careful titration of arginine).
Together, these ensure that each tryptic peptide (except for the most C-terminal peptide) carries
one and only one isotope-labeled residue at the C-terminus, which greatly simplifies data
analysis. 3 C and 15N are commonly used to label lysine (13C6-Lys, or 13C6,15N 2-Lys) and
arginine ( 13C 6-Arg, or C6 , 15N 4-Arg) residues. After culturing cells in SILAC media for 6 - 8
doublings, more than 90% of proteins can be labeled (75). Despite its success with immortalized
cell cultures, SILAC is generally not considered as cost-effective when labeling cells in live
animals, such as worms, fruit flies and rats. Typically, SILAC labeling can be applied up to three
conditions (light state - no labeling, medium state - 3 C label only, and heavy state - both 3C
and 15N labels).
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Alternative labeling methods are required if SILAC is not a viable solution. For example,
180 can be efficiently incorporated to the carboxyl termini of peptides if enzymatic digestion is
performed in H2 180 (77,78). Isotope-coded affinity tag (ICAT) method has been developed to
selectively modify cysteine residues with deuterated reagents, such as biotin derivatives with a
thiol-reactive group, for both affinity purification and isotopic labeling (79). Similarly, isotope-
coded protein label (ICPL) employs N-hydroxysuccinimide chemistry to modify the N-terminal
and lysine residue side chain amino groups with an isotope tag (80). Variations of this method
include isotope tags for relative and absolute quantitation (iTRAQ) and tandem mass tags (TMT),
which employs the same derivatization chemistry but utilizes isobaric tags that provide
fragmentation signatures during the tandem MS analysis (81,82). Finally, the C-terminal and
acidic amino acid (Asp and Glu) side chain carboxyl groups can be labeled via esterification with
deuterated alcohols (83,84). These techniques are collectively referred to as post-biosynthetic
labeling (85).
Quantitation of peptide abundance is achieved by taking the ratio of integrated peak
intensity of differentially labeled peptides. Protein level abundance information is then inferred
from peptide ratios, usually by taking the mean or median value of peptides belonging to the
same protein. This step can now be automated using commercially available software, such as
MaxQuant (86,87).
1.5 Conclusion
Here we have reviewed the current technology involved in proteomic studies of cells and
organelles. All of these experiments consist of two steps: purification of proteins of interest, and
subsequent identification of these proteins. Thanks to advances in MS technology, the second
step can be routinely done, and is limited only by the sensitivity and resolving power of the
instrument. The challenge remains in the first step, where the purification scheme varies from
case to case. Proximity-dependent promiscuous protein labeling offers a novel way of addressing
the problem as the physical purification step can be bypassed and replaced with a chemical
reaction. However, the currently available labeling reactions do not fulfill all the requirements.
We envision that an enzyme-catalyzed free radical reaction could be beneficial, due to the
short lifetime and reactive nature of free radicals in the cellular environment. In the following
two chapters, we discuss in detail the discovery, improvement, characterization and applications
of a class of heme peroxidase for promiscuous protein labeling.
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Chapter 2 Promiscuous protein labeling with ascorbate peroxidase
Work described in this chapter has not yet been published. Most of the experiments described
were performed in collaboration with Dr. Hyun-Woo Rhee, who synthesized various biotin-
phenol compounds and characterized the activity of ascorbate peroxidase with biochemical
assays. The focus of my work was on characterizing the spatial specificity of ascorbate
peroxidase labeling.
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2.1 Introduction
As outlined in Chapter 1, we envision that a promiscuous labeling enzyme would be
useful for acquiring proteomic information. For this method to work, the following criteria have
to be met:
1. The enzyme should be genetically targetable to and be active at different parts of the cell.
The enzyme should withstand both oxidizing (such as the secretory pathway) and
reducing (such as the cytosol) environments as well as pH levels ranging from around 4.5
(lysosome (1)) to 8.0 (mitochondrial matrix (2)).
2. The substrate of the enzyme should be a membrane-permeant small molecule that can be
added exogenously and triggers the reaction. Ideally, the enzyme does not recognize
endogenous metabolites present in mammalian cells, or its activity can be temporally
modulated by small molecules.
3. The substrate contains a functional handle for subsequent enrichment. Biotin is
commonly used as an affinity tag, which is recognized by streptavidin with femtomolar
dissociation constant. Alternatively, functional groups enabling bio-orthogonal reactions
can be used as a handle for enrichment. For example, if the substrate contains an azido
(or alkynyl) group, then the labeled proteins can be selectively immobilized onto an
alkyne-derivatized (or azide-derivatized) resin surface via click-chemistry (3).
4. The enzyme converts the substrate into a highly reactive intermediate with short half-life,
such that it has the potential to label any endogenous proteins and has small diffusion
radius.
Although to our knowledge no naturally occurring enzyme-substrate pair fulfills these
conditions, a class of free radical generating enzymes appears to be promising candidates. In
biological systems, the free radical is a two-edged sword. On the one hand, they have the
potential to cause deleterious effects to cells, such as DNA cleavages, and therefore their
formation as metabolic byproducts is under tight control (4). As a result, cells have evolved a
sophisticated system to rapidly clear away free radicals. On the other hand, the power of free
radicals can also be harnessed in enzymatic reactions to achieve otherwise difficult chemical
transformations. This has been demonstrated in the case of deoxyribonucleotide biosynthesis (5).
Because free radicals have extremely short life-time and high reactivity, we envision that through
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protein engineering, it would be possible to identify enzyme mutants and synthetic substrates that
are useful for promiscuous protein labeling. Among various free radical-generating enzymes, we
were particularly interested in a class of enzyme called heme peroxidases. In these enzymes,
because the small molecule substrate is non-covalently bound to the active site, the resulting
radical could be released to attack nearby biomolecules.
Heme peroxidases are categorized into three classes based on sequence homology,
cellular localization and biological origin (6). Class I is cytosolic peroxidases. Examples in this
group are cytochrome c peroxidase and ascorbate peroxidase. Class II is fungal secretory
peroxidases, which contains lignin peroxidase and manganese peroxidase. Class III is secreted
plant peroxidases, which contains horseradish peroxidase. Both class II and class III peroxidases
contain four disulfide bonds and two conserved calcium ions binding sites. Among these
enzymes, horseradish peroxidase (HRP) is known for recognizing a variety of substrates and has
found broad applications in biotechnology, ranging from chemiluminescence, enzyme-linked
immunosorbent assay (with 3,3',5,5'-tetramethylbenzidine), to electron microscopy contrast
generation (with 3,3'-diaminobenzidine). Unfortunately, HRP is inactive when expressed in the
cytosol.
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Figure 2-1. Structure of soybean cytosolic ascorbate peroxidase in complex with an aromatic
substrate.
Left: overall structure of ascorbate peroxidase monomer, with heme co-factor colored in black, distal
histidine in blue and bound aromatic substrate (salicylhydroxamic acid, structure shown on the right) in
green. Middle: close up view of residues around the heme active site. This figure is adapted from
references (7) and (8). PDB ID: I VOH
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In an effort to search for peroxidases as electron microscopy reporters, Jeffrey Martell in
our lab found that pea ascorbate peroxidase (APX), a class I heme peroxidase, is active toward a
panel of phenol-containing substrates, such as guaiacol and Amplex Red (9). Unlike HRP, APX
lacks disulfide bonds and is active in the mammalian cytosol and other organelles. The active site
of ascorbate peroxidase features a non-covalently bound heme molecule (Figure 2-1). The
catalytic cycle is depicted in Figure 2-2.
In the case of phenol-containing substrates, a phenoxyl radical is formed. Previous work
has shown that phenoxyl radicals are short lived (<1 msec (10)) and have limited diffusion radius
prior to labeling (<14 nm (11,12)). Quenching of phenoxyl radical occurs either through
hydrogen atom abstraction from a reducing agent or via covalent bond formation upon collision
with another free radical. In aqueous solution, these reactions are often diffusion-limited (13).
Together, these two reactions provide one mechanism of protein labeling with phenoxyl radicals,
as depicted in Figure 2-3. Previous work has shown that phenoxyl radicals can covalently react
with electron-rich amino acids such as tyrosine, phenylalanine, tryptophan, and cysteine. In the
case of tyrosine residue, dityramine formation was suggested as the labeling product (14-18).
H20+ R Resting 
state
0. -Fe(ill)-- H0
9R
H20
OH OH 0
1 11 .+
-Fe(IV)- -Fe(IV)-
Compound i > .C< Compound I
I-R |-R
Figure 2-2. Catalytic cycle of heme peroxidase.
Heme Fe (III) at its resting state gets oxidized by hydrogen peroxide into high-valence Fe(V) state,
forming Compound I. Compound I then undergoes one-electron transfer to abstract a hydrogen atom from
the aromatic substrate, with itself being reduced to Compound II. Compound II is capable of abstracting
another hydrogen atom from the substrate in a one-electron transfer reaction, returning to the resting state.
In each catalytic cycle, two free radicals are generated.
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Figure 2-3. Scheme of phenoxyl radical crosslinking.
In the first step, the radical is transferred from biotin-phenoxyl group to an electron-rich amino acid on
the endogenous protein target, such as the tyrosine residue. Hydrogen atom transfer results in the
formation of a tyrosyl radical on the protein surface. Because of electron delocalization, the radical may
stay on carbon center at the ortho- or para-position. Then, another nearby biotin-phenoxyl radical reacts
with the tyrosyl radical on the protein surface to form a covalent carbon-carbon bond. Subsequent
tautomerization yields the dityramine product.
2.2 Characterization of ascorbate peroxidase as a promiscuous labeling enzyme
Screening of biotin-phenol substrates
We measured the in vitro enzyme kinetics of ascorbate peroxidase toward aromatic
substrates. Guaiacol was used as a model aromatic substrate of peroxidase for determining
Michaelis-Menten kinetics. In this colorimetric assay, APX catalyzes the one-electron oxidation
of guaiacol into its phenoxyl radical, which subsequently polymerizes into tetraguaiacol, leading
to an increase in absorbance at 470 nm (8470 = 22 x 10' M~1 cm'1) (19). For comparison, we also
measured the kinetic parameters for HRP. Dr. Hyun-Woo Rhee performed these experiments and
summarized the results in Table 2-1.
Table 2-1. Michaelis-Menten kinetics of APX and HRP toward guaiacol
Enzyme kca, (s-) Km (mM) kca, /K, (M~ s')
wild-type APX 76.3 ± 8.0 6.9 ± 0.4 1.1 x 104
wild-type HRP 416 ±14 1.7 ±0.2 2.4 x 10'
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We therefore decided to test whether APX, in combination with a biotinylated phenol
substrate, could covalently tag cellular proteins in a spatially-resolved manner. The strong
interaction between biotin and streptavidin would allow for affinity capture of biotinylated
proteins under extremely harsh conditions. For example, stringent wash conditions (2M urea and
200 mM NaCl) can be applied to remove contaminants. Different substitution groups could fine-
tune the redox potential of the phenoxyl radical by changing the charge density of the aromatic
system. While electron-donating groups, such as hydroxy group and methoxy group, stabilize the
phenoxyl radical, electron-withdrawing groups, such as nitro group, destabilize it. Linker
structures between the biotin moiety and phenol affects both cell membrane permeability and
enzyme recognition.
We expressed APX in the cytosol of human embryonic kidney (HEK293T) cells, and
tested labeling with a panel of phenol derivatives conjugated to biotin (Figure 2-4). For
comparison, we also tested this panel of substrates with HRP targeted to the cell surface. The
simplest biotin conjugate (1) gave the strongest labeling of intracellular proteins following 1 min
reaction in the presence of 1 mM H2 0 2, as seen by streptavidin staining (Figure 2-4).
Interestingly, ortho-substituted phenols, whether it is nitro, hydroxy, or methoxy groups (2, 3,
and 4) all gave lower labeling yield. Putting a long linker between biotin and phenol (5) did not
affect reaction by HRP on the cell surface, but greatly diminished labeling with APX inside cells.
This is likely due to poor cellular membrane permeability of this substrate. Substitution groups
outside but adjacent to the aromatic ring also reduces labeling yield (6 and 7), presumably
because of steric clashes with residues in the active site. Aryl azide 8 was used in a previous
study with HRP and was believed to form a nitrene radical (20), but we were unable to reproduce
this labeling reaction. Based on its superior performance in labeling yield, we utilized biotin-
phenol probe 1 for all subsequent labeling experiments.
Figure 2-4. Reactivity of eight different biotin substrates towards APX and HRP.
This figure was generated by Dr. Hyun-Woo Rhee. Left: structures of biotin conjugates tested. These
differ in electronic properties, linker length, sterics, and charge. Right: immunostain of HEK293T cells
labeled with corresponding biotin-phenol conjugate. Cells expressed either cytosolic Flag-W41FAPX-NES
(left column) or cell surface HRP-myc-TM (right column). Confocal fluorescence images were overlaid
on top of DIC images. NES = nuclear export signal. TM = transmembrane domain of the PDGF receptor.
For APX, labeling was performed by incubating cells with 500 pM of the indicated biotin substrate for 30
min, then adding 1 mM H20 2 for I min to initiate biotinylation. For cell surface labeling with HRP, 100
ptM of the indicated substrate was added for 10 min, then 1 mM H20 2 was added for I min to initiate
labeling. Cells were then fixed, permeabilized, and stained. Scale bars, 10 tm.
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In vitro characterization of labeling product
We confirmed with mass spectrometry (MS) analysis that peroxidase-generated biotin-
phenoxyl radical forms a covalent adduct with tyrosine, but we were not able to detect reaction
products with any of the other nineteen amino acids (Figure 2-5). Statistics from protein structure
analysis shows that 80% of tyrosine residues are solvent-exposed (21). In the human proteome,
merely 2.1% proteins have no tyrosine residue. 3.3% proteins have 1 tyrosine residue, which has
80% chance of being surface-exposed. The remaining 94.6% proteins have 2 or more tyrosine
residues, which almost surely have at least one being surface-exposed. Based on this information,
we estimate that >90% of proteins have one or more surface-exposed tyrosine residues, so the
amino acid preference shown in phenoxyl radical labeling should not greatly limit our potential
depth of coverage.
In addition to testing with amino acids, we also labeled bovine serum albumin with
biotin-phenoxyl radical in vitro, and analyzed the reaction product by MS after tryptic digestion.
Four tryptic peptides with biotin-phenol labeling on tyrosine have been identified by MS.
BP-tyrosine conjugate tyrosine dimer BP-BP dimer
HRP MW 542.22 MW 360.13 MW 724.31
biotin-phenol (BP) + tyrosine H202  N N O
MW 363.16 MW 181.07 i rj - L + r A+
1 H
1,294 142 HN4,
1.200
l010a reaction product ,14,, M[BP] +1--o+gtv oto
1 D.e 72.7 (omIt HRP)
0.00*6 M[BP-tyrosine] +1 0.7 M[BP) + NaC: 0000
70e06 64.80 .
6.00. M[BP-BP] +1 40 2 3
4.14 a M[tyrosine dimerl +1 4 23
3.0046 7260 09
1 2301.8 441 7407
.0041. OL .14b- -k
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Figure 2-5. Amino acid specificity of labeling.
This figure was generated by Dr. Hyun-Woo Rhee. All 20 amino acids (each at 500 pM) were reacted in
vitro with 500 pM biotin-phenol, 10 nM HRP and 1 mM H20 2 for 10 min at room temperature. HRP was
used because it has the fastest in vitro kinetics. Apart from biotin-phenol dimer which was detected in all
reactions, only the tyrosine reaction gave product, with the masses and predicted structures shown above.
Product was not detected when HRP or H20 2 were omitted from the tyrosine reaction.
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Figure 2-6. Gel filtration chromatography was used to analyze the dimerization tendency of mutant
and wild-type soybean APX.
This figure was generated by Dr. Hyun-Woo Rhee and Jeffrey Martell. sbAPEX is triple mutant K14D,
W41 F, El 12K of soybean APX, and peaAPEX is from a previous study (9) The expected molecular
weight (MW) for monomer is 29 kDa. As expected (7), wild-type APX runs as a dimer at all protein
concentrations tested (250 nM-68 pM; apparent MW -58 kDa). sbAPEX runs as a monomer (apparent
MW -30 kD), even at a concentration of 270 ptM, while peaAPEX runs as a monomer at lower
concentrations but shows signs of dimerization at higher concentrations (as previously observed (9)).
Improving ascorbate peroxidase through mutagenesis
One problem with APX is that it is a homo-dimer (7). This limits its application as a
fusion tag to cellular proteins. In Jeffrey Martell's earlier work on using APX as an EM reporter
(9), ascorbate peroxidase from pea was engineered to be monomeric by introducing two
mutations (K14D and E112K) at the dimer interface. Examination of crystal structures of
recombinant ascorbate peroxidase from soybean and pea revealed that the dimer interfaces are
conserved (7). We therefore tested homologous mutations in both soybean APX and pea APX.
Gel filtration chromatography showed that the soybean APX mutant had even lower dimeric
association affinity (Figure 2-6).
However, the monomeric form suffers from low activity towards the biotin-phenol
substrate (data not shown). In the crystal structure, the active site contains a bulky tryptophan
residue (Trp4 1, in Figure 2-1). We reasoned that by mutating this tryptophan into another residue
with smaller side chain could help accommodate binding of biotin-phenol substrate. For this, we
mutated W41 into all other 19 amino acid residues and tested labeling by expressing the enzyme
in the cytosol. As shown in Figure 2-7, mutant W41F has the highest activity overall. An
aromatic residue at this position is favored probably because it facilitates aromatic substrate
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binding through n-t stacking interaction. For the same reason, W41 H also shows improved
activity, although not as good as W41F. Interestingly, mutation to another aromatic residue,
W41Y, fails to increase activity. Mutation to residues with small, hydrophobic side chains, such
as alanine, valine and cysteine also improves activity, which supports the hypothesis of opening
up the binding pocket. Among these, mutant W41V has especially high activity in some cells,
but we also observed a number of cells displaying decreased activity. This is probably due to
protein misfolding which compromises its activity.
Based on its reduced dimerization affinity and enhanced activity, we chose soybean APX
triple mutant (K14D, W41F, El 12K) for subsequent characterization and proteomic studies. For
simplicity, we name this triple mutant "APEX", for enhanced ascorbate peroxidase. We used
both biochemical and imaging methods to characterize the spatial specificity of APEX labeling.
monomeric APX (K14D, E112K) dimeric APX
anti-Filag
streptavidin-AF568
Figure 2-7 Engineering a monomeric peroxidase with high activity towards biotin-phenol.
This figure was generated by Dr. Hyun-Woo Rhee. Because previous studies have shown that mutations
at the W41 position boosted activity towards aromatic substrates (22), we tested all possible mutations at
W41 on a monomeric APX background. NES (nuclear export sequence)-targeted constructs were
expressed in HEK293T and labeling was performed live as in Figure 2-4. Peroxidase expression was
detected with anti-Flag staining, and biotinylated proteins were visualized with streptavidin-
AlexaFluor568 (AF568). Dimeric W 4 1FAPX-NES (used in Figure 2-4) is included for comparison.
Confocal images of anti-Flag, streptavidin, and DIC images are overlaid. Scale bars, 10 pm.
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Comparison between APX and promiscuous BirA labeling
As described in Chapter 1, promiscuous biotin ligase (pBirA) has also been used for
proteomic labeling (23), but it suffers from poor temporal and spatial resolutions. We verified
that the kinetics of promiscuous biotinylation with pBirA is much slower than APEX labeling,
requiring as much as 24 hours. Whereas 1 minute reaction with APEX gives strongly labeled
proteome, there is almost no product formation with pBirA in the same time window, as
measured by both fluorescence imaging (Figure 2-8) and Western blot analysis (Figure 2-9) of
biotinylated proteins. Even after 1-hour labeling with pBirA, the biotinylation level barely stands
out from endogenous biotinylated proteins (Figure 2-8). Labeling with pBirA became detectable
after 24 hours, and even so, we observed extremely low activity of pBirA targeted to the
endoplasmic reticulum lumen, suggesting that it is not a universally applicable enzyme (Figure
2-9).
APEX CpA at neutravidin-AF568
Mitotracker Deep Red + DIC neutravidin-AF568 (higher contrast)
mito-APEX
1 min labeling
mito-pBirA
10 min labeling
mito-pBirA
1 hr labeling
Figure 2-8. Biotinylation of mitochondrial proteins by mito-pBirA is undetectable after 10 min or 1
hour of labeling.
Confocal fluorescence images of immunostained HEK293T cells. For comparison, the top row shows I
min biotinylation by mito-APEX. For the bottom two rows, cells were transfected with mitochondria-
localized promiscuous BirA (mito-pBirA). 24 hours after transfection, 50 pM biotin was added to the
culture medium to permit promiscuous biotinylation. Mitotracker deep red staining was also used to
visualize mitochondria. The neutravidin channel is also shown at higher contrast. The staining seen in
rows 2 and 3 reflects endogenous biotinylated proteins (located in mitochondria) because the staining is
equivalent between transfected (V5-positive) and untransfected cells.
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Figure 2-9. Comparison of promiscuous biotinylation by APEX and pBirA with Western blot.
This figure was generated by Dr. Hyun-Woo Rhee. Labeling with APEX and promiscuous biotin ligase
(pBirA = RI 18G BirA) (23) was performed in live HEK293T cells in three different compartments (NLS
= nucleus-targeted with nuclear localization sequence; mito = mitochondrial matrix; KDEL =
endoplasmic reticulum-targeted via KDEL endoplasmic reticulum-retention sequence). APEX labeling is
performed for I min (1m) with 500 pM biotin-phenol and 1 mM H2 0 2 . pBirA labeling is performed for I
min (1 m) or 24 hours (24h) with 50 pM biotin, as previously described (23). Streptavidin blot analysis of
whole cell lysate is shown at right. The same samples are visualized by Ponceau stain at left.
2.3 Assessing the spatial specificity of APEX labeling
Evaluating APEX labeling by microscopy and Western blot analysis
To assess the spatial specificity of APEX-mediated biotinylation, we targeted APEX to
various organelles and compartments (nucleus, cytosol, mitochondrial matrix, endoplasmic
reticulum lumen, and cell surface) in human embryonic kidney (HEK293T) cells via genetic
fusion to targeting peptides, and imaged the resulting pattern of biotinylated targets with
streptavidin stain (Figure 2-10, panel A). In all of these compartments, the streptavidin stain
overlaps tightly with peroxidase localization. In the case of mitochondrial matrix and
endoplasmic reticulum lumen, we examined the localizations of enzyme and biotinylated targets
in COS-7 cells, because these organelles are more clearly discernible in these cells (Figure 2-10,
panel B). Immunostain shows complete overlap between the enzyme, biotinylated proteins and
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the organelle markers. The resolution of this analysis is limited by light diffraction, which is
about 230 nm in confocal microscopy.
A
streptavidin-
AF568
APEX HRP
+DIC
APFX-NI S APFX-NFS mito-APFX APEX-KDEL APEX-TM HRP-KDEL
APEX (anti-V5) APEX (anti-V5) neutravidin-AF568neutravidin-AF568 mito-GFP mito-GFP mito-GFP
HRP (anti-V5) neutravidin-AF568HRP (anti-V5) neutravidin-AF568 ER-GFP ER-GFP ER-GFP
Figure 2-10. Confocal microscopy analysis of APEX and HRP-catalyzed promiscuous biotinylation
in many cellular compartments.
A) HEK293T cells were transfected with APEX or HRP constructs targeted to various compartments. B)
COS-7 cells were transfected with APEX or HRP constructs and organelle markers (ER-GFP utilized the
N-terminal 29 amino acid residues of cytochrome P450 (24)). Labeling was performed with biotin-phenol
and H20 2 for 1 min. Cells were then fixed and stained with streptavidin-AlexaFluor568 (AF568) to
visualize biotinylated proteins, and antibody to visualize Flag, V5, or myc tags on the APEX/HRP
enzymes. NLS nuclear localization signal; NES = nuclear export signal; mito = mitochondrial matrix
signal; KDEL endoplasmic reticulum retention motif; TM = transmembrane helix of PDGF receptor.
Scale bars, 10 pim.
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We assessed the spatial specificity of biotin-phenol labeling at even higher resolution.
Electron microscopy is potentially useful and has been used in previous studies of similar
problems (11,12). However, sample preparation requires using gold nanoparticles, which tend to
generate non-specific background. We decided to use two-color super-resolution light
microscopy for comparing the localizations of enzyme and biotinylated targets at high resolution.
In recent years, many fluorescence-based imaging techniques have been developed to break the
diffraction limit barrier of -200 nm. These super-resolution microscopy techniques have been
widely used for visualization of detailed cellular structures, such as the cytoskeleton. Among
these, stochastic optical reconstruction microscopy, or STORM (25), has produced the best
spatial resolution. STORM relies on the sequential imaging and localization of individual small
organic fluorophores that can be photo-switched between bright and dark states.
In this analysis, we target APEX into the mitochondrial matrix of COS-7 cells and
performed promiscuous labeling with biotin-phenol as previously described. To compare the
localizations of biotinylated targets and the enzyme under super-resolution, we immunostained
the cells with streptavidin-Cy3/Cy5 and antibody conjugated with AlexaFluor405/AlexaFluor647
against APEX, respectively. Two-color STORM image in Figure 2-11 showed that the patterns
of biotinylated proteins and overlapped tightly with that of APEX in the mitochondrial matrix.
The lateral resolution of STORM image on our setup was measured to be 22 nm.
streptavidin mito-APEX
(Cy3/Cy5) (anti-V5) merge
Figure 2-11. STORM imaging analysis of APEX promiscuous labeling in mitochondria.
Biotinylated targets were labeled with streptavidin-dye conjugate, and mito-APEX, with V5 epitope tag,
was labeled with anti-V5 antibody. We estimated the degree of cross-talk between channels by two-color
imaging of fixed cell samples prepared as described above. We estimate that the maximum crosstalk of
streptavidin into the anti-V5 channel is 5% (AlexaFluor405/AlexaFluor647 is activated by the 561 nm
laser by 5% relative to activation by the 405 nm laser). The maximum crosstalk for anti-V5 into the
streptavidin channel is 14% (Cy3/Cy5 is activated by the 405 nm laser by 14% relative to activation by
the 561 nm laser).
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In addition to imaging analysis, we collected these labeled cells and analyzed the whole
cell lysate using Western blot, in which streptavidin-HRP specifically detects biotinylated
proteins. Figure 2-12 shows that APEX yields different patterns, or "fingerprints", of
biotinylated endogenous proteins in these compartments.
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
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Figure 2-12. Western blot analysis of APEX and HRP-catalyzed promiscuous biotinylation in
various cellular compartments.
This figure was generated by Dr. Hyun-Woo Rhee. HEK293T cells were transfected and labeled with
biotin-phenol and H20 2 , and then lysed. Whole cell lysates were analyzed by 10% SDS-PAGE, with
Ponceau staining (left) or streptavidin-HRP visualization of biotinylated proteins (right). Arrowheads
point to endogenously biotinylated proteins (26).
APEX labeling does not cross cellular membranes
So far, our imaging results suggest that the reactive species generated by APEX does not
cross a variety of cellular membranes, but the resolution at best is still limited to -22 nm. We
therefore developed a cell surface labeling assay to more rigorously demonstrate that APEX-
catalyzed tagging does not cross the plasma membrane (Figure 2-13). In this assay, HEK293T
cells were transfected with W41AAPX targeted to the cytosol (via the NES targeting sequence) or
the inner leaflet of the plasma membrane (via the CAAX targeting sequence). Labeling was
performed with alkyne-phenol and H20 2 for I min. Thereafter click chemistry was performed at
the cell surface with a membrane-impermeant AlexaFluor647-picolyl azide (27) conjugate. Only
if the phenoxyl radical can cross the plasma membrane will alkyne be present at the cell surface
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and detectable by the AlexaFluor647 reagent. Dimeric w41AAPX was used in this experiment
because it has higher activity in the mammalian cytosol than monomeric APEX.
As a control, cells were fixed and permeabilized prior to click chemistry to detect the
total pool of alkyne-phenol labeling. Quantitation shows that the signal at the surface represents
less than 2% of the total signal. The same results were obtained when we used biotin-phenol
instead of alkyne-phenol and detected labeling at the cell surface with a membrane-impermeant
streptavidin-AlexaFluor568 conjugate.
A
extracellular
alkyne-phenol
cytosol H2021 min
OR
P No signal
Click chemistry with
membrane-impermeant
AF647-picolyl azide AF647 AF647t
B
AF647
W41AAPX-CAAX W41AAPX-NES
nuclear YFP AF647 nuclear YFP
surface
total
Figure 2-13. Peroxidase-generated phenoxyl radicals do not cross the plasma membrane.
(A) Assay scheme. APX is targeted to the inner leaflet of the plasma membrane. Alkyne-phenol is used
here and the labeling is subsequently detected with AlexaFluor647 (AF647)-picolyl azide using click
chemistry. (B) Images with W4 ^A APX-CAAX (left) and W4 1AAPX-NES (right). Nuclear-localized YFP was
a transfection marker. Bottom rows (labeled "total") show detection of the entire alkyne-phenol labeling
in fixed and permeabilized cells. Insets show the same fields of view with 50-fold greater contrast.
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Preserving spatial specificity by immediate quenching of labeling reaction
When developing the labeling protocol, we found that APEX is a particularly stable
enzyme, and is not easily inactivated in the presence of 4% formaldehyde during cell fixation.
This poses the risk of decreasing the spatial resolution from residual APEX activity after cell
fixation or cell lysis. To solve this problem, we added a quencher cocktail of Trolox (5 mM, a
free radical quencher), ascorbate (10 mM, a free radical quencher) and sodium azide (10 mM, a
peroxidase inhibitor) to eliminate residual activity. We showed by imaging that brief treatment of
HEK293T cells with this quencher cocktail could reduce subsequent biotin-phenol labeling by
over 90% (Figure 2-14). By Western blot analysis, we also showed that this treatment indeed
eliminated labeling of OMM proteins with a matrix-targeted enzyme.
No quencher
SA-647
Anti-Flag
(enzyme)
overlaid
with DIC
120
100
% 80
60
40
20
0
NaN 3 Trolox + ascorbate
NaN 3 + Trolox
+ ascorbate
I
No quencher NaN3 Trolox +
ascorbate
All quenchers
Figure 2-14. Quencher cocktail effectively reduces biotin-phenol labeling intensity.
Top: HEK293T cells express mitochondrial matrix-targeted wvAPX were treated with various quenchers
for I min followed by biotin-phenol labeling. Cells were then fixed and stained with streptavidin-
AlexaFluor647 (SA-647) to visualize biotinylated proteins, and antibody to visualize Flag tag on the
enzyme. Bottom: quantitation of streptavidin-AlexaFluor647 fluorescence signal.
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2.4 Controlling labeling radius
While the high spatial specificity of APEX labeling in membrane-bounded compartments
are useful for studying organellar proteomics, a further challenge lies in carefully defining, and
possibly controlling, the radius of peroxidase-catalyzed labeling when it is not membrane-
enclosed. A powerful application of labeling radius control would be the proteomic mapping of
macromolecular complexes. The labeling radius of APEX is determined by the diffusion of the
product radical and its life time, which in turn is determined by the dynamic equilibrium between
radical generation and radical quenching.
H20 2  neutravidin-AF647 APEX (anti-V5) merge
(pM)
0
40
200
1000
Figure 2-15. Titration of H2 0 2 does not affect labeling radius.
HRP was targeted to mitochondria in fixed HeLa cells via anti-Tom20 antibody. 100 ptM biotin-phenol
and various concentration of H202 were added to cells for 1 min. Thereafter, cells were washed, stained,
and imaged. Fluorescence images are shown with enzyme marked in yellow and biotin signal in pink.
Zoom-in views at concentrations 40 pM and 200 pM H2 0 2 show comparison of the extent of signal
diffusion from the enzyme source at different H2 0 2 concentrations (biotin signal is not normalized).
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Kigher c-ontras!
An imaging readout following live cell labeling can be misleading because biotinylated
proteins can themselves diffuse during the 1 min labeling window. Moreover, it is difficult to
control various factors affecting the labeling radius in an in vivo experiment. Instead, we chose to
perform promiscuous labeling on fixed cells and then use fluorescence imaging to measure the
radius of labeling, where a larger radius corresponds to wider distribution of biotin signal relative
to the enzyme localization. Note that, in this experiment, we chose HRP as the promiscuous
labeling enzyme instead of APEX for the following reasons: 1) Both enzymes generate the same
biotin-phenoxyl radical, so conclusions of radical diffusion and lifetime drawn from studying
HRP can be extended to APEX labeling; 2) HRP is more active than APEX, thereby giving
stronger labeling signal that is more readily detectable; and 3) various HRP-antibody conjugates
are readily available, allowing highly specific targeting of HRP enzyme to subcellular structures
on fixed cells.
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Figure 2-16. Biotin-phenol probe titration does not affect labeling radius.
HRP was targeted to mitochondria in fixed HeLa cells via anti-Tom20 antibody. 1 mM H202 and various
concentrations of biotin-phenol were added to cells for I min. Thereafter, cells were washed, stained, and
imaged. Left: fluorescence images, with enzyme shown in yellow and biotin signal shown in pink. Right:
cross-section analysis of intensity distribution of two channels. Horizontal axis is the coordinate in unit of
pixels along the line drawn in images on the left, and vertical axis is the normalized fluorescence intensity.
Red line, showing wider spread, represents fluorescence cross-section distribution of the biotin signal, and
the green line represents the enzyme signal. Each pixel is 160 nm in size.
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Using fluorescence microscopy, we investigated the effect of the following factors on the
radius of biotin-phenol labeling by HRP enzyme: H20 2 and biotin-phenol concentrations, and
radical quenchers. We started by testing whether lower substrate concentration could result in
smaller radius of labeling. HRP enzyme was targeted to fixed and permeabilized HeLa cells via
using an anti-Tom20 antibody. Labeling was performed with varying concentrations of biotin-
phenol and H20 2 for 1 min. At lower concentrations of H2 0 2, the labeling intensity significantly
decreased. However, we found that the labeling radius did not change significantly by titrating
H20 2 (Figure 2-15). Titration of biotin-phenol also showed decreased signal intensity at lower
probe concentration, but the labeling radius remained the same (Figure 2-16).
Phenoxyl radicals are known to be quenched by a variety of small molecule reducing
agents, such as Trolox (vitamin E analog), ascorbate (vitamin C), thiols and gallate. These
quenchers readily donate a hydrogen atom to the phenoxyl radical, reducing it to phenol. The
resulting quencher radical is lower in energy and thus incapable of regenerating phenoxyl
radicals. Varying the amount of quencher would allow us to tune the radical lifetime, thereby
controlling its labeling radius. We tested various substituted phenols and thiols for their ability to
reduce the APEX labeling radius (Figure 2-17). Gallate emerged as a potent quencher of biotin-
phenol labeling reaction and it significantly reduced the labeling radius at sub-stoichiometric
concentration (5 pM gallate with 100 ptM biotin-phenol). Mercaptoethanol and cysteamine
(mercaptoethylamine) also reduced the labeling intensity and radius when they are present at
high concentrations (100 pM). Trolox (10 pM) and ascorbate (20 pM) were potentially useful
for reducing the labeling radius, but at this concentration they almost completely abolished the
labeling signal. Titration is required in future studies to find the optimal concentration for these
two quenchers. The other two phenol structures (4-iodophenol and vanillin) failed to reduce the
labeling radius.
In the future, our next goal is to apply these quenchers to fine-tune the labeling radius of
biotin-phenol in live cells. This is potentially useful for mapping the component and structure of
macromolecular protein complexes. We also noted that the intracellular concentration of thiols
typically far exceeds the thiol quencher concentration (100 pM) tested in the above analysis. For
example, glutathione is present in millimolar concentrations. Therefore, even without additional
quenchers, the biotin-phenol labeling with APEX in live cells may have already had limited
radius due to the quenching effect by those endogenous thiol molecules.
61
nAv-647 nAv-647(not normalized)
OH
0
mj -", 
H
HOH
OCH 3
OH
Gallate Ho
(5 u M ) O 0
Mercaptoethanol
(100 uM) OH
Cysteamine H 2N
(100 uM)
CH3
0
Trolox H3 -o
(10 uM) H ,H
+ HOH
Ascorbate HO
(20 uM)
anti-tom20
62
No quencher
anti-tom20 merge
lodophenol
(10 uM)
Vanillin
(10 uM)
Figure 2-17. Addition of free radical quencher reduces the labeling radius.
HRP was targeted to mitochondria in fixed HeLa cells via anti-Tom20 antibody. 100 pM biotin-phenol, I
mM H202 and various quenchers (structures and concentrations shown on the left, with the reactive
hydrogen atom shaded in light blue) were added together to cells for I min. Thereafter, cells were washed,
stained, and imaged. Biotin signal was detected with neutravidin-AlexaFluor647 (nAv-647), and enzyme
signal was detected with anti-Tom20 immunofluorescence. Fluorescence images were shown next to the
quencher structures. In the case of Trolox + ascorbate, the biotin signal was too low, so 10-times longer
exposure was used in the nAv-647 channel. The bottom row, "anti-tom20", is the immunostain of enzyme
with antibody-AlexaFluor647 conjugate, which serves as a reference for comparison with the same
imaging wavelength.
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2.5 Conclusion
In summary, we have implemented proximity-dependent promiscuous protein labeling
using ascorbate peroxidase and a biotin-phenol substrate. In this approach, the enzyme acts as a
point source that constantly generates biotin-phenoxyl radicals which diffuses away to attack
proteins nearby. Through rational design and screening, we have identified an enzyme-substrate
pair that gives the highest activity of labeling. Using confocal and super-resolution microscopy,
as well as a membrane-permeability assay, we demonstrated that the promiscuous labeling is
restricted to membrane-bounded compartments. We further tested the effect of radical quenchers
on biotin-phenol labeling and indeed found that they helped reduce the labeling radius on fixed
cells. In addition to co-applying radical scavengers such as gallate and thiols to cells, it should
also be possible to modulate the labeling radius using electron withdrawing substituents on the
aromatic ring. A future direction would be to screen biotin-phenoxyl radicals with small labeling
radius and high reactivity, while at the same time identify enzymes with improved activity
toward these substrates through protein engineering.
The next chapter describes the application of this promiscuous protein labeling technique
to the study of mitochondrial matrix and endoplasmic lumen proteomes.
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2.6 Experimental methods
Genetic constructs
Table 2-2 summarizes the plasmids used for peroxidase expression in mammalian cells.
Table 2-2. Genetic constructs
Construct name Features
Flag-APEX-NES Flag: DYKDDDDK
NES: LQLPPLERLTLD
Flag- W4FAPX-NES
Flag-APEX-NLS NLS: PKKKRKVDPKKKRKVDPKKKRKV
Flag-W4 1AAPX-CAAX CAAX: RSKLNPPDESGPGCMSCKCVLS
ss-HA-APEX- myc-TM ss: Ig-K chain signal sequence in pDisplay
HA: YPYDVPDYA
myc: EQKLISEEDL
TM: transmembrane domain of PDGF receptor
ss-HA- HRP- myc-TM
ss-APEX-V5-KDEL KDEL: endoplasmic reticulum retention motif
V5: GKPIPNPLLGLDST
ss-HRP-V5-KDEL
mito-V5-APEX mito matrix targeting sequence:
MLATRVFSLVGKRAISTSVCVRAH
LACTB( i-68 -V5-APEX LACTB-s68) leader sequence:
MYRLLSSVTARAAATAGPAWDGGRRGAHRRPGLPV
LGLGWAGGLGLGLGLALGAKLVVGLRGAVPIQS
(reference (28))
PPOX- V5-APEX PPOX GenBank ID NM_000309.3
CPOX- APEX-Flag CPOX GenBank ID NM_000097.5
CPOX(1-120>-V5-APEX-CPOX121-453) CPOX(I-120) is the mitochondrial targeting signal sequence
of CPOX (29)
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For bacterial expression, His6-APEX and His6-wtAPX were cloned into pTRC99 vector,
under the control of lacO operator. In general, genetic constructs were prepared by directional
ligation into restriction enzyme-cut vectors, overlap-extension PCR, and QuikChange
mutagenesis. wtAPX = wild-type soybean ascorbate peroxidase (GenBank ID NM_001250856),
a gift from Emma Raven (University of Leicester). APEX = wtAPX with three mutations (K14D,
W41F, El 12K). The HRP (horse radish peroxidase) gene was a gift from Frances Arnold
(Caltech). Human CPOX and PPOX genes were obtained from the Broad Institute. The LACTB
gene was from Timothy A. Brown and David A. Clayton (HHMI Janelia Farm Research
Campus). Sub-cellular targeting sequences for the mitochondrial matrix (9), nucleus (30), cytosol
(31), and plasma membrane (32) are based on previous literature. Note that HA tags are not used
for immunofluorescence or Western blot detection in this work, because they are tyrosine-rich
and hence damaged by the peroxidase/biotin-phenol reaction.
Reagents
Biotin conjugate 5 (biotin-XX-tyramide) was purchased from Invitrogen. Biotin
conjugate 8 (EZ-link photo-activatable biotin) was purchased from Pierce. The other biotin
conjugates were synthesized by Dr. Hyun-Woo Rhee according to this general scheme:
x 0Q)NHH 0 00O
HO HN \XOH NH H0
H HN X
HATU. DIPEA H \,s
DMSO
All products were purified by HPLC and characterized by Q-TRAP MS instrument
(Applied Biosystems). Biotin-phenol conjugate 1 was characterized by IH-NMR.
Horseradish peroxidase (HRP) was purchased from Sigma. APEX and wtAPX were expressed in
BL2 1 -DE3 E. coli and purified as previously described (9).
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In vitro enzyme kinetics
This assay (9) measures the formation of tetraguaiacol by absorbance at 470 nm, after
one-electron oxidation of guaiacol into its phenoxyl radical. 20 nM of each enzyme was used,
and guaiacol concentration ranged from 0.25-30 mM. For APEX and APX, 90 ptM H20 2 was
used to exceed its Km, of 20 ptM (33). For HRP, 10 mM H20 2 was used to exceed its Km of 1.53
mM (34). To achieve high reproducibility, we found it was important to pre-mix H2 0 2 and
guaiacol, establish a baseline, and then add enzyme to initiate the reaction. Absorbance at 470
nm was measured for I min at 4 second intervals.
Mass spectrometry analysis of in vitro labeling
Reactions were assembled as follows: 500 ptM amino acid (all 20 were purchased from
Sigma), 500 ptM biotin-phenol, 1 mM H20 2, and 10 nM HRP in PBS pH 7.4. HRP was added
last to initiate the reaction. After 10 minutes at room temperature, reactions were quenched by
addition of sodium azide (final concentration = 1 mM). Product mixtures were analyzed by LC-
MS. The LC was a Shimadzu UFLC-XR equipped with a 4.6 x 50 mm C18 column running a
gradient of 5% to 95% acetonitrile in 0.1% trifluoroacetic acid/water. The MS was an Applied
Biosystems Q-TRAP.
Immunostaining and con focal fluorescence imaging
HEK293T cells were transfected and labeled with biotin-phenol as described below for
proteomics. After labeling, cells were washed with a quencher cocktail (10 mM sodium
ascorbate, 10 mM sodium azide, 5 mM Trolox) in DPBS (Dulbecco's Phosphate Buffered Saline)
three times before fixation in 4% formaldehyde in PBS at room temperature for 15 min.
Thereafter, cells were washed three times with PBS, and permeabilized with pre-chilled
methanol at -20 'C for 5 min. Cells were blocked overnight with 1% casein in PBS ("blocking
buffer") at 4 'C. For immunostaining, blocked cells were incubated with primary antibody
(mouse anti-Flag (Sigma) at 1:300 dilution, mouse anti-V5 (Invitrogen) at 1:2000 dilution, or
mouse anti-myc (Millipore) at 1:1000 dilution) in blocking buffer for 1 hr at room temperature.
Samples were washed 4x 5 min with PBS at room temperature, then incubated with secondary
antibody (goat anti-mouse AlexaFluor488 conjugate (Invitrogen) at 1:1000 dilution) and
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neutravidin- AlexaFluor647 or streptavidin- AlexaFluor568 (50 nM) in blocking buffer for 1 hr
at room temperature. The neutravidin/streptavidin conjugates were prepared by coupling
neutravidin (Invitrogen) or homemade streptavidin protein with AlexaFluor647-NHS or
AlexaFluor568-NHS esters (Invitrogen) following the manufacturer's instructions. Labeled cells
were washed 4x 5 min with PBS before imaging.
Fixed cells were imaged in DPBS at room temperature. Confocal fluorescence images
were acquired on a Zeiss AxioObserver.Zl microscope with a 63x oil-immersion objective,
equipped with a Yokogawa spinning disk confocal head containing a Quad-band notch dichroic
mirror (405/488/568/647 nm). YFP/ AlexaFluor488 (491 nm laser excitation, 528/38 emission
filter), AlexaFluor568 (561 nm laser excitation, 617/73 emission filter), AlexaFluor647 (640 nm
laser excitation, 700/75 emission filter), and DIC images were collected using Slidebook
software (Intelligent Imaging Innovations). Images were acquired for 20 to 500 milliseconds and
recorded on a Cascade 11:512 camera. Fluorescence images in each experiment were normalized
to the same intensity range.
STORM super-resolution fluorescence imaging
U2OS cells were plated on Lab-TekTM II Chambered Coverglass (Thermo Scientific) pre-
coated with human fibronectin. At 60-70% confluence, cells were transfected with mito-APEX
(0.2 tg plasmid DNA per well) using Lipofectamine 2000 (0.5 pLL per well). 4 hours after
transfection, the media was replaced. 24 hrs later, cells were labeled with biotin-phenol as
described below for proteomics. After 1 minute of labeling, samples were immediately quenched
by aspirating off the probe/H 20 2 solution and replacing with a quencher solution (10 mM sodium
azide, 10 mM sodium ascorbate, and 5 mM Trolox in DPBS) for 1 min at room temperature.
Thereafter, cells were washed three times with PBS, fixed with 3.7% formaldehyde at room
temperature for 20 min, and permeabilized with pre-chilled methanol at -20 'C for 5 min. Finally,
cells were blocked overnight with blocking buffer (1% casein in PBS) at 4 'C.
Samples were then stained with mouse anti-V5 antibody (Invitrogen) at 1:2000 dilution
in blocking buffer for 1 hour at room temperature, then washed 4x 5 min with PBS, before
incubating with a mixture of donkey anti-mouse AlexaFluor405/AlexaFluor647 conjugate
(1:2000 dilution) and streptavidin-Cy3/Cy5 conjugate in blocking buffer for 5 min at room
temperature. The antibody conjugate was prepared by amide-coupling donkey anti-mouse
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antibody (Jackson Immunoresearch) with AlexaFluor405-NHS and AlexaFluor647-NHS esters
(Invitrogen). The streptavidin conjugate was prepared by coupling homemade streptavidin
protein with Cy3-NHS and Cy5-NHS esters (Invitrogen). Labeled cells were washed 4x 5 min
with PBS.
For STORM imaging, fixed cells were transferred to STORM imaging buffer (10%
glucose (w/v), 50 mM Tris pH 8.2, 10 mM NaCl, 0.56 mg/mL glucose oxidase, 0.8 mg/mL
catalase, and either 1% p-mercaptoethanol (v/v) or 7.7 mg/mL cysteamine). STORM images
were acquired on a home-built setup constructed on an Olympus IX-81 stand. A polychroic
mirror (DiOl-R405/488/561/635, Semrock) was used to reflect lasers onto the sample. 405 nm
and 561 nm laser lines (0.1 - 10 mW) were used alternately to activate fluorophore pairs, and a
642 nm laser line (140 mW) was used to image AlexaFluor647 and Cy5. Fluorescence emissions
from AlexaFluor647 filtered with a dual-pass filter (FFOI-577/690, Semrock). Samples were
illuminated by lasers in the pseudo-TIRF mode, and images were collected on an EMCCD
camera (Evolve, Photometrics). Super-resolution images were typically reconstructed from more
than 10,000 frames of localizations for each channel. Data were analyzed using Insight3 software
from Prof. Xiaowei Zhuang (Harvard University). The lateral resolution is determined by
measuring straying dye single molecules that non-specifically adsorbs on the glass substrate
(Figure 2-18).
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Figure 2-18. Determine the resolution of STORM setup.
Left: overlay of single-molecule clusters by their center of mass. Right: modeling with Gaussian in x and
y dimensions.
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Streptavidin blotting of whole cell lysate
HEK293T cells were transfected, labeled, and lysed as described below for proteomics.
Lysates were separated on 10% SDS-PAGE gels, and then transferred to nitrocellulose
membranes. Total protein was visualized by Ponceau S staining (10 minutes in 0.1% (w/v)
Ponceau S in 5% acetic acid/water). Thereafter membranes were washed extensively to remove
the Ponceau stain, and blocking was performed with 3% (w/v) BSA in PBS with 0.1% (v/v)
Tween-20 ("blocking buffer") at 4 'C overnight. To detect biotinylated proteins, membranes
were immersed in a solution of 0.3 mg/mL streptavidin-HRP (Thermo Scientific) at room
temperature for 60 min before rinsing with blocking buffer 4x 5 min. Blots were developed with
the SuperSignal West Pico reagent (Thermo Scientific), and imaged using an Alpha Innotech
digital camera.
Imaging assay to determine the membrane-permeability of the phenoxyl radical
HEK293T cells were transfected with W4 1AAPX targeted to either the cytosol (NES) or
inner leaflet of the plasma membrane (CAAX). 24 hrs after transfection, cells were incubated
with alkyne-phenol and 1 mM H20 2 for 1 min at room temperature. After washing cells three
times with DPBS, click chemistry was performed on the cell surface by incubating with
membrane-impermeant AlexaFluor647-picolyl azide conjugate (10 ptM) and a pre-formed
mixture of CuSO4 (200 pM), THPTA (1 mM) and sodium ascorbate (2.5 mM) for 10 min at
room temperature (27). Cells were quickly washed with DPBS three times and immediately
imaged live by confocal microscopy as described above.
For comparison, click chemistry was performed also on fixed and permeabilized cells, in
order to visualize the total population of alkyne-phenol-labeled molecules. For this labeling, cells
were first blocked after fixation using 1% bovine serum albumin + 1% casein in PBS for 30 min
at room temperature. Then cells were treated with AlexaFluor647-picolyl azide conjugate (2.5
pM) and a pre-formed mixture of CuSO 4 (1 mM), TBTA (100 pM) and sodium ascorbate (2.5
mM) in the same blocking buffer for 1 hour at room temperature.
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Proteomic labeling with promiscuous BirA
The promiscuous BirA (pBirA) gene was obtained through site-directed mutagenesis of
wild-type E. coli BirA to introduce the R 118G mutation (23,35). HEK293T cells were
transfected with pBirA or APEX plasmids using Lipofectamine 2000 (Invitrogen). After 4 hours
transfection, labeling was initiated by addition of 50 ptM biotin to the culture medium for 24
hours. Alternatively, 28 hours after transfection, 50 ptM biotin was added for I min. Labeling
was terminated by cell lysis in SDS-PAGE loading buffer.
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Chapter 3 Spatially-resolved organellar proteomic mapping
Work described in this chapter has not yet been published. Most experiments described were
performed in collaboration with Dr. Hyun-Woo Rhee. Dr. Namrata Udeshi and Dr. Steven Carr
from Broad Institute performed mass spectrometry proteomics experiments. Prof. Vamsi Mootha
provided valuable advice on proteomic data analysis. Jeffrey Martell and Dr. Eliza Vasile
performed electron microscopy analysis.
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3.1 Introduction
Having established that APEX catalyzes covalent biotinylation of endogenous proteins in
living cells using biotin-phenol as a substrate, we used it to map the proteome of the
mitochondrial matrix and endoplasmic reticulum lumen.
The mitochondrion is the power house of the cell, producing more than 90% of cellular
ATP in the heart (1). It is also well established that cell apoptosis is initiated by protein release
from the inter-membrane space of the mitochondria into the cytosol (2). As discussed in Chapter
1, all previous proteomic studies of mitochondria have used density centrifugation as a first step
to purify intact mitochondria, which is a procedure known to disrupt mitochondrial structure and
function (3). For this reason, the specificity of MitoCarta, the most comprehensive inventory of
mitochondrial proteins (4), was improved by integrating proteomic data with literature curation,
fluorescence imaging data, mitochondrial targeting sequence prediction, transcriptional analysis,
and phylogenetic profiling. In contrast, high-quality inventories of sub-mitochondrial
compartments are not currently available.
The endoplasmic reticulum is another important organelle in the cell. It serves as the
entry point of secretory pathway, both for secreted proteins (such as hormones and extracellular
matrix proteins) and for plasma membrane proteins (such as receptors, ion channels and
transporters). It is also involved in the synthesis of lipids and cholesterol (5). The endoplasmic
reticulum quality control and endoplasmic reticulum-associated degradation are all important
biological processes that have gained increasing attention over the past decades (6).
3.2 Proteomic mapping of the mitochondrial matrix
Promiscuous protein labeling with APEX in mitochondrial matrix
We wished to test whether our peroxidase-mediated live cell labeling method could yield
a more accurate and complete catalog of mitochondrial matrix proteins. As outlined in Figure 3-1,
APEX is transiently expressed in HEK293T cells and is genetically targeted to the mitochondrial
matrix by fusing to the targeting sequence of cytochrome c oxidase subunit 4 (7).
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Figure 3-1. Scheme of promiscuous labeling in mitochondrial matrix.
The APEX peroxidase is genetically targeted to the mitochondrial matrix (or other cellular compartment
of interest), via fusion to a 24-amino acid mitochondrial targeting peptide. Labeling is initiated by
addition of biotin-phenol and H20 2 to live cells for I min. Cells are then lysed, and biotinylated proteins
are recovered with streptavidin-coated beads, eluted, separated on a gel, and identified by mass
spectrometry. The peroxidase-generated phenoxyl radical is short-lived and membrane-impermeant and
hence covalently tags only neighboring and not distant endogenous proteins.
We confirmed the mitochondrial localization of APEX by electron microscopy because
conventional light microscopy cannot resolve sub-mitochondrial spaces. We took advantage that
APEX can also act as an EM reporter and performed DAB staining. We confirmed with EM-
resolution that APEX is correctly localized to the mitochondrial matrix (Figure 3-2).
Zoom out Zoom in Zoom in
Figure 3-2. Electron microscopy (EM) showing the localization of mito-APEX in the mitochondrial
matrix of HEK293T cells.
Contrast (dark regions) was generated by APEX-catalyzed diaminobenzidine polymerization, followed by
OS04 staining. Zoom out view shows specific staining of mitochondria in transfected cells. Zoom in
views highlight staining in the mitochondrial matrix.
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Figure 3-3. Labeling the mitochondrial matrix proteome with biotin-phenol.
Top: confocal fluorescence imaging of biotinylated proteins. Mitochondrial matrix-targeted APEX in
HEK293T is visualized by anti-V5 (AlexaFluor488) staining. Proteins biotinylated by APEX (500 tM
biotin-phenol and 1 mM H2 0 2 , 1 minute) are stained with neutravidin (AlexaFluor647). Only transfected
cells (green) displayed biotin signal (red) in the mitochondria. Negative control omitting either reagent
(biotin-phenol or H20 2) abolished labeling. Bottom: gel analysis of biotinylated mitochondrial matrix
proteins, before and after streptavidin bead-enrichment. Substrates are biotin-phenol and H2 0 2. Consistent
with imaging results shown above, labeling occurred only when both enzyme and substrates were present.
Ponceau stain showed equal amount of loading of cell lysate into each lane. Coomassie stain showed that
proteins enriched from streptavidin-coated beads had a different pattern on the gel, as compared to total
cell lysate. Mammalian cells have four endogenously biotinylated proteins (8), which are seen in the
negative control lanes of the streptavidin blot.
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Next we characterized mitochondrial matrix-targeted APEX labeling with biotin-phenol
in living HEK293T cells by fluorescence imaging. Promiscuous labeling was achieved by
addition of biotin-phenol and H20 2. Negative controls in Figure 3-3 show that labeling was not
detected when either biotin-phenol or H20 2 was omitted. Untransfected cells in the same field of
view also did not show streptavidin staining, indicating that endogenous mammalian peroxidases
do not activate biotin-phenol to a significant degree. After labeling HEK293T cells for I min
with APEX, biotin-phenol, and H20 2, streptavidin blotting detects numerous biotinylated
proteins in the cell lysate (Figure 3-3). Negative controls omitting either the enzyme or the
substrate gave no enriched proteins (2 and 3rd lanes to the right in Figure 3-3, bottom).
Comparison of Coomassie stain of streptavidin bead-enriched samples and whole cell lysate (4 th
and 5th to the right in Figure 3-3, bottom) shows different protein bands, indicating that a subset
of proteins are selectively enriched.
Determine mitochondrial matrix proteome
We proceeded to purify labeled proteins using streptavidin-coated magnetic beads.
Although these beads bind fairly specifically to biotinylated molecules, they nevertheless have
the capacity to adsorb unlabeled proteins through hydrophobic interactions. This creates a
protein background which can easily flood sensitive MS readouts. In order to facilitate
subtraction of this background due to non-specific binding to streptavidin beads, we established
"heavy" and "light" isotope-labeled HEK293T cell cultures using the SILAC approach (stable
isotope labeling by amino acids in cell culture (9)), as described in Chapter 1.
The SILAC labeling scheme is outlined in Figure 3-4. Two replicate heavy SILAC
cultures were labeled by pre-loading biotin-phenol for 30 min, then adding 1 mM H202 to initiate
biotinylation. After 1 minute, cells were lysed using a mixture containing radical quenchers
(Trolox and ascorbate) and a peroxidase inhibitor (sodium azide) to halt biotinylation. Two light
SILAC cultures were processed in parallel as negative controls. These light cultures were treated
identically to the heavy cultures, except that in the first light sample, APEX was omitted, and in
the second light sample, biotin-phenol and H20 2 were omitted. In this way, the first replicate
subtracts background from any endogenous peroxidase activity, while the second replicate
normalizes the effect of APEX expression on the endogenous protein expression levels.
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Figure 3-4. SILAC labeling scheme.
In replicate 1, the negative control state is no APEX transfection. This could subtract background labeling
caused by endogenous peroxidase activity. In replicate 2, the negative control is no biotin-phenol/H 20 2
labeling. This could eliminate perturbation of protein expression level due to expression of mitochondrial
matrix-targeted enzyme. Heavy medium contains 13C6, '5N2-Lys and "C 6,'5N4-Arg.
Immediately after labeling and quenching, cells were pelleted and stored at -80 'C. After
cell lysis, heavy and light lysates were first combined, and then enriched with streptavidin beads.
Proteins eluted from the beads were separated on a polyacrylamide gel, and subsequently cut into
gel bands. Each gel bands were treated with trypsin to digested proteins into peptides, which
were extracted from the gel and analyzed by LC-MS/MS (liquid chromatography, tandem MS)
using a Q Exactive instrument.
To determine the mitochondrial matrix proteome, we calculated heavy/light (H/L) SILAC
ratios for each MS-identified protein, and chose cut-offs with <10% false-positive rates (FPR)
(Figure 3-5). Replicate I contained 527 proteins above the H/L cut-off of 2.07, while replicate 2
contained 579 proteins with H/L ratio above 2.37. We took the intersection of these two groups
to be our mitochondrial matrix proteome (495 proteins). Figure 3-6 shows that the correlation
between replicate I and replicate 2 H/L ratios is very high (r = 0.91) for proteins in our matrix
proteome.
Because these 495 proteins in our mitochondrial matrix proteome were obtained in a
fundamentally different approach than traditional method, we were very interested in comparing
this list with the literature in terms of both specificity and sensitivity. This comparison is
described in the next two sections.
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Figure 3-5. Determine the cutoff point for enrichment.
Left: distribution of SILAC ratios (H/L) from the replicate I experiment. The top panel in blue shows
"true positive" analysis: the number of proteins within each SILAC ratio range (bin size 0.1) with prior
mitochondrial annotation. The bottom panel in grey shows "false positive" analysis: the number of
proteins within each SILAC ratio range appearing in a hand-curated list of 2410 non-mitochondrial
proteins ("false positive list") (4). Right: false-positive rate (FPR) as a function of SILAC enrichment
factor (H/L). At a given SILAC enrichment level, FPR is defined as the ratio of the (conditional)
probability of finding a false-positive protein and the (conditional) probability of finding a mitochondrial
protein. Therefore, FPR measures the likelihood of finding a false positive versus a true mitochondrial
protein. We selected an FPR of 0.1 (10%) as our cut-off point, i.e. 10 times more likely for a protein to be
mitochondrial than a false positive non-mitochondrial protein.
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Figure 3-6. Defining our mitochondrial matrix proteome.
Left: our mitochondrial matrix proteome is defined as the intersection of the two enriched populations in
both replicates. Right: good correlation between SILAC ratios for replicates I and 2.
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Specificity analysis of mitochondrial matrix proteome
In the previous chapter, we assessed the spatial specificity of promiscuous protein
labeling with APEX using a series of imaging assays. Those experiments suggested that the
labeling is restricted to the same side of the membrane where the enzyme is targeted. Another
measure of its spatial specificity would come from analysis of our matrix proteome.
First of all, we assessed the specificity of enrichment for mitochondrial proteins. Taking
advantage of existing knowledge about mitochondria biology from the literature, we have
assembled a list of proteins with previous mitochondrial annotation from Gene Ontology
database (10), MitoCarta (4), and specific literature research. We found that 94% of our 495
proteins can be found in this list, compared to merely 8% of proteins in the entire human
proteome (Figure 3-7). The 31 enriched proteins not on the list were called "mito orphans".
While the localization of some of these simply has not been studied, the others have been
previously known to localize outside mitochondria. Indeed, as shown later in Figure 3-12,
immunofluorescence study on six of these "mito orphans" revealed complete or partial overlap
with mitochondrial markers, strongly suggesting mitochondrial association.
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Figure 3-7. Our proteome is specific to mitochondrial matrix proteins.
Left two columns show the fraction of proteins in the entire human proteome (column 1) or in our matrix
proteome (column 2) with prior mitochondrial annotation in the Gene Ontology Cell Component database
(10), MitoCarta (4), or literature. Right two columns show the distribution of proteins (with prior sub-
mitochondrial localization information) throughout the mitochondria, for all known mitochondrial
proteins (column 3), and for our matrix proteome (column 4). OMM is the outer mitochondrial membrane.
IMS is the inter-membrane space. The numbers of proteins, rather than fractions, in each category is
indicated in the column.
83
We next assessed the specificity of enriching mitochondrial matrix proteins. As shown in
Figure 3-7, of the 230 proteins in our list with prior information regarding sub-mitochondrial
localization (matrix, IMS, or outer membrane (OMM)), 97% are known to be matrix proteins,
compared to 69% for all characterized mitochondrial proteins. Our dataset is therefore strongly
enriched for mitochondrial matrix proteins. Note that we excluded inner membrane (IMM)
proteins from this specificity analysis because some of them can be labeled by matrix-targeted
enzyme if they are exposed to the matrix side. In this way, their labeling is not as indicative for
spatial specificity as IMS and OMM proteins.
To further assess the specificity of our matrix proteome, we examined several protein
complexes of the inner mitochondrial membrane that have been structurally and/or topologically
characterized. Figure 3-8 illustrates complexes I-IV and ATP synthase of the electron transport
chain. Only subunits that come into contact with the matrix space and are sterically exposed
appear in our proteome (shaded red). Subunits that are embedded in the membrane or face the
inter-membrane space (IMS) were not detected.
A similar analysis of the proteins of the TOM/TIM/PAM protein import pathway shows
that, again, only matrix-exposed proteins are labeled (Figure 3-9). Our data clearly indicate that
biotinylation catalyzed by matrix-localized APEX did not reach beyond the inner mitochondrial
membrane.
Complex I Complex || Complex IlIl Complex IV ATP synthase
(core subunits)
IMS E K D 1 H B D
ma6i F E FE
marx5 BA A F
* not detected 3 2 A
* detected
Figure 3-8. Analysis of labeling specificity for inner mitochondrial membrane protein complexes.
The protein subunits of Complexes I-IV and ATP synthase, for which structural information is available,
are illustrated (based on PDB IDs IZOY, ILOL, 1OCC and references (11,12)). Subunits detected in our
mitochondrial matrix proteome are shaded red; those not detected are shaded grey. Note that structural
information is not available for all 45 subunits of Complex 1, so some subunits that appear exposed here
may not be exposed in the complete complex.
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Figure 3-9. Analysis of labeling specificity for mitochondrial translocase complexes.
Same analysis as in Figure 3-8, for proteins of the TOM/TIM23/PAM mitochondrial protein import
machinery (13) that spans the outer and inner mitochondrial membranes.
Depth of coverage analysis of mitochondrial matrix proteome
To analyze our depth of coverage, we searched our matrix proteome for five groups of
well-established matrix proteins (Figure 3-10). Within each group, 80-90% of the proteins were
detected. Interestingly, we found that nearly identical subsets of proteins within each group were
detected in replicate I and replicate 2. As shown in Figure 3-10, each mitochondrial matrix
protein in these five categories has similar levels of enrichment in two replicates. This argues
that the coverage/sensitivity of our method is in fact quite high, but only for ~85% of proteins.
We sought to understand why certain matrix proteins were consistently not detected. We
quickly ruled out lack of or low expression levels (Figure 3-11). Lack of surface-exposed
tyrosines is also unlikely to be the cause, because we earlier estimated that >90% of proteins
have one or more surface-exposed tyrosine (see argument in Section 2, Chapter 2, and reference
(14), the caveat of this analysis is that it is based on sampling crystallographic structures of
proteins from various sources, yet the.surface tyrosine exposure may be different for the subset
of mitochondrial matrix proteins). It is still possible that these non-labeled matrix proteins are
sterically buried within macromolecular complexes in the context of living cells.
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Figure 3-10. Depth of coverage of our mitochondrial matrix proteome.
Left: five groups of well-established mitochondrial matrix proteins were analyzed (i-v). For each group,
80-91% of proteins were detected in our matrix proteome. Right: correlation analysis shows that nearly
identical subsets of proteins within each group were detected in the replicate I and replicate 2
experiments.
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Figure 3-11. Correlation between SILAC ratio and protein expression level in U2OS cells.
We limited our analysis to soluble matrix proteins. SILAC ratios are from replicate 1. Protein expression
level data are from reference (15).The bottom strip, in red, shows protein expression levels for matrix
proteins from Figure 3-10 that are not detected in our matrix proteome. Enrichment ratio is not correlated
with protein copy number (r = 0.043).
86
f*1
0*.*J3.
Insights fom the proteomic dataset
Our mitochondrial matrix proteome provides a number of novel insights. First, 6% of our
list, or 31 proteins, have not previously been linked to mitochondria, including the purine
biosynthesis enzyme PAICS and several proteins related to RNA processing and modification
(RPUSD3, TRUB2, PUSLI related to tRNA pseudouridine synthase and METT5DI, METTL8,
TRMT61B, TRMTI 1, NSUN3 related to tRNA methyltransferase). Nine proteins in our orphan
list fall just below the cut-off point for MitoCarta (4), and another five proteins have predicted
mitochondrial targeting sequences. Two orphans lack any prior annotation or characterization
(C2orf69 and Cl 5orf6 1). Due to the extremely high specificity of our proteome, and by the fact
that many of our orphans have high H/L ratios in both replicates, corresponding to false-positive
rates near 0%, it is highly likely that these orphans are bonafide mitochondrial matrix proteins,
at least in HEK293T cells.
TRMT61B TRUB2 RPUSD3 PREPL PNPO TRMT11
anti-V5
+ DIG
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ratio mito/non-mito: 12.2 8.0 7.4 7.3 2.0 1.7
Figure 3-12. Immunofluorescence imaging analysis of a subset of "mito orphan" proteins.
Genes encoding for these proteins were obtained from Broad Institute and confirmed by sequencing.
Proteins are tagged with V5 epitope tag at the C-terminus. Anti-Tom20 immunostain is used here as a
marker of mitochondria. The extent of mitochondrial localization was quantified by taking the intensity
ratio of fluorescence signal that falls in the mitochondrial regions over that outside these regions.
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Using immunofluorescence imaging, we did follow up studies on some of these proteins.
The extent of mitochondrial localization was quantified by taking the ratio of fluorescence
intensity in the mitochondrial regions over that outside these regions. We found that TRMT61B,
TRUB2, RPUSD3, and PREPL completely co-localize with mitochondrial marker, while PNPO
and TRMTI 1 partially overlaps with the marker (Figure 3-12). This study strongly supports our
claim that these orphans are true mitochondrial proteins in HEK293T cells.
Second, we found that 240 proteins in our proteome have previously been associated with
mitochondria but have not been known to localize to the matrix. Unsurprisingly, these include
proteins related to DNA replication and repair (5 proteins), gene transcription (6 proteins), RNA
processing (16 proteins), protein synthesis and folding (24 proteins), and proteolysis (8 proteins).
In addition, we observed 25 metabolic enzymes (related to heme, folate, ubiquinone, and lipid
production) and 15 proteins involved in redox homeostasis. Notably, I1 proteins related to
apoptosis were found in our list.
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Figure 3-13. Literature model of CPOX and PPOX localization within the mitochondria.
Left: sub-mitochondrial localization of the eight core enzymes involved in heme biosynthesis (18,19).
Four of these enzymes are detected in our matrix proteome and are colored red (with H/L ratios from
replicate I shown in parentheses). We do not detect the four cytosolic enzymes. Drawing adapted from
(18). Right: previously proposed model (19,20) based on computation and protease-accessibility assays
(16) showing the docking of a PPOX dimer and a FECH (ferrochelatase) dimer through the inner
mitochondrial membrane. N- and C-terminal ends of PPOX are labeled. Our data contradict this model
because the PPOX-APEX EM images in (C) show that the C-terminus of PPOX is in the matrix, not the
IMS. PPOX and FECH structures are from PDB IDs ISEZ and 2QD1.
Third, our matrix proteome contains two proteins previously annotated as outer
mitochondrial membrane proteins (COASY, SAM50) and four proteins previously annotated as
residing in the IMS (CPOX, PPOX, PNPTI, CHCHD3). It is possible that these proteins are
88
dual-localized within mitochondria, or that previous annotations of sub-mitochondrial
localization are incorrect. We followed up on two of these proteins, coproporphyrinogen-III
oxidase (CPOX) and protoporphyrinogen oxidase (PPOX), due to their importance in heme
biosynthesis (Figure 3-13). Protease-treatment of purified mitochondria has previously suggested
that both CPOX and PPOX are located in the IMS (16,17), but we strongly detect both proteins
in our matrix proteome (H/L ratios > 3.7 in both replicates).
To resolve the discrepancy between our findings and previous studies, we fused both
enzymes directly to APEX for EM analysis. Figure 3-14 shows that PPOX-APEX gives clear
staining in the matrix. Since the diaminobenzidine polymer generated by APEX does not cross
membranes (7), we conclude that the C-terminus of PPOX is located in the mitochondrial matrix.
In contrast, both fusions of APEX to CPOX give no detectable matrix stain and instead highlight
clusters within some regions of the IMS. Therefore, the N- and C-terminal ends of CPOX do not
appear to localize to the matrix; our detection of CPOX in the matrix may be due to an internal
region of CPOX being matrix-exposed.
CPOX APEXM APEX cPO 53  IMS-APEX
Figure 3-14. EM study of sub-mitochondrial localization of the heme biosynthesis enzymes CPOX
and PPOX.
This figure was generated by Jeffrey Martell and Dr. Eliza Vasile at Koch Institute. APEX was fused to
the C-terminus of full-length PPOX and CPOX (21,22). In the third construct, APEX was inserted into
full-length CPOX after the mitochondrial leader sequence (22). EM contrast was generated from APEX
with diaminobenzidine and OsO 4. As a control, an EM image is shown for APEX targeted to the IMS
with the 68 amino acid N-terminal signal peptide of LACTB (23). All scale bars, 200 nm.
89
Our proteomic results on endogenous PPOX and our EM imaging of recombinant PPOX-
APEX are not consistent with a previous literature model in which PPOX interacts with
ferrochelatase (FECH), the last enzyme of heme biosynthesis, through the inner mitochondrial
membrane (Figure 3-13) (20). If PPOX resides in the matrix, as we believe it does, then this
localization has implications for the nature of its interactions with FECH and CPOX, as well as
the mechanism by which the substrate of PPOX (protoporphyrinogen IX) is tr4nsported across
the inner mitochondrial membrane (perhaps via a novel transporter) (19).
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Figure 3-15. Example of MS/MS spectrum of directly labeled peptide.
This MS/MS spectrum was recorded on the SILAC heavy labeled [M + 2H] ion (m/z 1086.54)
corresponding to the pyruvate dehydrogenase El Is peptide VFLLGEEVAQ'PYDGAYK. The measured
precursor mass is within I p.p.m. of the calculated mass. Observed singly charged fragment ions are
labeled in the spectrum and indicate that Y63 is modified with biotin-phenol. Note that besides tyrosine,
we also searched the raw MS proteomic data for modification on other amino acids (Trp, Cys, Phe, His,
Met, Ser, Thr, Gin, Asn, Val) and did not find evidence of labeling.
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Taking advantage of the sequencing power of MS/MS data, we were able to detect 167
directly biotinylated peptides and to verify that the labeling site is on a tyrosine residue. These
peptides are derived from a subset of proteins in our matrix proteome. One example of MS/MS
analysis is depicted in Figure 3-15.
We analyzed the peptides that map to soluble proteins with known structure, or
membrane proteins with known topology. Figure 3-16 shows that peroxidase-catalyzed
biotinylation favors surface exposed tyrosine sites for the soluble proteins: the biotinylation sites
map to surface-exposed rather than buried tyrosine residues in 58 of 60 cases. In addition, we
found 15 biotinylated peptides that are derived from I1 transmembrane proteins. The
biotinylation site maps to the matrix-exposed side of the protein rather than the IMS side in 14
out of 15 cases. Three examples are shown in Figure 3-17.
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Figure 3-16. Mapping biotinylated peptides to soluble matrix proteins.
Left: occurrence of surface-exposed tyrosine residue in soluble proteins with known structure. (i) is from
reference (14). (iii) is based on analysis of the 60 biotinylated peptides we detect that map to soluble
proteins with known structure (39 proteins). (ii) is based on all the tyrosines (biotinylated or not, 401 in
total) within these 39 proteins. The criterion for "surface-exposed" is having >10 A2 solvent-accessible
area (14). Right: protein structures showing the positions of five of the biotinylated tyrosines (colored red,
bp = biotin-phenol modification). Non-labeled tyrosines within each protein are colored blue. Sequences
of detected biotinylated peptides are shown beneath each protein structure.
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Figure 3-17. Mapping biotinylated peptides to transmembrane proteins.
Shown here are three specific examples. Biotinylation sites are depicted by the red circle. Sequences of
detected biotinylated peptides are given underneath.
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3.3 Secretory pathway proteome
We next applied the proximity-dependent promiscuous labeling technique to the
endoplasmic reticulum lumen. Because endoplasmic reticulum lumen is an oxidative
environment, we have the option of using either HRP or APEX. We reasoned that HRP is a
better choice for its higher activity. Furthermore, because HRP is inactive in the cytosol, this
automatically eliminates any potential background labeling outside the secretory pathway due to
(a small fraction of) mis-targeted enzyme.
Promiscuous protein labeling in the endoplasmic reticulum lumen with HRP
HRP was genetically targeted to the endoplasmic reticulum lumen of U2OS cells by
attaching a C-terminal KDEL targeting sequence. Biotin-phenol labeling was performed in the
same way as for the matrix proteome experiment. Super-resolution fluorescence imaging showed
tightly correlated localizations between the enzyme and biotinylated targets (Figure 3-18).
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Figure 3-18. Promiscuous protein labeling in the endoplasmic reticulum lumen.
U2OS cells expressing endoplasmic reticulum-targeted HRP were labeled with biotin-phenol and H20 2 .
After cell fixation, permeabilization and blocking, biotinylated targets were labeled with streptavidin-dye
conjugate and endoplasmic reticulum-HRP, with V5 epitope tag, was labeled with anti-V5 antibody. Top:
labeling scheme. Bottom: STORM super-resolution image of HRP enzyme (in green) and biotinylated
targets (in red).
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Enrichment and subsequent LC-MS/MS analysis of the labeled proteome followed the
same protocol as described in the previous section. Figure 3-19 shows the distribution of protein
enrichment ratio H/L in log scale. The cutoff point was determined to be 1.13 in log2 unit. A total
of 309 proteins were enriched above this cutoff point.
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Figure 3-19. Distribution of protein enrichment ratio.
Top: SILAC labeling scheme. The light state is negative control omitting biotin-phenol reagent. Bottom:
distribution of SILAC ratio (H/L) in log2 unit. The graph clearly shows a bimodal distribution, with an
H/L cutoff point at around 1.13 in log2 unit.
Specificity analysis of our secretome
Interestingly, despite the fact that we targeted the HRP specifically to the endoplasmic
reticulum lumen, and that our imaging characterization so far showed correct endoplasmic
reticulum pattern for both the enzyme and the biotinylated targets, this proteomic dataset is not
specific to endoplasmic reticulum proteins. Endoplasmic reticulum proteins account for only half
of the enriched proteome. Proteins in the remaining half were known to be extracellular proteins,
integral membrane proteins, or proteins localized to the Golgi apparatus. It appears that the entire
secretory pathway was labeled! We reason that because the endoplasmic reticulum is the first
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stage in the secretory pathway, HRP in the endoplasmic reticulum lumen has the potential to
label any passing by proteins in this pathway. We broke up this secretome into five localization
categories (Figure 3-20).
others
integral
ER
extracellular
Golgi
Figure 3-20. Distribution of protein localizations in our secretome dataset.
Nearly half of proteins are in the endoplasmic reticulum. This is followed by 22% of proteins secreted
into the extracellular matrix, and 17% of proteins on the cell surface. Golgi proteins comprise another 6%.
The remaining 7% have either unknown localization or located elsewhere.
Analysis of endoplasmic reticulum membrane proteins
As is shown in case of the mitochondrial matrix proteome, the biotin-phenoxyl radical
labeling is limited to membrane bounded space. A protein is labeled only if a portion of it is
exposed to the space where the enzyme is targeted. Analysis of the endoplasmic reticulum
membrane proteins in our secretome further supported this observation. Figure 3-21 lists the top
20 most abundant endoplasmic reticulum membrane proteins (24), ranked by their abundance in
U2OS cells (15). Fourteen proteins (70%) in this list are enriched in our dataset. Some of these
proteins have known topology and the location of transmembrane domain. As expected, these
proteins all have a large portion exposed to the endoplasmic reticulum lumen. For the remaining
six proteins below the cutoff point of enrichment, four of them are single-transmembrane
proteins with large cytoplasmic domains and virtually no lumen-exposed portion, and another
one (DAD 1) has three transmembrane domains with fewer than 10 lumen-exposed amino acid
residues (25).
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Rank Protein name Lumen Cytosol
exposure exposure
1 VAPA - +
2 Calnexin + +
3 Bap3l NA NA
4 Ribophorin I + +
5 Climp63 + +
6 Ribophorin i + +
7 Sec6l beta 
- +
8 Ribosome-binding protein 1(p180) - +
9 SRP Receptor beta NA NA
10 VAPB 
- +
11 Dad1 +
12 Malectin + +
13 Surfeit locus protein 4 NA NA
14 Sec6l alpha NA NA
15 TRAP delta + +
16 TRAP alpha + +
17 Magtl (OST3/OST6 family) NA NA
18 STT3 NA NA
19 Signal peptidase complex subunit 3 NA NA
20 Transmembrane protein 97 NA NA
Figure 3-21. Analysis of 20 abundant endoplasmic reticulum transmembrane proteins in U20S cells.
For each entry, a plus sign in lumen exposure or cytosol exposure means at least 10 amino acid residues
are present in these spaces. Otherwise, it is indicated as a minus sign. "NA" means analysis not available.
The above analysis suggests that this method is potentially useful for mapping the
topology of membrane proteins. However, to be a truly useful method, a larger number of
biotinylated peptides need to be identified and then mapped to protein sequences. Currently, this
is technically challenging because we detected only a small number of directly labeled peptides
due to their high hydrophobicity which causes problems with poor elution from the LC column
and poor detection sensitivity on the MS.
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3.4 Conclusion
In summary, we have developed a novel method for mapping the proteomic composition
of cellular organelles, using genetically-targetable peroxidase enzymes that catalyze the
generation of short-lived, highly-reactive, promiscuous, and membrane impermeant radicals in
living cells. With a temporal resolution of 1 minute, labeled proteins were harvested and
identified by MS using well-established techniques. We note that in addition to its simplicity, the
method has no noticeable toxicity and requires far less material than conventional organellar
proteomics (1 - 4 mg of crude protein required prior to streptavidin enrichment, compared to
entire animal organs (26,27)). Another feature of our methodology is that the same peroxidase,
APEX, used for proteomic mapping in live cells can also be used for EM visualization (7), which
is useful for verifying the localization of APEX in cells and for follow-up studies on proteomic
hits.
Our initial demonstration on the human mitochondrial matrix proteome shows that
specificity is exceptionally high, due to the fact that labeling is performed in living cells while
membranes and other structures are still intact. Depth of coverage is also high for the majority of
proteins - likely those that are sterically accessible to the phenoxyl radical. Demonstration of this
labeling method to the secretory pathway also shows high spatial specificity.
We envision many future applications of this technology, spanning cell biology and
neuroscience. Other organelles and sub-cellular compartments such as the IMS and synaptic cleft
could be proteomically mapped. With improvements in our ability to recover directly
biotinylated peptides, and perhaps an expansion of the amino acid reactivity of our radicals, we
could also potentially use the method to perform large-scale mapping of the topology of
membrane proteins or analyze the three-dimensional architecture of macromolecular complexes
in living cells.
96
3.5 Experimental methods
Labeling of the mitochondrial matrix proteome
Culturing of HEK293T cells in SILAC media over 8 days was performed as previously
described (28). On day 0, P8 HEK293T cells were split into two T25 flasks at 10-15%
confluence. One flask was cultured in light SILAC media: a custom preparation from Caisson
Laboratories containing L-arginine (ArgO), L-lysine (LysO), 10% dialyzed fetal bovine serum
(Sigma), penicillin, streptomycin, glutamine, and 4.5 g/L glucose in DMEM. The second flask
was cultured in heavy SILAC media, with the same composition as above, except ArgO and LysO
were replaced by L-arginine- 3 C6 , 15N 4 (ArglO) and L-lysine-"C 6 ,15N 2 (Lys8) (Sigma Isotech).
Every two days, before cells reached confluence, the heavy and light SILAC cultures were split
into fresh SILAC heavy and light media, respectively. After three passages in T25 flasks, on day
6, light and heavy SILAC cultures were expanded into T75 flasks at 20% confluence and
cultured for two more days. We prepared two T75 flasks (HI, H2) for heavy SILAC cells and
three T75 flasks (L1, L2, L3) for light SILAC cells.
On day 9, the HEK293T cells (HI, H2, L2, and L3) in T75 flasks (-7-8 million cells per
flask) were transfected with mito-APEX (15 tg plasmid DNA) using 75 p.L Lipofectamine 2000
in 30ml DMEM media. 4 hours after transfection, the media was replaced with fresh light or
heavy SILAC media, and the cells were incubated overnight. On day 10, 18 hours after
transfection, a biotin-phenol solution in 20 mL SILAC media was added to SILAC flasks HI, H2,
LI, and L3 (final concentration = 500 [M). Cells were incubated for 30 min at 37 'C before
addition of H20 2 (final concentration = 1 mM) for 1 minute at room temperature. After 1 minute
labeling, samples were immediately quenched by aspirating off the probe/H 20 2 solution and
replacing with quencher solution (10 mM sodium azide, 10 mM sodium ascorbate, and 5 mM
Trolox in 20 mL DPBS) for I min at room temperature. To ensure complete quenching and
removal of residual biotin-phenol, cells were washed twice with quencher solution and twice
with DPBS. For the L2 flask (negative control with biotin-phenol and H20 2 omitted), cells were
washed three times with DPBS. After the final wash, 7 mL of quencher solution was added to
each flask, and cells were collected by gentle pipetting followed by centrifugation at 200 rpm for
5 min at room temperature. Supernatant was discarded, and the cell pellet was stored at -80 'C.
On day 11, cell pellets were lysed as follows. Pellets were thawed on ice, then 300 tL
RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%
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Triton X-100, lx protease cocktail (Sigma Aldrich), 1 mM PMSF, 10 mM sodium azide, 10 mM
sodium ascorbate, and 5 mM Trolox) was added to each pellet. Lysates were clarified by
centrifugation at 13,000 rpm for 10 min at 4 'C. Protein concentration in the supernatant was
measured using the Pierce 660 nm Protein Assay kit, with BSA as the reference standard.
The following optimizations were performed to determine the final live cell labeling
conditions used. First, we wished to restrict the H20 2 exposure time to 1 min, to minimize
toxicity to cells and maximize the temporal resolution of our method. Given this temporal
restriction, we found that lowering the H20 2 concentration to <1 mM significantly reduced the
biotinylation signal, assessed by imaging. We suspect that this is the case despite the low Km of
APX for H20 2 (~20 ptM, (29)) and the high membrane permeability of H20 2 , because of the
endogenous catalase activity in mammalian cells. For biotin-phenol, we tested loading for 1 min,
3 min, 10 min, and 30 min and found much stronger labeling with the 30 min pre-incubation
prior to H20 2 addition for 1 min; this may be because the biotin-phenol probe has limited
membrane permeability. After labeling, we also found that it was critical to wash and lyse cells
in buffer containing quenchers (Trolox, ascorbate, and sodium azide). Without addition of
quenchers, we observed labeling of the outer mitochondrial membrane protein TOM20 by
matrix-localized APEX, by both MS and Western blot (data not shown), suggesting that
peroxidase-mediated biotinylation continues after dissolution of the mitochondrial membranes.
Upon addition of quenchers to the wash and lysis buffers, labeling of TOM20 was eliminated.
Enrichment of biotinylated proteins, in-gel protein digestion and extraction
SILAC-labeled whole cell lysates prepared as described above were mixed in a 1:1 ratio
(by protein concentration): HI cells were mixed with LI cells, and H2 cells were mixed with L2
cells. In addition, L3 cells were spiked in at 5% (by protein concentration) to each HI/LI and
H2/L2 pair to facilitate subsequent quantitation. Approximately 500 piL of streptavidin-coated
magnetic beads (Pierce cat. no. 88817) were prepared by washing twice with RIPA lysis buffer
(formulation given above). 4 mg of each cell lysate mixture (at 4-5 mg/mL protein concentration)
was combined with the streptavidin bead slurry. The suspension was incubated at room
temperature for 1 hour with gentle rotation. Thereafter, beads were washed with 2x 1 mL RIPA
lysis buffer, once with I mL of 2M urea in 10 mM Tris-HCI pH 8.0, and again with 2x 1 mL
RIPA lysis buffer. Finally, biotinylated proteins were eluted from the streptavidin beads by
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incubation with 60 ptL of 1 x NuPAGE LDS Sample Buffer (Invitrogen) supplemented with 20
mM DTT and 2 mM biotin at 95 'C for 5 min.
Proteins eluted from streptavidin beads as described above were loaded onto a NuPAGE
Novex Bis-Tris 4-12% gel and separated for 1 hour using 130V. The gel was stained overnight
with Coomassie G-250 (Invitrogen) and subsequently destained with water. Lanes for each
replicate were manually cut into 16 gel bands. Gel bands were destained in 50:50
acetonitrile:100 mM ammonium bicarbonate pH 8.0 for several hours followed by dehydration
with acetonitrile. Dehydrated gel bands were swelled with 100 ptL of 10 mM DTT in 100 mM
ammonium bicarbonate for one hour while shaking. The DTT solution was subsequently
removed and 100 ptL of 55 mM iodoacetamide in 100 mM ammonium bicarbonate was added to
each gel band and allowed to react for 45 min in the dark. The iodoacetamide solution was
removed and bands were dehydrated with acetonitrile. Approximately 10-50 tL of 20 ng/piL
sequencing-grade trypsin (Promega) was added to each sample and digestion was completed
overnight with shaking at room temperature.
After the overnight digestion, excess trypsin solution was removed from each sample and
bands were incubated with 20 ptL of extraction solution (60% acetonitrile/0.1% TFA). The
extraction solution was collected after 10 min and this process was repeated 2 additional times.
The final peptide extraction was completed by incubating gel bands with 100% acetonitrile for 1-
2 min. Extracted peptides were dried to completeness in a vacuum concentrator, then
reconstituted in 100 pL of 0.1% formic acid and loaded onto C 18 StageTips (30), washed twice
with 50 ptL of 0.1% formic acid, and finally eluted with 50% acetonitrile/0.1% formic acid.
StageTip eluates were dried in a vacuum concentrator.
Determination of the cut-offpoint for our matrix proteome
Protein level information was obtained from the MaxQuant Protein Groups table.
Leading protein groups identified as reverse hits or contaminants were removed from the data set.
The replicate I sample (based on the HI/LI SILAC pair, where LI lacks APEX) and the
replicate 2 sample (based on the H2/L2 pair, where L2 lacks biotin-phenol and H20 2) were
analyzed separately. For each dataset, only protein groups identified by three or more distinct
peptides with quantified ratios were retained for further analysis. Protein SILAC ratios were
normalized such that the median value is 1.
99
In order to determine the cut-off SILAC ratio for the dataset, proteins were categorized
into two classes: (1) "mito" for those previously known to be localized to mitochondria; and (2)
"false-positive" for those found in a "false positive" list of 2410 non-mitochondrial proteins
compiled by Vamsi Mootha's lab (4). Histogram distributions of SILAC ratios in log2 units were
generated for these two classes, with bin size of 0.1. For each bin, the probability of finding a
protein in each class, namely P(SILAC ratio, if in this class), was calculated as the ratio of the
count in each bin and the total count of the class. The false-positive rate (FPR, or the probability
of finding a protein in the false-positive class versus the true-positive class) was defined as the
ratio of two probabilities:
_ P(SILAC ratio, if false positive)
P(SILAC ratio, if mito)
The cut-off point for each dataset is defined as the SILAC ratio at which the FPR reaches
0.1 (i.e. it is 10 times more likely to have a true-positive than a false-positive hit). The cut-off
points (in log2 units) for replicates I and 2 were 1.05 and 1.25, respectively, which gives 527
enriched protein groups for replicate I and 579 enriched protein groups for replicate 2. The
overlap of these two enriched datasets contains 495 protein groups, which we take to be our
mitochondrial matrix proteome. The numbers of detected peptides, detected proteins, and
enriched proteins for each replicate, as well as the overlap between the two replicates results are
summarized in Table 3-1.
Table 3-1. Summary of MS analysis.
Replicate I Replicate2
# detected peptides 50032 54744
overlap 39947
# detected proteins 3430 1 3599
overlap 3147
# enriched proteins 527 1 579
overlap 495
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Structural mapping of biotinylatedpeptides
Biotinylated peptide information was obtained from the MaxQuant Evidence table. All
peptides identified as reverse or contaminant hits were excluded, and only biotinylated peptides
with score >50 were retained for this analysis. For each modified peptide sequence associated
with multiple MS/MS scans, the highest score for these scans was recorded.
For analysis of solvent accessible tyrosine residues, protein structure models were
obtained through searching UniProt accession IDs in the Swiss Model Repository, and only
models with sequence homology >85% were included in the analysis. Solvent accessible surface
areas for individual tyrosine residues were calculated in PyMOL. Membrane topology
information for each entry was obtained from the UniProt database.
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Part B
Fluorescence imaging analysis of protein localization and trafficking
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Chapter 4 Introduction to fluorescence imaging analysis of protein trafficking
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4.1 Introduction
The protein composition of cellular compartments is maintained by the continual flux of
entering and exiting proteins. The resulting protein trafficking among various compartments is
crucial for many aspects of cell physiology. Protein trafficking into the nucleus allows
transcriptional control of gene expression, and proteins destined for secretion are first
synthesized in the endoplasmic reticulum, and then modified in the Golgi, sorted into secretory
vesicles, and eventually released into the environment. One prominent example of protein
trafficking is clathrin-mediated endocytosis of cell surface receptors (1). While internalization of
nutrient receptors is crucial for taking up ligand from the environment, internalization of
signaling receptors provides a means of signal attenuation and desensitization, and subsequent
targeting from endosome to the lysosome achieves protein degradation.
Because of its high spatial resolution and high detection sensitivity, fluorescence
microscopy has become an indispensable tool for studying protein localization and trafficking.
This has been aided by the development various protein labeling techniques during the past
decades. This chapter introduces these chemical and physical tools.
4.2 Existing methods for fluorescent labeling of specific proteins
Specific protein labeling methods can be broadly categorized into two classes: the "tag-
less" approaches versus those requiring fusion to protein or peptide tags. The "tag-less" approach
is exemplified by the use of antibodies to target endogenous proteins. Because the large size of
antibodies precludes their entry across the cell membrane, for live cell applications, this method
has been limited to cell surface proteins. Even so, their large size often interferes with ligand
binding and/or receptor trafficking, not to mention their often weak targeting affinity and
tendency to crosslinking underlying receptors (monovalent Fab fragments can be used to avoid
crosslinking problem). In the special case of cell surface receptor proteins, specific labeling has
been traditionally achieved by using a fluorescently labeled ligand (2,3). One caveat with this
method is the activation of underlying receptor, and therefore it is not possible to study the
receptor in its basal, ligand-free state. Although the number of antibodies against endogenous
protein targets has been steadily increasing over the past decades, not every protein has an
antibody available.
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Alternatively, a peptide or protein tag can be fused to the protein of interest in order to
facilitate specific labeling. The most prominent example of protein tag is the development of
fluorescent proteins (4). The ability to genetically encode these fluorescent labels ensures perfect
targeting specificity and has revolutionized the field of protein labeling and imaging. During the
past decades, fluorescent proteins have been engineered to span the palette of the entire visible
spectrum (5), including the near infrared range (6), or to possess unique photophysical properties
that afford advanced imaging modalities such as super-resolution microscopy (7). One limitation
of fluorescent proteins is their lack of brightness and photostability, especially when comparing
to commonly used organic fluorophores. To overcome this problem, many novel protein tags
have been developed for site-specific protein labeling with small, organic fluorophores. These
include HaloTag (8), SNAP/CLIP tag (9), and DHFR tag (10).
HaloTag was engineered from bacterial dehalogenase whose natural function is to
catalyze the hydrolysis of chloroalkanes or bromoalkanes into alcohols, thereby protecting the
bacteria from toxicity of these xenobiotics. In this enzymatic catalysis, a covalent adduct of alkyl
chain with aspartic acid side chain is transiently formed in the active site as an intermediate. The
engineered version of HaloTag is capable of trapping this intermediate and utilizes it as a means
of covalently modifying the protein. Similarly, SNAP tag and CLIP tag were both engineered
from human 0 6 -alkylguanine-DNA alkyltransferase. The natural function of the enzyme is to
transfer the alkyl group from 0 6 -alkyl-guanine onto itself, thus protecting DNA from damaging
by alkylating agents. The result is covalent modification of the enzyme at its active site cysteine
residue. Protein engineering alters the substrate specificity of the enzyme: while SNAP tag
recognizes 06 -benzylguanine derivatives, CLIP tag recognizes 06 -propargylguanine derivatives
(9). These techniques are attractive to biologists due to the covalent nature of labeling and their
fast kinetics. The second-order rate constants of SNAP/CLIP are on the order of 103 - 104 M-1 S-1,
and the rate constant of HaloTag approaches 106 M-1 s- 1, which is close to diffusion-controlled
rate limit. Unlike these enzyme variants that feature covalent modification, the DHFR tag utilizes
strong, yet non-covalent interactions between the protein scaffold and its ligand. Trimethoprim
was designed as a competitive enzyme inhibitor, with a binding affinity of 10-8 M towards
dihydrofolate reductase (DHFR) (10).
The major drawback with all the labeling methods mentioned above is the large tag size,
which typically exceeds 100 amino acids. This can interfere with protein function, block
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interaction with other proteins, or alter trafficking properties. The use of small peptide tag is
therefore advantageous over these bulky protein fusions. The introduction of epitope tags suits
for this purpose and can be viewed as an extension of antibody-based approach (11). It retains
the benefit of high specificity of antibody recognition with the added advantage of being able to
target any proteins of interest regardless of their immunogenicity. However, it also shares all the
limitations with the antibody. Site-specific protein labeling techniques aim to directly modify the
protein of interest with a probe, thus bypassing the requirement of antibodies. A number of
methods have been developed, which include poly His (12-14), tetra-cysteine tag for
FlAsH/ReAsH (15), SorTag (16), aldehyde tag (17), AcpS/Sfp (18,19), biotin acceptor peptide
(20), and lipoic acid acceptor peptide (21-26).
The poly His tag utilizes the coordination complex formed between tandem imidazole
groups on the histidine side chain, a probe containing nitrilotriacetic acid moiety, and a transition
metal ion such as nickel (II) or zinc (II). Originally developed for purifying recombinant proteins,
this technique has been adapted for protein labeling in living cells by using (12,13).
FlAsH/ReAsH techniques developed by Tsien et al. (15) is another example of utilizing strong
interaction between a peptide motif and the probe. The tetra-cysteine (-CCxxCC-) structure in
the peptide tag tightly associates with the biarsenical moiety of small molecule probes, with
dissociation constant as low as 10-1 M.
The other peptide tags can all be recognized for post-translational modification by
respective enzymes. The SorTag is a hexapeptide motif (LPETGG) at the C-terminus of protein.
It is recognized by a prokaryotic transpeptidase, sortase, for covalent conjugation with a probe-
containing pentaglycine peptide. The aldehyde tag is a pentapeptide sequence CxPxR, in which
the cysteine residue can be selectively oxidized into formylglycine by formylglycine generating
enzyme. The aldehyde group in formylglycine can then be targeted with aminooxy- or
hydrazide-functionalized probes (27). In the case of AcpS/Sfp, phosphopantetheinyl transferase
enzyme recognizes these sequences and transfer modified coenzyme A onto the serine residue of
the peptide. E. coli biotin ligase, BirA, specifically recognizes a 15-amino acid peptide sequence
(acceptor peptide) and catalyzes the formation of amide bond between biotin carboxyl group and
the lysine side chain amino group. Likewise, the lipoate protein ligase (LplA), also from E. coli,
recognizes a 13-amino acid peptide sequence and modifies its lysine residue with lipoic acid.
Recently, LplA has been engineered to recognize a variety of small molecule probes, including
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coumarin derivatives (21-23), aryl azide (24), alkyl azide and alkyne (25), and aryl-aldehyde or
hydrazine (26). These LpIA-based labeling methods are collectively termed "probe incorporation
mediated by enzyme", or PRIME.
Together, these various protein labeling techniques are valuable for studying protein
localization and trafficking in the context of living cells.
4.3 Fluorescence microscopy for studying protein localization and trafficking
The high spatial resolution and compatibility with live cell experiment of fluorescence
microscopy make it a powerful tool for examining the localization and trafficking of proteins
within the living cells. The development of digital recording with sensitive camera greatly
facilitates quantitative analysis of images, either individually or in time-series. During the past
decades, various advanced imaging methods have been developed to improve the optical
resolution. Confocal and multi photon microscopy achieve optical sectioning either by rejecting
out-of-focus light (28) or by limiting the excitation volume via non-linear optical absorption (29);
total internal reflection fluorescence (TIRF) microscopy utilizes evanescent field illumination to
limit the excitation field to a thin layer near the glass substrate, typically less than 100 nm thick
(30); super-resolution imaging techniques, such as stimulated emission depletion (STED), photo-
activatable localization microscopy (PALM), and stochastic optical reconstruction (STORM),
have achieved spatial resolution down to 25 nm and temporal resolution as fast as 0.5 second in
live cells (31-33).
Additionally, various microscopic methods have been developed to monitor protein
trafficking process in live cells. Fluorescence recovery after photobleaching (FRAP) allows
examining the diffusion of biomolecules (proteins, lipids, etc.) inside the cell in real time. In this
method, biomolecules of interest are fluorescently labeled in live cells, and an intense laser beam
is directed to the sample to transiently photobleach fluorophores in a selected region, such as the
nucleus. This is immediately followed by sequentially imaging the cell to watch how
fluorescently labeled molecules redistribute into the photobleached region. From this time-series
analysis, the diffusion coefficient can be deduced. A variation of this technique is fluorescence
loss in photobleaching (FLIP), in which the photobleaching laser beam is kept on. Due to
diffusion of fluorophores, the fluorescence intensity outside the photobleaching region will
decrease over the time, which provides information about diffusion coefficient. An alternative
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approach is to use photo-activatable protein fusions and selectively photo-activate a sub-cellular
region, such as the Golgi apparatus, and study how this cohort of fluorescent protein traffics
inside the cell (7).
Single-particle tracking with quantum dots is by far the most powerful method for
studying protein trafficking on the cell surface. As in the case of super-resolution imaging
techniques, fitting the point spread function of single-particle fluorophore gives localization
accuracy of tens of nanometers. Due to the brightness and photostability of the fluorescent probe,
the trajectories of individually labeled molecules are recorded in real time, with a temporal
resolution on the order of milliseconds. Compared to ensemble fluorescence measurement of
molecular diffusion, single-particle tracking experiment has the potential of revealing the
heterogeneity within the sample. For example, trajectory analysis in single-particle tracking is
able to distinguish between the mobile and immobile populations within the same cell, whereas
ensemble analysis of the same sample only shows the average diffusion properties. In addition,
by analyzing the trajectory in different cellular region, single-particle tracking could also provide
information about the spatial heterogeneity of the cell surface, such as the presence of diffusion
barriers.
The first single-particle tracking experiment dates back to 1982, when Webb et al. used
fluorescently labeled low density lipoprotein (LDL) particle to observe the dynamics of its
receptor (LDLR) on the surface of cultured fibroblast cells (34). LDL is suitable for such studies
because its hydrophobic core of cholesterol esters can be easily loaded with multiple organic dye
molecules such as the carbocyanine lipid analog Dil. This affords the brightness necessary for
identifying individual LDL particles under the microscope.
Since then, various nanoparticles have been utilized for single-particle tracking. Colloidal
gold particles with diameters ranging between 15 - 40 nm are strong light scatter sources, and
thus have been employed for single-particle tracking in bright-field microscopy. Fluorescent
labels are favored because of the dark background in imaging. For example, fluorescent
microspheres with diameters ranging between 30 - 100 nm have been used to track membrane
anchored proteins (35,36). Phycobiliproteins, such as commercially available R-phycoerythrin
(R-PE), contain more than 30 fluorophores per protein molecule, and therefore are extremely
bright at the single molecule level (37). Similar to the LDL particle, certain virus particles can
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also be labeled with lipophilic fluorophores. This has allowed direct visualization of viral entry
into mammalian cells (38).
Another important class of nanoparticles for single-particle tracking is the quantum dots.
These semiconductor nanoparticles feature core-shell binary structure, with their band gap, and
thus emission spectra, tunable by the particle size. Quantum dots have broad excitation spectrum,
large extinction coefficients (105 - 106 M-1 en at the first exitonic absorption peak) and high
fluorescence quantum yield (as high as 0.8), which make them ideal for single-particle tracking
probes (39). In addition, quantum dots are highly photostable, being able to withstand continual
illumination for minutes without photobleaching. Due to occasional photo-ionization, these
particles do exhibit blinking during single-particle tracking. On the one hand, this is a drawback
that complicates data analysis; on the other hand, it can be used as a means to validate the
presence of single quantum dot, instead of a cluster of particles. The narrow emission bandwidth
(full-width at half maxima 30 - 90 nm) of QDs also makes them useful for multiplex imaging
(39).
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4.4 Conclusion
Studying protein localization and trafficking requires the coordinated efforts of chemical
biology and physical instrumentation. Here, we have reviewed various techniques for
fluorescently labeling proteins of interest and microscopy methods for observing their
localization as a function of time with high spatial and temporal resolutions. Each of these
labeling methods comes with its own strength and weakness. One should be judicious when
choosing among these tools for addressing a specific biological question. By carefully combining
these techniques, it would be possible to achieve multiplex labeling and imaging within the same
sample, which makes it possible to study the spatial and temporal correlation between several
proteins of interests.
The biotin ligase/acceptor peptide approach features small peptide tag size, stable
protein-fluorophore linkage, rapid labeling kinetics and ease of operation. In addition, it is also
capable of selectively labeling the cell surface. This added advantage makes it especially
attractive for studying cell surface receptor proteins. Therefore, in the next two chapters, we
focus on the application of this labeling method in both ensemble fluorescence imaging and
single-particle tracking experiments.
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Chapter 5 Ensemble fluorescence imaging analysis of receptor trafficking
Except for Section 5.4, work described in this chapter has been published in: P. Zou and A. Y.
Ting. Imaging LDL receptor oligomerization during endocytosis using a co-internalization assay.
ACS Chemical Biology 2011, 6, 308-313. This chapter is adapted from this publication.
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5.1 Introduction
In this chapter, we examine the clathrin-mediated endocytosis of the LDL receptor using
a novel fluorescence imaging assay based on biotin ligase/acceptor peptide labeling.
Internalization is often a highly regulated process, and there have been many well-studied cases
where the oligomerization state of a receptor is closely correlated with its internalization activity
(reviewed in ref. (1)). Oligomerization could promote internalization either by directly triggering
cross-reactivity between monomers, as is in the case of cross phosphorylation of the epidermal
growth factor (EGF) receptor, or indirectly by increasing the local concentration of
internalization motif which recruits the formation of the endocytic machinery to these loci at the
plasma membrane (2). For this reason, equipped with this live cell imaging assay, we seek to
understand whether receptor oligomerization plays a role in the endocytic process.
Clathrin-mediated endocytosis
Clathrin-mediated endocytosis is one of the most well studied endocytic internalization
mechanism. In this process, ligand-bound receptors are targeted to clathrin-coated pits, which are
cage-like structure formed by clathrin polymer near the cell surface. Then the cell membrane
around the pits invaginates into the cell and eventually pinches off to trap the ligand-receptor
complex into a clathrin-coated vesicle. As the vesicle moves away from the plasma membrane,
its clathrin shell disassembles and recycles back to the cell surface, leaving only a membrane-
bound vesicle. After entering the cell, these uncoated vesicles then fuse with each other to form
endosomes, where a sorting mechanism takes place to separate ligand from its receptor. Certain
type of receptors, such as the low-density lipoprotein (LDL) receptor and transferrin receptor, are
recycled back to the plasma membrane, while other receptors and most ligands are retained in the
endosome and eventually targeted to the lysosome for degradation (3). The whole process is
extremely fast and efficient. In the case of the LDL receptor, it is constitutively internalized and
recycled once every -12 min, completing a total of ~150 round trips in its life span of -30 hours
(4).
The LDL receptor is an integral membrane protein with a large extracellular domain
(residues I - 767) that binds to the LDL particle, a single transmembrane domain (TMD,
residues 768 - 789), and a short cytoplasmic tail (residues 790 - 839) bearing an NPxY motif
("'NPVY) that is recognized for clathrin-mediated endocytosis (5,6). It binds to LDL at neutral
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pH but releases it at endosomal pH (- 5) (7). Mutations in the NPxY motif, especially at the
Tyr807, often lead to a significant decrease in receptor internalization, as revealed in patients
afflicted with familial hypercholesterolemia (FH683 with W792Stop mutation and J.D. with
Y807C mutation) (8-10).
Existing methods for measuring receptor oligomerization state
Many cell surface receptors form dimers or higher-order oligomers. Oligomerization state
often plays an important role in regulating receptor function, such as ion conductance (11),
enzymatic activity (12), and effector recruitment during signal transduction (13). Receptor
oligomerization can be dynamically regulated in both temporal and spatial dimensions. In time,
oligomerization state may be altered by molecular events such as ligand binding (12,13). In
space, the extent of oligomerization may vary in different cellular compartments - such as at the
cell surface, in the endoplasmic reticulum, or in endocytic vesicles (14). Receptor dimerization
and internalization are usually investigated separately using different assays. A new method for
analyzing the oligomerization state during the process of internalization would benefit
mechanistic studies of receptor function.
Most methods used to characterize receptor oligomerization require removing the
receptor from the cellular context. For example, oligomerization can be probed via co-
immunoprecipitation from cell lysate (15), or via direct measurements of receptor size using gel-
filtration chromatography or electrophoresis (16). However, these methods do not replicate
physiological conditions, and the requirement for receptor solubilization raises the possibility of
missing transiently formed oligomers or aggregating receptors due to incomplete solubilization
(16). Chemical crosslinking can also be used to probe receptors in living cells, but it has limited
efficiency and sensitivity (17); in addition, its non-specific nature could lead to false positives by
crosslinking via nearby proteins. Recently, a strategy called RASSL (receptor activated solely by
a synthetic ligand) (18) has been applied to study the co-internalization of mutant and wild-type
beta-2-adrenergic receptor (19). However, this requires chemical synthesis of selective ligands
and avoids receptor activation.
Compared with traditional biochemical assays, light microscopy offers high spatial and
temporal resolution. Recently, numerous fluorescence imaging methods have been developed to
probe receptor oligomerization in living cells. These include single-molecule subunit counting
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(20), bimolecular fluorescence complementation (15), fluorescence resonance energy transfer
(16), and fluorescence recovery after photobleaching (21). Limited by the fluorescence labeling
methods used in these assays, many of these approaches do not distinguish between specific
cohorts of receptors. For these reasons, we sought to develop a new methodology, based in single
living cells, to selectively probe the oligomerization state of the receptor subpopulation that is
undergoing endocytic internalization.
5.2 Fluorescence imaging assay for receptor internalization
Cell surface fluorescence labeling of LDL receptor
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Figure 5-1. BirA-mediated site-specific biotinylation of AP peptide.
In the first step, BirA catalyzes the formation of biotin-adenylate (biotin-AMP) ester from biotin and ATP,
where inorganic phosphate (PPi) is released as a byproduct. The resulting adenylate ester is tightly held at
the substrate binding site until binding of the acceptor peptide (AP) substrate, and an amide bond is
formed with the concomitant release of adenosine monophosphate (AMP). The central lysine residue is
highlighted in red.
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We selected the low density lipoprotein receptor (LDLR) to demonstrate our
methodology. As described in the previous section, LDL receptor is a constitutively internalized
and recycled receptor, and it mediates the clearance of LDL cholesterol from plasma. To develop
the internalization assay, we need to specifically label the cell surface population of LDL
receptor. The N-terminus of mature LDLR was fused to a 15-amino-acid "acceptor peptide" (AP)
(fusion after the leader sequence), which is specifically biotinylated by an E. coli biotin ligase
BirA (Figure 5-1). To selectively label the cell surface population of LDLR with fluorescent
probe, BirA is expressed in the endoplasmic reticulum, so that AP-tagged receptor is efficiently
biotinylated as it travels through the endoplasmic reticulum in the secretory pathway (Figure 5-2).
Cell surface pool of biotinylated AP-LDLR is then labeled with AlexaFluor568-conjugated
monovalent streptavidin (mSA-Alexa568), which is a 54 kDa protein. This labeling is fast (2
minutes for the mSA step), highly stable (Kd~ 5x10-14 M between biotin and mSA), and does not
artificially induce receptor crosslinking (22). Figure 5-3 shows that BirA/mSA labeling of AP-
LDLR is site-specific and requires co-expression of endoplasmic reticulum-targeted BirA.
mSA-Alexa568 B
0 labeling
Cytoplasm
B
Endoplasmic
AP reticulum
Figure 5-2. Scheme for selective labeling of cell surface AP-LDLR.
Biotin ligase is targeted to the endoplasmic reticulum (BirA-ER), where it site-specifically conjugates
biotin onto AP-LDLR. As the biotinylated receptor traffics to the cell surface, it is tagged with
fluorophore-conjugated monovalent streptavidin (mSA) (14). Because mSA is membrane-impermeant,
only the surface population of the receptor is fluorescently labeled. B = biotin.
124
Nuclear Streptavidin-
marker Alexa568
AP(K->A)
omit
enzyme
Figure 5-3. Specific labeling of AP-LDLR.
T-REx CHO A7 cells expressing AP-LDLR, BirA, and a nuclear YFP transfection marker (in a separate
plasmid) were incubated with 10 pM biotin overnight. Biotinylated AP-LDLR on the cell surface was
labeled with mSA-Alexa568 at 4 'C for 10 min. Negative controls are shown with AP-LDLR replaced by
a K-+A point mutant in AP, and with BirA omitted (bottom). Scale bars = 10 pm.
Cell surface fluorescence quenching
We wish to quantify the fluorescence intensity that is contributed by the cell surface
receptor only. During endocytic internalization, this intensity is expected to decrease over the
time. By observing the same field of view and taking the ratio of remaining intensity over the
total intensity at time zero, we are able to calculate the level of internalization for each cell.
Image-based segmentation is potentially useful for discerning the membrane fluorescence
intensity versus intracellular signal, but it is not clean, especially when internalized vesicles are
close to the plasma membrane.
An alternative approach is to selectively quench the fluorescence of labeled receptors at
the cell surface. An ideal quencher must be membrane-impermeant, and should have broad
absorbance, high extinction coefficient, and low fluorescence quantum yield. We compared
Trypan blue (23), QSY dyes (Invitrogen), and BHQ dyes (Biosearch Technology) for this
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purpose. QSY21 was the most promising for quenching mSA-Alexa568 fluorescence in solution,
but it had limited water solubility and gave incomplete quenching at the cell surface. We
therefore prepared a conjugate of QSY21 and spermine, to increase polarity and electrostatic
attraction to the phospholipid bilayer. In vitro measurements showed that 40 pM QSY21-
spermine quenched 80 nM mSA-Alexa568 fluorescence by 94% (Figure 5-4).
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Figure 5-4. Characterization of QSY21-spermine.
Top: structure of QSY21-spermine. Bottom: absorption spectrum of QSY21-spermine in PBS pH 7.4
(blue). Fluorescence emission spectra of 80 nM mSA-Alexa568 in PBS pH 7.4 before (red) and after
(black) the addition of 40 pM QSY2 I -spermine.
To test cell membrane-permeability of QSY21-spermine, we incubated cells with
resorufin acetate, which readily enters cells by diffusing across the plasma membrane. Inside
cells, resorufin acetate is hydrolyzed by endogenous esterases to yield a red fluorescent product,
resorufin. While QSY21-spermine efficiently quenches resorufin fluorescence in solution, we
verified that this reagent does not quench intracellular fluorescence in cells loaded with resorufin
(Figure 5-5). On live cells, we observed 91% quenching of mSA-Alexa568 labeled surface AP-
LDLR by 40 ptM QSY21-spermine within 1 min (Figure 5-6).
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Figure 5-5. Testing membrane permeability of QSY21-spermine.
Top: representative images taken immediately before and after the addition of QSY21 -spermine to T-REx
CHO A7 cells loaded with resorufin acetate (a gift from Daniel S. Liu). Scale bar = 20 pm. Bottom left:
distribution of quenching extents, for single cells from images on the top. Mean is shown : s.d. Bottom
right: fluorescence quenching of 100 tM resorufin by 160 pM QSY21-spermine in PBS pH 7.4.
Internalization assay
Before applying these labeling and surface quenching protocols to image LDLR
internalization, we utilized the T-REx system (Invitrogen) to control AP-LDLR expression level
in CHO ldlA-7 (T-REx CHO A7), a cell line that lacks endogenous LDLR (24). Details are
described in the Experimental methods. We proceeded to image wild-type LDLR internalization
in single cells. For quantitation, background-corrected total Alexa568 intensities were recorded
for each labeled cell before (IB) and after (IA) treatment with QSY21 -spermine. We used the ratio
IA / IB to express the percent of internalized receptor for single cells. The frequency distribution
histograms of this ratio and characteristic images are shown in Figure 5-6.
Immediately after labeling, cells displayed a ring-like fluorescence pattern. This
fluorescence was nearly completely quenched after addition of QSY21 -spermine. However, if
the labeled cells were incubated at 37 'C for 5 minutes, fluorescence puncta were observed
inside cells, suggesting internalization of labeled AP-LDLR into endosomes. Indeed, QSY21 -
spermine added at this time point quenched only fluorescence from the cell surface, but not
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fluorescence from internal puncta. During the 5-minute incubation at 37 'C, the percent of
internalized receptors increased from 9.0 ± 3.3% to 43.7 ± 19.2% (mean + s.d.). This
internalization rate is comparable to previously reported values (~ 55% internalization for 5-
minute incubation) obtained using radioactively labeled LDL (5,25), but the notable advantage of
our assay is its single cell resolution.
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40 9.0 3.3% 4 43.7± 19.2%
C U
2 0  20-
CUU
LL U
0 0
0 50 100 0 50 100
% of labeled receptor internalized % of labeled receptor internalized
Figure 5-6. Internalization analysis time course of wild-type LDL receptor.
T-REx CHO A7 cells (lacking endogenous LDLR) expressing BirA and AP-LDLR were labeled with
mSA-Alexa568. These cells were then incubated at 37 'C for 5 min. Representative images are shown
immediately before and after surface fluorescence quenching with QSY21-spermine. Percent of
internalized receptor was quantified for single cells, and the distributions of these percentages are shown
in histograms, with pink lines denoting the interquartile range (25-75%). Data are given as mean ± s.d.
Scale bars = 10 pam.
We used the same assay to analyze the internalization of three LDLR mutants. Previous
studies have shown that Y807 mutants (Y807C and Y807A) and C-terminally truncated mutant
(A792) of LDLR are defective in endocytic internalization, due to lack of targeting to clathrin-
coated pits (17). Indeed, our assay shows that all three LDLR mutants remained on the cell
surface during the 5-minute incubation period (Figure 5-7), which contrasts with the rapid
internalization of wild-type LDLR.
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Figure 5-7. Internalization analysis of mutant LDLR.
T-REx CHO A7 cells expressing BirA and the indicated LDLR construct(s) were labeled with mSA-
Alexa568, as described in Figure 5-6, and then incubated at 37 'C for 5 min. Representative images are
shown immediately before and after surface fluorescence quenching with QSY21 -spermine. Percent of
internalized receptor was quantified for single cells, and the distributions of these percentages are shown
in histograms, with pink lines denoting the interquartile range (25-75%). Data are given as mean ± s.d.
Scale bars = 10 ptm.
5.3 Determine receptor oligomerization state during endocytic internalization
Chemical crosslinking experiments have detected LDLR dimers in both purified samples
and in cells (17). In addition, LDL particles have been visualized on fixed cells by electron
microscopy, and have been observed to form dimers on the cell surface and within clathrin-
coated pits (26). It is unclear, however, if the underlying receptors are also dimeric, if they are
dimeric in the ligand-free state, and if cell fixation alters protein distribution. New methodology
is needed to study this fundamental aspect of LDLR biochemistry more completely and with
greater accuracy.
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Figure 5-8. Scheme for oligomerization assay.
Cells co-expressing wild-type and mutant LDLR are labeled with mSA-Alexa568 and subsequently
incubated at 37 0C to allow WT receptor to internalize. If internalizing receptors remain as monomers,
then labeled AP-mutant receptor will remain on the cell surface (first row). Receptor oligomerization is
revealed as co-internalization with the WT receptor (second row) and/or co-retention with the mutant
(third row). The extent of internalization is quantified for each cell, by surface fluorescence quenching
with QSY2 I -spermine after the incubation period.
Oligomerization assay
Building upon the internalization assay described in the previous section, we established
a fluorescence imaging method to probe LDLR oligomerization state during the endocytic
process in living cells. As shown in Figure 5-8, this method utilizes internalization-defective
LDLR mutants and is composed of two symmetric assays. The first assay tests whether co-
expression of wild-type LDLR facilitates internalization of these mutants. Conceptually, this
strategy is similar to co-immunoprecipitation; the interaction is detected by "co-internalization"
of mutant with the wild-type receptor into the cell. The second assay tests whether co-expressed
mutant receptors negatively affect the internalization of wild-type LDLR. In other words, the
interaction is manifested via "co-retention" of the wild-type with the mutant receptor on the cell
surface. Taken together, these two assays provide complementary information of how receptors
associate with each other and whether there is a dominant effect on internalization from either
the wild-type or the mutant.
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Figure 5-9. Co-internalization analysis of A792 LDLR.
T-REx CHO A7 cells (lacking endogenous LDLR) expressing BirA and the indicated LDLR construct(s)
were labeled with mSA-Alexa568. Top: lack of co-internalization of mutant with the wild-type. Bottom:
lack of co-retention of the wild-type with the mutant. Representative images are shown immediately
before and after surface fluorescence quenching with QSY21 -spermine. Percent of internalized receptor
was quantified for single cells, and the distributions of these percentages are shown in histograms, with
pink lines denoting the interquartile range (25-75%). Data are given as mean ± s.d. Scale bar = 10 ptm.
To test for oligomerization via this co-internalization assay, we co-expressed wild-type
LDLR with each of the three LDLR mutants in T-REx CHO A7 cells, and quantified the extent
of internalization. In the case of truncation mutant A792 LDLR, we co-expressed AP-tagged
mutant with untagged wild-type receptor. Our assay shows that A792 LDLR remains
internalization-defective whether or not the wild-type is co-expressed (p = 0.71). In the
complementary assay, we co-expressed AP-tagged wild-type and untagged mutant LDL receptor.
We found that the internalization of the wild-type receptor does not slow down with A792 LDLR
co-expression (Figure 5-9). These experiments suggest that A792 LDLR does not interact with
the wild-type receptor during endocytic internalization. We note that the same amount of plasmid
DNA of mutant and wild-type receptors was used to transfect cells, and that efficient co-
expression was achieved in about 90% of transfected cells for all these experiments, as measured
by immunofluorescence staining (see Experimental methods, Figure 5-24). However, one caveat
of this analysis is that we did not experimentally check for the relative expression level.
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Figure 5-10. Internalization analysis of Y807 LDLR mutants.
T-REx CHO A7 cells expressing BirA and the indicated LDLR construct(s) were labeled with mSA-
Alexa568, as described in Figure 5-6, and then incubated at 37 'C for 5 min. Top: co-internalization of
mutant with the wild-type. Bottom: co-retention of the wild-type with the mutant. Representative images
are shown immediately before and after surface fluorescence quenching with QSY21-spermine. Percent
of internalized receptor was quantified for single cells, and the distributions of these percentages are
shown in histograms, with pink lines denoting the interquartile range (25-75%). Data are given as mean
s.d. Scale bars = 10 pim.
In the case of Y807 mutants, we performed the same set of experiments. We observed
that both Y807C and Y807A entered cells more rapidly in the presence of wild-type LDLR (p <
0.001, Figure 5-10). At the same time, we found that the internalization of the wild-type receptor
slows down significantly when it is co-expressed with Y807C mutant (comparing to Figure 5-6).
These results suggest that Y807 mutants oligomerize and co-internalize with the wild-type
LDLR.
As a negative control for this analysis, we co-expressed transferrin receptor (TfnR) with
AP-Y807C LDLR. Like LDLR, the internalization of TfnR is mediated by clathrin-dependent
pathway (27), yet these two receptors do not associate with each other. Enhanced green
fluorescent protein (EGFP) was fused to the C-terminus of TfnR to facilitate examination of its
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expression level. As expected, the internalization of AP-Y807C LDLR remained low and was
uncorrelated with the expression level of TfnR-EGFP (R2 < 0.001) (Figure 5-11).
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Figure 5-11. Internalization analysis of Y807C LDLR co-expressed with transferrin receptor (TfnR)
as a negative control.
T-REx CHO A7 cells were co-transfected with AP-Y807C LDLR, BirA, and transferrin receptor fused to
EGFP (TfnR-EGFP). Internalization after 5 min at 37 'C was imaged and analyzed. Top: representative
images of TfnR expression (EGFP channel), and mSA-Alexa568 labeling before and after quenching with
QSY21-spermine. Scale bar = 10 lpm. Bottom left: plot of the internalization extent for single cells against
TfnR expression level. R2 = 0.0007. Bottom right: histogram showing the distribution of internalization
extents. The pink line denotes the interquartile range (25-75%).
Why do internalization-defective mutants behave differently toward wild-type co-
expression? We believe that in the case of A792 LDLR, the region required for LDLR
oligomerization may be deleted, and thus co-internalization is not possible. Indeed, previous
work has suggested that the cytoplasmic domain of LDLR is required for its oligomerization (17).
An interesting direction for future work would be to extend this co-internalization analysis to
LDLR mutants with various truncated regions. This would allow us to identify the location of
this hypothesized oligomerization domain.
To support our fluorescence imaging analysis of receptor oligomerization, we sought to
detect such interactions using traditional method: co-immunoprecipitation (co-IP) assay. We
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have designed two sets of co-IP experiments. In the first set, wild-type LDL receptors are
differentially fused to AP-tag and HA epitope tag, and are co-expressed in T-REx A7 cells at
controlled expression level. In another set, the AP-tagged LDL receptor is a truncation mutant
A792, which has been suggested to be oligomerization-incompetent in our imaging analysis.
These configurations are identical to our previous imaging experiments.
Figure 5-12 shows the SA-HRP blot and anti-HA western blot analysis of co-IP fractions.
SA-HRP blot (panel A) confirms successful pull down of AP-WT LDLR from the lysate. Anti-
HA Western blot (panel B) demonstrates successful expression of HA-WT LDLR. However, the
majority of HA-WT LDLR (> 95%) is not co-immunoprecipitated with AP-LDLR, as indicated
by the strong signal in the unbound fraction and almost non-existent signal in the elute fraction in
panel B. We tried to push the limit of detection sensitivity by loading maximum amount of
sample on the gel and by applying longer exposure time when developing the blot. Under these
conditions, we were able to detect weak signals from co-IP experiments. The bottom of panel B
shows that HA-WT LDLR was co-immunoprecipitated with AP-WT LDLR, but not with AP-
A792 LDLR.
These results are consistent with our imaging assays. Indeed, the A792 mutation disturbs
receptor oligomerization, and at the same time, it destroys the co-internalization. It is likely that
LDL receptor monomers oligomerize only transiently, such that at any given time, the interacting
subpopulation constitutes only a small fraction of the total receptor pool which cannot be
captured efficiently by co-IP and detected with western blot analysis. Additionally, LDL receptor
oligomers might not be stable enough to survive cell lysis conditions. This demonstrates that our
imaging analysis is more sensitive in detecting oligomer formation than traditional biochemical
assays.
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Figure 5-12. Co-immunoprecipitation analysis of LDLR oligomerization.
T-REx CHO A7 cells expressing BirA and the indicated LDLR construct(s) were lysed and analyzed by
(a) streptavidin-HRP blot and (b) anti-HA blot. Whole lysate was analyzed ("Lysate"), along with the
streptavidin-enriched fraction ("Eluted"), and the unbound supernatant ("Unbound"). Control lanes are
shown with untransfected cells, and cells expressing only AP-WT LDLR. AP-A792 LDLR is -5 kDa
smaller than AP-WT LDLR.
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LDL ligand does not affect oligomerization state
To test whether the addition of ligand could affect LDL receptor oligomerization, we
repeated the above panel of experiments with LDL added into the medium at saturating
concentrations, and we obtained the same results (Figure 5-13). Since each LDL particle contains
only one copy of ApoB-100 protein, which binds to LDLR in a 1:1 molar ratio (28), it is unlikely
that LDL binding would promote oligomerization of LDLR. Consistent with these observations,
our mutation analysis suggests that LDLR oligomerization is mediated by its cytoplasmic tail,
which is inaccessible to LDL.
Regarding whether LDL promotes receptor internalization, two models have been
proposed in the past: the escalator model and the elevator model. The escalator model states the
receptor is constitutively internalized whether or not the ligand is present. In this model, the
bound ligand is passively endocytosed into the cell, in the same way as passengers carried by the
escalator. To support this model, electron microscopy studies have shown that LDLR is
spontaneously localized in clathrin-coated pits and internalized even in the absence of its ligand
(29). The elevator model, on the other hand, states that that receptor internalization is dependent
on ligand binding. That is, bound-ligand actively triggers receptor internalization (via
conformational change), in the same way as passengers press button to call for elevator. Previous
experiments using monensin, a carboxylic ionophore that inhibits receptor recycling, indicated
that half of the LDLR population on the cell surface is internalized only if LDL is added into the
medium (25), thus supporting the elevator model. Our experiment helps resolve this issue by
showing that the extent of internalization for wild-type LDLR is the same whether or not it is
bound to LDL (p > 0.4, Figure 5-14).
We note that the same batch of LDL proteins have been shown to bind to cells expressing
LDL receptor when they were added at 100 pg/mL (see Experimental methods, Figure 5-22).
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Figure 5-13. Internalization analysis of wild-type and mutant LDLR in the presence of LDL.
T-REx CHO A7 cells expressing BirA and the indicated receptor(s) were labeled with mSA-Alexa568 in
the presence of 100 pig/mL LDL, and then incubated at 37 'C for 5 minutes with 10 ptg/mL LDL.
Representative images are shown immediately before and after surface quenching with QSY21 -spermine.
The distribution of these ratios is shown in histograms, and pink lines denote the interquartile range (25-
75%). Data are given as mean ± s.d. Scale bar = 10 ptm.
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Figure 5-14. Summary of LDLR internalization analysis.
The presence of LDL does not affect receptor internalization (p > 0.4, Kolmogorov-Smirnov test). Unlike
the truncation mutant A792 LDLR, the internalization of Y807C LDLR mutant increases significantly
when co-expressed with wild-type LDLR. Meanwhile, the internalization of wild-type LDLR slows down
significantly only when it is co-expressed with Y807C mutant, but not with A792 LDLR. Data are given
as mean ± s.e.m.
5.4 Enzymatic incorporation of unnatural probe desthiobiotin
In addition to its natural biotin substrate, BirA also recognizes an analogue, desthiobiotin
(DTB), and efficiently ligates it to AP peptide (30). Due to structural similarities, both DTB and
biotin bind to the same site on streptavidin, but the absence of sulfur atom in DTB causes a
reduction of binding affinity by approximately 100-fold, which makes its binding to streptavidin
effectively reversible (31). Taking advantage of this difference in reversibility, it is possible to
distinguish between biotinylated versus desthiobiotinylated targets. In tissue imaging, this would
be useful for removing background streptavidin-fluorophore labeling from endogenous
biotinylated protein.
We started with testing the extent of reversibility of streptavidin binding to DTB. To
maximize DTB labeling signal, we prepared the N-hydroxysuccinimide ester of DTB (DTB-
NHS) and used it to non-specifically label primary amines in cells. Figure 5-15 shows that
desthiobiotinylated cells are readily labeled with streptavidin-dye conjugate, and this labeling is
completely abolished when cells are pre-blocked with unlabeled streptavidin. Further, incubating
blocked cells with 1 mM biotin at 37 'C for 1 hour causes streptavidin to dissociate from DTB
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targets and rescues the subsequent labeling signal. Encouraged by this initial result, we moved on
to improving enzymatic DTB ligation to acceptor peptides.
Block with Incubate with
streptavidin biotin
37 C
Figure 5-15. Reversible binding of streptavidin to DTB.
CHO cells were non-specifically desthiobiotinylated with DTB-NHS. Cells were likely dead due to high
toxicity of this reagent, but they are not permeabilized. DTB on the cell surface could be easily detected
with streptavidin-Alexa568 conjugate. This labeling was completely abolished if cells were pre-blocked
with streptavidin. Because the binding of streptavidin to DTB is reversible, the blocking could be relieved
by incubating cells with 1 mM biotin at 37 'C for 1 hr. Top: fluorescence image; bottom: overlay with
DIC.
Enzyme-mediated DTB ligation to AP peptide
We started with in vitro ligation experiments using purified BirA enzyme. Figure 5-16
confirms that BirA efficiently mediates the ligation of DTB to AP peptide. Omitting either ATP
or the enzyme gives no product formation. Reaction products were purified by reversed-phase
HPLC and subsequently confirmed by MS. Under the same reaction condition (1 hour incubation
at 30 'C), quantitative conversion was observed for both biotinylation and desthiobiotinylation of
the AP peptide. We then tested whether site-specific DTB labeling of plasma membrane proteins
could be achieved using BirA targeted to the endoplasmic reticulum. However, this proved to be
unsuccessful, even with the presence of 1 mM DTB in the cell culture medium. In comparison,
10 tM biotin in the cell culture medium is sufficient for completely biotinylating the AP-fusion
of cell surface protein (data not shown).
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Figure 5-16. In vitro desthiobiotin ligation using purified BirA.
Top: HPLC analyses of ligation reaction. Purified AP peptide (100 pM) was incubated with 2 pM BirA, 1
mM DTB, 4 mM ATP, and 5 mM magnesium acetate in bicine buffer pH 8.3, at 30 *C for 1 hour. The
reaction was quenched with 45 mM EDTA, and analyzed with reversed-phase HPLC. Bottom: mass- spec
confirmation of ligation products.
140
AP 1 hr incubation at 30 C.
AP-biotn
AP-DTB
05 :
GAS:
OA
0,35
0.3
02s:
02:
O15
0.1'
0
RT [mdi
The alternative approach is cell surface desthiobiotinylation of AP with purified BirA. It
has been shown earlier that BirA purified from E. coli often tightly binds to biotin or biotin
adenylate (bio-AMP). The existence of biotin or bio-AMP at sub-stiochiometric level is less a
problem for in vitro ligation experiments, in which BirA is applied with catalytic amount (2 1iM
enzyme versus 100 pM AP substrate), than it is a problem for cellular labeling. A simple
estimation showing that BirA enzyme is about 103- to 10 4-fold in excess of AP peptide in a
standard labeling protocol. Contaminating biotin and/or bio-AMP can be removed by first
incubating BirA with purified AP peptide and ATP and then dialyzing away small molecules
from the reaction mixture. As expected, this recycled BirA gave no labeling in the absence of
biotin (Figure 5-17). Further, the presence of 1 mM DTB in the reaction mixture gave
specifically labeling of cells transfected with AP-CFP-TM. Compared to biotin, DTB ligation is
a much slower reaction and requires high concentration of DTB probe (1 mM). This problem is
even more severe for intracellular labeling. We reasoned that the intracellular DTB level was too
low for efficient ligation, even with 1 mM DTB added to the culturing media.
Shorter
AF568 + CFP exposure
AF8 Z CFP
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Figure 5-17. Cell surface desthiobiotinylation of AP-CFP-TM protein with exogenous BirA.
DTB on the cell surface was targeted with streptavidin- Alexa568. Cells were incubated with 0.3 ptM
BirA, 4 mM ATP, 5 mM MgCl 2, and 1 mM DTB in DPBS at room temperature for 30 min. 10 piM biotin
was used instead of DTB as positive control for labeling (first row). Omitting DTB or biotin in the
reaction gave no labeling.
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Figure 5-18. Wild-type BirA efficiently ligates DTB-AMP to AP peptide on the cell surface.
Left: fluorescence images comparing DTB adenylate labeling with biotinylation and DTB ligation on AP-
CFP-TM. Right: quantitation of streptavidin-AlexaFluor568 (AF568) labeling intensity in these images,
with background subtracted.
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Figure 5-19. Titration of DTB adenylate probe and quantitation.
Cells were incubated with WT BirA and DTB adenylate (DTB-AMP) probe for 10 min at room
temperature. Background was subtracted from quantiations.
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We set out to boost desthiobiotin ligation efficiency both on the cell surface and inside
cells. On the cell surface, we reasoned that we could improve the kinetics by supplying the
enzyme with its activated intermediate, desthiobiotin adenylate. This bypasses the first catalytic
step of carboxyl group activation, which turned out to be the rate-limiting step of catalysis.
Indeed, we found that cell surface ligation is significantly improved by using desthiobiotin
adenylate. The level of labeling with 100 pM probe for 10 min is comparable to biotinylation,
presumably saturating all the AP sites on the cell surface (Figure 5-18 and Figure 5-19).
To facilitate intracellular desthiobiotin labeling, we reasoned that cellular loading with
desthiobiotin is likely a slow process, due to the negatively charged carboxyl group. This could
be improved by using the acetoxymethyl ester of desthiobiotin (DTB-AM ester) which readily
permeate through the plasma membrane. Once inside the cell, DTB-AM ester could be
hydrolyzed by endogenous esterases to unmask the proper desthiobiotin. We observed that, with
100 1 M DTB-AM supplied into the media, labeling of AP-actin with cytosolic BirA completed
in about 1 hour (Figure 5-20).
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Figure 5-20. Intracellular DTB ligation using AM ester.
Left: fluorescence images showing the time course analysis of DTB-AM ester labeling. Right:
quantitation of time course analysis.
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Applications of intracellular DTB labeling
Our goal is to develop a method to detect desthiobiotin (DTB) targets with streptavidin,
while omitting background from endogenous biotin. This would be especially useful for fixed
tissue imaging. After cell surface labeling with DTB, cellular fixation and membrane
permeabilization, cells were pre-blocked with streptavidin. Washing with biotin selectively
dissociate streptavidin from DTB-labeled targets, but not endogenous biotinylated proteins
(Figure 5-21).
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Figure 5-21. Blocking endogenous biotin signal using enzyme-mediated destiobiotinylation.
There was a high level of endogenous biotin signal. This background, together with DTB label, could be
almost completed blocked with streptavidin. Incubation with 1 mM biotin at 30 'C for 30 min selectively
rescued DTB label on the cell surface. Arrows indicate labeling of endogenous biotin in untransfected
cells.
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5.5 Conclusion
In summary, we have developed a fluorescence imaging assay to probe LDLR
oligomerization during internalization. The endocytosis of both wild-type and internalization-
defective receptor mutants were analyzed in the context of receptor co-expression in living cells.
If receptor monomers interact with each other, co-expressed wild-type and mutant receptors are
expected to mutually affect each other's internalization rates.
Using site-specific protein labeling mediated by biotin ligase and monovalent streptavidin,
as well as cell surface fluorescence quenching with a novel reagent, we quantified LDLR
internalization under various conditions. We found that, during endocytosis, LDLR is capable of
oligomerizing in a ligand-independent manner, and that this interaction is likely mediated by its
cytoplasmic domain. LDLR dimerization was suggested in previous electron microscopy studies
and chemical crosslinking experiments but has never been observed directly in live cells, free of
potential artifacts from cell lysis and fixation. An important feature is that our assay does not
require the use of ligand, making it possible to study receptor oligomerization in both ligand-
bound and ligand-free states. This allowed us to discover that the rate of receptor internalization
is not altered by the binding of low density lipoprotein ligand.
The assay described here utilizes known mutations that cause defects in receptor
internalization. We chose the LDLR as a demonstration of this method, but we envision that this
assay could be applied to other receptors as well. One potential limitation of such extension is
that the internalization-defective mutant receptor has to be carefully chosen so as to avoid
disrupting monomer interaction and/or receptor function.
Instead of using the natural substrate biotin, we also demonstrated that BirA efficiently
catalyzes the ligation of desthiobiotin onto acceptor peptide, and that the kinetics of this reaction
can be improved by using DTB adenylate ester for cell surface labeling or acetoxymethyl ester
for intracellular applications. DTB labeling allows subtraction of endogenous biotinylation
background from fixed cell sample, which is important for tissue imaging.
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5.6 Experimental methods
Reagents and constructs
Enzymes used in cloning and restriction digestions were purchased from New England
BioLabs. Oligonucleotides used in cloning and mutagenesis were purchased from Invitrogen.
CHO ldlA-7, a Chinese hamster ovary cell line defective in endogenous LDLR, was a kind gift
from Prof. Monty Krieger (MIT) (24). HeLa and CHO-KI cells were purchased from ATCC.
Dulbecco's modified Eagle medium (DMEM), Dulbecco's phosphate buffered saline (DPBS)
were purchased from Gibco. Fetal bovine serum (FBS) was purchased from PAA Laboratories.
Bovine serum albumin (BSA) was purchased from Amresco, L-proline was from USB Corp.,
sodium pyruvate and resorufin were from TCI America, and biotin was a gift from Tanabe USA.
Spermine and 37% (v/v) formaldehyde were purchased from Alfa Aesar. Tween 20 was
purchased from Sigma-Aldrich. Blasticidin, AlexaFluor568 succinimidyl ester, QSY21
succinimidyl ester, rabbit a-HA, and goat a-rabbit conjugated to AlexaFluor647 were purchased
from Invitrogen.
Monovalent streptavidin (mSA) and its conjugate with Alexa Fluor 568 (Invitrogen) were
prepared as previously described (32). By measuring the absorbance spectrum, the purified
conjugate had a concentration of 7.9 [tM and an average dye-to-protein ratio of 2.9. This
conjugate was stored at -80 'C.
QSY21-spermine was prepared by mixing QSY21 succinimidyl ester (Invitrogen) with
spermine in DMSO/DMF solution. 1.0 mg (1.3 pmol) QSY21 succinimidyl ester was dissolved
in 50 tL of anhydrous DMSO. To this solution was added 1.25 mg of spermine (6.2 pmol) in 25
gL DMF, and the reaction mixture was incubated at room temperature in the dark for 4 hours.
The resulting solution was used directly in subsequent quenching assays (typically at 1:400
dilution) without purification. ESI-MS: m/z 866.40 (calculated for C5 H6oN 70 4 S [M*] m/z
866.44). The starting material, QSY21 succinimidyl ester, was detected on the mass spectrometer
(m/z 779.46, calculated [M*] m/z 779.25) at the beginning of the reaction, but this peak
disappeared at the end of the reaction.
Fluorescently labeled LDL particles (Dil-LDL and DiD-LDL) were prepared by
incubating LDL solution with Dil or DiD overnight, followed by dialysis against PBS pH 7.4 to
remove excess dye molecule. Low density lipoprotein (LDL) at a concentration of 7.6 mg/mL
was obtained from Prof. Monty Krieger (MIT). 200 pL of this solution was mixed first with an
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equal volume of PBS pH 7.4, and then 2.0 pL of Dil (30 mg/mL) in DMSO. The mixture was
incubated at 37 'C for 4 hours. At the end of incubation, the solution was centrifuged at 12,000 g
for 10 min to pellet aggregates, and the supernatant was further filtered with a 0.22 ptm
centrifugal filter (Amicon). The clarified Dil-LDL solution was dialyzed against PBS pH 7.4 and
stored in the dark at 4 'C. The same protocol was used for preparing DiD-LDL.
The AP-WT LDLR construct was created by PCR-amplifying the AP-WT LDLR gene
(33) with flanking restriction sites, Nhe I and B/p I, and then ligating into digested pcDNA4-
mCherry-LplA vector (a gift from Dr. Katharine A. White (34)). The resulting construct places
AP-LDLR expression under control of an inducible promoter, featuring two tetracycline operator
2 sites located downstream of a CMV immediate-early promoter. All AP-LDLR mutants were
created by site-directed mutagenesis using QuikChange (Stratagene).
HA-WT LDLR was created by first inserting the HA epitope tag into AP-WT LDLR
(AP-HA-WT LDLR) via inverse PCR (35), and then removing the AP tag via QuikChange
(Stratagene). YFP-tagged histone H2B (H2B-YFP) has been used as a nuclear marker of
transfection (33). BirA-KDEL in pDisplay vector (33) originally contained an HA epitope tag
immediately downstream of its Ig K-chain leader sequence. In the present study, this epitope tag
was removed by QuikChange. Transferrin receptor-EGFP fusion construct (TfnR-EGFP) was a
gift from Prof. Mark Howarth (University of Oxford).
Fluorescence measurement
A Tecan Sapphire platereader and 96-well polystyrene microplates with clear flat-bottom
(Greiner) were used to measure the absorption spectrum of QSY21 -spermine and the
fluorescence emission spectrum of mSA-Alexa568 and resorufin. For the absorption
measurement, 100 tL of 160 ptM QSY21-spermine solution in PBS pH 7.4 was prepared. For the
fluorescence measurement, 100 pL of 80 nM mSA-Alexa568 (or 100 ytM resorufin) in PBS pH
7.4 was prepared. The solution was excited at 530 nm, and its fluorescence spectrum was
recorded from 560 nm to 700 nm. The same excitation and emission range was used to measure
the quenched fluorescence from a 100 tL solution of 80 nM mSA-Alexa568 (or 100 YtM
resorufin) in the presence of 40 ptM (or 160 gM) QSY21-spermine. Background absorption and
fluorescence were measured for PBS pH 7.4, and subtracted from the above measurements. Each
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measurement was performed in triplicate. To quantify the extent of fluorescence quenching, the
area under the Alexa568 emission curve was integrated for both quenched (AQ) and unquenched
(Ao) cases. The quenching efficiency was reported as (Ao -AQ)/ Ao.
Testing membrane permeability of QSY21 -spermine
T-REx CHO A7 cells at -80% confluence were incubated with 100 ptM resorufin acetate
(a gift from Daniel S. Liu) in DPBS at room temperature for 5 min. Thereafter, cells were
washed with ice-cold DPBS five times, for 3 min each time, to remove excess dye. Immediately
after taking a fluorescence image, the buffer was aspirated and 160 ptM QSY21-spermine in ice-
cold DPBS was added onto the monolayer of cells. Another fluorescence image of the same field
of view was taken 1 min after adding the quencher. Quantitation of fluorescence quenching was
performed as described for receptor internalization analysis.
Mammalian cell culture and transfection.
HeLa and T-REx CHO-KI cells were cultured in growth medium (DMEM supplemented
with 10% FBS, 70 mg/L L-proline and 220 mg/L sodium pyruvate) at 37 'C under 5% (v/v) CO 2.
For the T-REx CHO A7 stable cell line, the medium was further supplemented with 10 ptg/mL
blasticidin. Cells were transfected using either Nucleofector (Amaxa) or Lipofectamine 2000
(Invitrogen).
The protocol for nucleofection is as follows. 1 million T-REx CHO A7 cells suspended in
100 pL nucleofection solution (120 mM KCI, 10 mM KH 2 PO 4 , 2 mM EGTA, 25 mM HEPES, 5
mM MgCl 2 , 0.5 mM CaCl2, 5 mM oxidized glutathione, 2 mM ATP, pH 7.5) were mixed with
1.8 - 2.0 pg of DNA and nucleofected with the U-023 program. Cells were rescued with pre-
warmed growth medium and plated onto the center of homemade 35 mm imaging dishes with
glass (No. 1.5) bottoms at a density of 50,000 - 100,000 cells per dish.
The protocol for Lipofectamine 2000 transfection is as follows. 40,000 - 80,000 T-REx CHO A7
cells were plated onto the center of homemade 35 mm imaging dishes with glass (No. 1.5)
bottoms. 12 - 24 hours after plating, these cells were transfected with 0.3 jig of DNA mixed with
I piL Lipofectamine 2000 in 250 jiL DMEM, following manufacturer's protocol. 4 - 5 hours
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after transfection, the medium was aspirated and complete culture medium was added to cells in
the imaging dishes.
Unless stated otherwise, if cells were transfected with pcDNA4 constructs and BirA-
KDEL, 10 pM biotin and 50 ng/mL tetracycline were supplied to the growth medium. Typically,
cells were labeled and imaged 24 - 36 hours after transfection, at 70 - 90% confluence.
Fluorescence microscopy and data analysis
Typically, cells were labeled with mSA-Alexa568 24 ~ 36 hour after transfection, at 70 -
90% confluence. To quench cell surface fluorescence signal, QSY21-spermine solution at 40 pM
in ice-cold DPBS was added into the imaging dish.
Images were acquired with a fully motorized epi-fluorescence microscope (Axio
Observer.Z1, Carl Zeiss) using a 40x oil-immersion lens (Carl Zeiss). The system was controlled
using Slidebook 4.2 software (Intelligent Imaging Innovations). Digital images (16 bit) were
obtained with a cooled EMCCD camera (QuantEM:512SC, Photometrics) with exposure times
between 200 msec and 500 msec. A xenon lamp in a Lambda DG4 device (Sutter Instruments)
was used to excite all fluorophores, and the filter set information is listed in Table 5-1.
Nomarski-type differential interference contrast (DIC) was used for transmitted-light imaging of
all samples.
Table 5-1. Filter set information
Fluorophore Excitation Emission Dichroic
YFP and EGFP 493/16 525/30 502
Alexa568, Dil, resorufin 570/20 605/30 585
Alexa647 and DiD 630/20 680/30 660
Image analysis was performed using Slidebook 4.2 software. To quantify internalization,
a mask for each labeled cell was individually created based on AlexaFluor568 signal in the pre-
quench image, and then these masks were copied to the corresponding post-quench (+QSY)
image. Occasionally, stage drift caused a shift of a few pixels between images taken before and
after quenching, and this was corrected manually by shifting the masks. After subtracting
background in the AlexaFluor568 channel, the percent of labeled receptor internalized was
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calculated for each mask by taking the ratio of fluorescence intensities before and after
quenching.
The frequency distributions of internalization extent for two data sets were compared
using the two-sample Kolmogorov-Smirnov test, and the p-values were reported.
Cell surface labeling ofAP-receptors with mSA-Alexa568
T-REx CHO A7 cells expressing AP-LDLR (wild-type or mutant) and BirA were labeled
at 4 'C as previously described (33). Briefly, cells were washed three times with ice-cold DPBS,
and then incubated with 80 nM mSA-AlexaFluor568 in DPBS containing 1% (w/v) BSA at 4 'C
for 10 min. At the end of incubation, excess labeling reagent was removed by gently washing
cells three times with ice-cold DPBS. Thereafter, cells were either imaged directly or incubated
at 37 'C for internalization experiments.
Control expression level of AP-LDLR in T-REx CHO A 7 stable cell line
CHO ldlA-7 cells stably expressing the tetracycline repressor protein (T-REx CHO A7)
were obtained by transfection with pcDNA6/TR (Invitrogen) using Lipofectamine 2000
(Invitrogen). The cells were then grown in 10 pg/mL blasticidin in growth medium for 10 days.
Colonies of surviving cells were isolated by pipetting and expanded in the same blasticidin-
containing growth medium. Candidate cell lines were tested for tetracycline-induced expression
of pcDNA4-mCherry, using mCherry fluorescence as readout of expression level.
By measuring the uptake of fluorescently labeled LDL particles in cells transiently
expressing AP-LDLR, we determined that 50 ng/mL tetracycline induces AP-LDLR expression
to a level comparable to endogenous LDLR in wild-type CHO-KI cells and HeLa cells (Figure
5-22). T-REx CHO A7 cells were transfected with AP-WT LDLR and BirA targeted to the
endoplasmic reticulum. Cells were cultured in tetracycline-free growth medium overnight. 12 -
16 hours after transfection, the growth medium was supplemented with various concentrations of
tetracycline (0, 20, 50, 100, 200, 500 ng/mL) to induce AP-LDLR expression. 24 - 36 hours after
induction, cells were incubated with 100 tg/mL Dil-LDL for 1 hour at 37 'C. For comparison,
untransfected HeLa and wild-type CHO-KI cells expressing endogenous LDLR were analyzed
in the same manner.
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Figure 5-22. Titration of AP-LDLR expression level in T-REx CHO A7 cells.
Cells transiently transfected with AP-LDLR (wild-type) plasmid were cultured in growth medium
containing various concentrations of tetracycline for 24 - 36 hours to induce AP-LDLR expression. Top:
representative images of cells after incubation with 100 tg/mL DiI-LDL at 37 'C for 1 hour. Images show
DiI fluorescence overlaid with DIC. Untransfected cells did not take up Dil-LDL. Bottom left: for
comparison, untransfected HeLa and wild-type CHO-K I cells expressing endogenous LDLR were labeled
with DiI-LDL and imaged in the same manner. Bottom right: plot of whole-cell Dil-LDL signal (mean ±
s.e.m.) against tetracycline concentration. The pink region denotes the Dil signal level in wild-type CHO-
KI and HeLa cells. 50 ng/mL tetracycline was used for subsequent experiments in this work.
Using the same ligand uptake assay, we also verified that receptors labeled with mSA-
Alexa568 bind and internalize LDL to the same extent as unlabeled receptors, suggesting that the
mSA label does not affect these functions (Figure 5-23). T-REx CHO A7 cells were transfected
with AP-WT LDLR and BirA as described above. 24 - 36 hours after transfection, cells were
first surface-labeled with 200 ng/mL mSA-Alexa568 for 10 min and then incubated with 10
pg/mL DiD-LDL for 1 hour at 4 'C. For comparison, mSA-AlexaFluor568 labeling was omitted
in the control group. To assess LDL uptake, these cells were further incubated with 10 tg/mL
unlabeled LDL at 37 'C for 1 hour and then re-imaged in the same manner. Separate experiments
showed that the 10-min labeling protocol with mSA-AlexaFluor568 saturates cell surface AP-
LDLR with both biotin and mSA; i.e., labeling was complete (data not shown).
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Figure 5-23. The mSA label on AP-LDLR does not affect LDL binding and internalization.
T-REx CHO A7 cells transfected with AP-LDLR (wild-type) and BirA were labeled with mSA-Alexa568
at 4 'C for 10 min, incubated with 10 tg/mL DiD-LDL at 4 'C for 1 hour, and then imaged (a, top panel).
Thereafter, cells were further incubated with 10 tg/mL unlabeled LDL at 37 'C for 1 hour, and then re-
imaged (b, top panel). The bottom panels show the same analyses without mSA-Alexa568 labeling. The
distributions of whole-cell DiD-LDL intensity for single cells are plotted in histograms. Pink lines
indicate interquartile ranges (25-75%), and p-values are calculated using the Kolmogorov-Smirnov test.
There is no significant difference between labeled and unlabeled receptors in LDL binding and uptake.
Receptor internalization assay
T-REx CHO A7 cells were transfected with BirA, H2B-YFP transfection marker, and
wild-type and/or mutant LDLR (differentially tagged with either AP or HA, as indicated in each
figure). 24 - 36 hours after transfection, cells weresurface labeled with mSA-AlexaFluor568,
and then these cells were rinsed twice with DPBS pre-warmed to 37 'C, before incubating at
37 'C for 5 min. At the end of the incubation, cells were chilled with ice-cold DPBS and imaged
on the microscope. To assess the effect of LDL on receptor internalization, 100 pg/mL LDL was
added to the buffer during mSA-Alexa568 labeling, and 10 tg/mL LDL was added to the buffer
during the subsequent incubation.
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Figure 5-24. Confirmation of LDLR co-expression by epi-fluorescence imaging.
After labeling with mSA-AlexaFluor568, cells were fixed and stained with primary anti-HA antibody
followed by AlexaFluor647-conjugated secondary antibody to detect co-expressed (non-AP-tagged)
receptor. Representative images are shown for each combination. By counting fluorescently labeled cells,
the efficiency of HA-WT co-expression with the AP-mutant was calculated to be: 94% for AP-A792 (n =
81), 89% for AP-Y807C (n = 82), and 92% for AP-Y807A (n = 65). The efficiency of AP-WT co-
expression with HA-tagged mutant LDLR was calculated to be: 94% for HA-A792 (n = 62), and 95% for
HA-Y807C (n = 74).
Prior to imaging, buffer was aspirated from the imaging dish and -500 pL of 40 pM
QSY21-spermine solution in ice-cold DPBS was added to cover the monolayer of cells. Within I
min after quenching, fluorescence and DIC images were taken again for cells in the same field of
view. We note that it was necessary to perform our live imaging assay for a 5-min incubation
period only. Longer incubations gave significant internalization of the LDLR mutants, probably
via non-specific pathways.
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Evaluation of LDLR co-expression efficiency using immunostaining
T-REx CHO A7 cells were transfected with HA-tagged and AP-tagged LDLRs (as
indicated in Figure 5-24), and BirA as described above. 30 hours after transfection, cells were
washed with DPBS and labeled with mSA-Alexa568 at 4 'C for 15 min. After washing off
excess labeling reagent, cells were fixed with 4% (v/v) formaldehyde in PBS for 10 min at room
temperature. After washing three times with PBS, cells were permeabilized and blocked with
blocking buffer (0.1% v/v Tween 20 + 3% w/v BSA in PBS) overnight at 4 'C. For
immunostaining, cells were probed with rabbit a-HA (0.6 pg/mL in blocking buffer) for 1 hour,
washed 4x 5 min with blocking buffer, labeled with goat a-rabbit conjugated with Alexa647 (4
tg/mL in blocking buffer) for 1 hour, and then washed again 4x 5 min with blocking buffer at
room temperature.
Co-immunoprecipitation analysis of LDLR oligomerization
3 - 4 x 106 T-REx CHO A7 cells were co-transfected with HA-WT LDLR, BirA, and
either AP-WT LDLR or AP-A792 LDLR. 24 - 36 hours after transfection, cells were treated
with lysis buffer (125 mM Tris-maleate pH 6, 2 mM CaCl 2, 160 mM NaCl, 1% (v/v) Triton X-
100, and 1 mM PMSF) and then centrifuged to yield a clear lysate supernatant. Biotinylated
proteins were pulled down from this supernatant using streptavidin magnetic particles (Roche
Applied Science), pre-blocked using 0.1% (w/v) bovine serum albumin. The supernatant was
collected and designated as the "unbound" fraction. The bound fraction was dissociated from the
beads by heat denaturation, and designated as the "eluted" fraction. Lysate of cells without
transfection was used as a negative control. Lysate of cells transfected with only AP-WT LDLR
was used as a positive control for the SA-HRP blot, and a negative control for the anti-HA blot.
These fractions, as well as the whole lysate, were analyzed by both SA-HRP blot and
anti-HA western blot. After transferring the protein bands from SDS-PAGE gel to nitrocellulose
membrane, the membrane was blocked with blocking buffer (3% w/v BSA in PBS, with 0.1%
v/v Tween-20) at 4 'C overnight. For the SA-HRP blot, the membrane was incubated with 0.3
pg/mL SA-HRP (Thermo Scientific) at room temperature for 30 min, and then rinsed with
blocking buffer 4x 5 min. For the anti-HA western blot, the membrane was first incubated with
0.8 ptg/mL rabbit anti-HA primary antibody (Invitrogen) for I hour, then washed with blocking
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buffer 4x 5 min, then incubated with goat anti-rabbit secondary antibody-HRP conjugate (Bio-
Rad Laboratories, 1:5000 dilution in blocking buffer) for 30 min. The membrane was finally
washed 4x 5 min with blocking buffer. The blot was developed with SuperSignal West Pico
Reagents (Thermo Scientific) following the manufacturer's protocol, and imaged with a digital
camera.
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Chapter 6 Single molecule imaging analysis of receptor internalization
Except for Section 6.3, work described in this chapter is unpublished. Section 6.3 is adapted
from publication: J. D. Cohen, P. Zou, and A. Y. Ting. Site-specific protein modification using
lipoic acid ligase and bis-aryl hydrazone formation. ChemBioChem 2012, 13, 888-894. Dr. Justin
Cohen developed site-specific aryl hydrazine ligation technique.
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6.1 Introduction
This chapter aims to resolve the detailed mechanism of receptor-mediated endocytosis at
the single-molecule level, using recently developed site-specific protein labeling techniques in
conjunction with fluorescence microscopy. Specifically, two models have been proposed in the
literature regarding how receptors are targeted to the clathrin-coated pits (Figure 6-1) (1). It has
been difficult to distinguish these models in experiments, and it is not known whether the
mechanism is different for ligand-free receptors and ligand-bound ones (2). We used the low
density lipoprotein receptor (LDLR) as a model system.
Model 1: Pre-existing CCP - Model 2: De novo formtion of CCP
clathrin-Coated Pit
Out
Figure 6-1. Two proposed models for receptor entrapment into the CCPs.
In the first model, CCP forms prior to ligand binding, and the entrapment is achieved by lateral diffusion
of LDL receptor into the pit. In the second model, LDL binding induces the formation of CCP by
recruiting clathrin and adaptor proteins.
This study is facilitated by novel site-specific protein labeling techniques utilizing the .
coli biotin ligase, BirA. In the previous chapter, we demonstrated that streptavidin labeled with
organic fluorophores are useful for studying receptor trafficking at the ensemble level.
Alternatively, it can be used to decorate quantum dots (QDs) for applications in single-molecule
fluorescence imaging (3,4). Because of their intense brightness and resistance to photobleaching,
QDs are ideal probes for single-molecule fluorescence imaging. Although streptavidin-
functionalized QDs are commercially available, they are multivalent and have a large size (20 ~
30 nm) due to their thick passivation layer. This has become a problem for their biological
applications because these large particles may affect the function of targeted proteins and have
limited access to crowded cellular environments. Therefore, it is crucial to develop novel coating
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methods to reduce QD size, while simultaneously maintaining high QD stability, solubility, and
passivation.
Previously published small molecule QD coating ligands include mercaptoacetic acid (5),
cysteine (6), peptides bearing cysteine residues (7), dihydrolipoic acid (DHLA) (5) and
poly(ethylene glycol)-appended DHLA (8). Although QDs coated with these ligands are small in
size, they often suffer from instability in the buffer during their storage. This problem calls for
the design and synthesis of new coating. In this chapter, we have engineered quantum dots for
single-molecule fluorescence imaging and using them to examine two proposed mechanisms of
clathrin-coated pit initiation.
6.2 Engineering small QDs for studying receptor-mediated endocytosis
Establishing a model system
As shown in Figure 6-1, two models have been hypothesized to account for the
entrapment of a receptor into the CCP:
1) "Pre-existing pit" model: upon ligand binding, the receptor is targeted to a pre-
existing CCP on the cell surface;
2) "De novo pit formation" model: a ligand-bound receptor recruits clathrin and adaptor
proteins, forming a new CCP beneath it.
The key to solving this problem lies in determining the temporal order of the CCP
formation and the reduction in receptor mobility. This highly dynamic process is not amenable to
traditional methods such as biochemistry and immunocytochemistry, because they often provide
a static, ensemble-averaged picture of the cell; instead, single-molecule fluorescence microscopy
allows us to examine the dynamic behavior of individual receptors and CCPs in live cells, thus
providing the answer to the above question.
In order to specifically label LDL receptor in mammalian cells, the AP-tag was fused to
the N-terminus of the LDL receptor, immediately after its leader sequence (AP-LDLR).
Biotinylated LDL receptors on the cell surface could be imaged by targeting them with red-
emitting streptavidin-derivatized QDs. The experiment also requires labeling CCPs. In previous
research, this is achieved by fusing a fluorescent protein to one component in the endocytic
machinery, such as the clathrin light chain or the 72 subunit of the adaptor protein AP2 (2). The
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construct used in my experiment has a2 fused with Venus (a2-Venus, a gift from Prof. Xiaowei
Zhuang at Harvard University). Because multiple copies of a2-Venus are concentrated in a CCP,
whose diameter (~100 nm) is smaller than the wavelength of the emitted light, each CCP appears
as a strongly fluorescent, diffraction-limited spot when visualized under a microscope (Figure
6-2).
Figure 6-2 shows the images from a proof-of-principle experiment, in which I used a total
internal reflection fluorescence (TIRF) microscope to image both the CCP and LDL receptor on
the cell surface. Internalization events were observed in real-time - as a receptor moves into the
cell, it leaves the evanescent field localized near the plasma membrane, and the QD attached to it
becomes dark. In this experiment, the two proposed receptor entrapment models can be
distinguished by the order of appearance and disappearance of Venus and QD signals. The
preliminary data seem to favor the pre-existing CCP model.
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Figure 6-2. Single-molecule fluorescence imaging experiment with commercial QDs.
Left: TIRF image of the basal membrane of a Chinese hamster ovary (CHO-K I) cell. These cells were
transiently transfected with AP-LDLR, BirA and a2-Venus. CCPs are labeled with Venus (green) and the
LDL receptors are specifically targeted with commercial QDs (red) via biotin ligase. Right: "pre-existing
pit" model (top) and the tile view of the square region in (A) (bottom). Each column represents a different
time point, and the arrows in each panel locate an internalization event, which supports the "pre-existing
pit" model. Images are matched into the four phases of the model.
The above co-localization study was done with commercially available QDs which are
known to be large in size and multivalent. Our next goal is to engineer small, monovalent QDs to
further investigate this problem. In order to minimize the effect of protein overexpression, we
have also developed a COS-7 cell line that stably expresses a2-Venus.
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Engineer small, monovalent QD reagents
QDs used in biological applications must fulfill the following requirements: small size,
high targeting affinity, fast labeling kinetics, reduced tendency to crosslinking the target,
complete passivation, and biocompatibility. Reduced-size QDs have been made by our group and
others (6), but they have been plagued by problems of short shelf-life, poor water solubility, and
non-specific binding to cells. Based on the properties of existing QD ligand (6,9), we designed a
new coating structure with the following rationale:
1) Poly(ethylene glycol) (PEG) is commonly used to passivate macromolecules, inorganic
particles and surfaces. It improves the solubility of QDs and reduces non-specific
adsorption of QDs to cells. While longer PEG linkers usually provide a better
passivation, shorter ones facilitate functionalization of QDs with proteins.
2) One end of the PEG segment is conjugated to dihydrolipoamine, whose thiol groups
coordinate to the zinc sulfide layer on the QD surface.
3) The other end of the PEG terminates as a carboxyl group, whose negative charge at
neutral pH both improves water solubility and facilitates electrophoretic purification of
streptavidin-conjugated QDs. It also provides a functional handle for amide coupling.
The synthetic scheme of this ligand is shown in Figure 6-3. Essentially, it is achieved by
coupling lipoamine to one end of poly(ethylene glycol) diacid (PEG diacid) through an amide
linkage.
The quality of this ligand was subsequently determined by testing ligand-coated QDs at
three levels: 1) biocompatibility, 2) targeting specificity after protein conjugation, and 3)
potential for generating monovalent QDs.
Level I: biocompatibility. Starting with QDs in its growth solution (courtesy of Wen Liu
and the Bawendi lab), we performed a cap exchange reaction to replace the hydrophobic trioctyl
phosphine oxide (TOPO) on the QDs surface with my purified ligand. The resulting QDs coated
with this new ligand were soluble in phosphate buffered saline (PBS) solution and have a
hydrodynamic diameter of -l2 nm, as determined by dynamic light scattering. This size is
significantly smaller than commercial QDs. To test whether these QDs were properly passivated,
we incubated them with cells in the culturing medium and observed minimal stickiness.
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Figure 6-3. The synthetic scheme of novel QD coating ligand.
Lipoamine was prepared by reducing the lipoamide with lithium aluminum hydride, and PEG diacid was
prepared by oxidizing PEG with Jones reagent. In both cases, the starting material was commercially
available, and the procedures were documented in the literature. The final product required conjugating
PEG diacid and lipoamine in strictly one-to-one ratio, and this was facilitated by using a phenacyl group
to protect one of the two carboxyl groups in PEG diacid. In this protecting step, a sub-stoichiometric
amount of bromoacetophenone (a.k.a. phenacyl bromide) was reacted with PEG diacid, and the desired
mono-protected product was purified from a mixture of unprotected and di-protected by-products. After
conjugating lipoamine to phenacyl-protected PEG diacid, the protecting group was removed by reductive
cleavage with sodium borohydride. In the same reduction reaction, the dithiolane ring opened to form two
thiol groups, yielding the final product as viscous, colorless oil. The product was characterized by TLC,
MS and NMR.
Level II: specific cellular targeting. Conjugating mSA to these reduced-size QDs was
facilitated by the interaction between the His-tag of mSA and the zinc/cadmium sulfide coating
of QDs (10). Here, shorter PEG segment in the ligand structure allows better accessibility of the
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QD surface to the His-tag. The resulting mSA-QD conjugate were targeted to biotinylated LDL
receptors on the cell surface. Again, minimal non-specific binding was observed (Figure 6-4).
H2B-YFP,
Figure 6-4. Specific targeting to biotinylated LDL receptor on the cell surface.
Confocal images of CHO-KI cells transiently transfected with AP-LDLR, BirA and H2B-YFP as a
transfection marker. Most transfected cells have YFP in the nucleus, and they are specifically labeled with
mSA-QD.
Level III: control of monovalency. In order to make QDs truly useful for biological
applications, it is desirable to use monovalent QDs to avoid crosslinking the target. To this end,
QDs derivatized with only one copy of mSA should be separated from the mixture. Previously,
this could be achieved by agarose gel electrophoresis (9). Due to the negative charge on the
carboxyl group, QDs prepared with the novel ligand have high electrophoretic mobility, as
shown in Figure 6-5. Conjugation to mSA significantly lowered this mobility, and QDs with
different copy numbers of mSA were resolved into discrete bands on the agarose gel.
Monovalent QD can be purified by isolating its band and extracting soluble content out of the gel,
as previously described (4).
QD605 1uM
mSA (uM)
$ 0 0.2 0.4 1.0 2.0
4- mQD
1 kb-+ +-QD
Figure 6-5. Separating mSA-conjugated QDs with new coating.
Agarose gel (1% in TAE buffer) electrophoresis of mSA-QD. Monovalent QD can be resolved from
unconjugated QD and QDs with higher copy number of mSA.
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The above three levels of analyses demonstrated the utility of this new QD coating ligand.
However, the stability of these QDs decreases over the time - they begin to precipitate from the
solution and become sticky to cells about 3 ~ 4 days after the preparation. This instability is
thought to arise from the slow dissociation of dithiol ligand from the QD surface as well as the
oxidation of thiols into disulfide groups, which has weak interaction with QDs. By comparing
the stability of QDs coated with these negatively charged ligands (DHLA-PEG-COOH) and
those with DHLA-PEG-OH (structure shown in Figure 6-3), we found that DHLA-PEG-OH
coating significantly improves the stability of QDs, in spite of the structural similarity of these
ligands. This difference in stability leads to the hypothesis that the dense negative charge created
by DHLA-PEG-COOH on the QD surface tend to destabilize this coating layer, promoting
ligand dissociation due to electrostatic interactions; neutral DHLA-PEG-OH ligand, on the other
hand, does not have such problem.
6.3 Single-molecule imaging with phycoerythrin
For biotechnological applications requiring extreme fluorophore brightness, such as
fluorescence activated cell sorting (FACS), phycoerythrin has been used as a much brighter
alternative to organic dyes and a smaller and less expensive alternative to QDs. R-phycoerythrin
(R-PE) is a 240 kDa protein of disk-shape, with a diameter of 11 nm and a thickness of 6 nm,
containing 34 phycobilin-type chromophores. It is usually obtained by purification from red
algae (11). With an extinction coeffient (s) of 2.0 x 106 M-Icm-1 at 566 nm and quantum yield
(QY) of 0.85, it is more than 25 times brighter than AlexaFluor568 (, = 91,300 M-cm-' at 568
nm; QY = 0.69), an organic fluorophore with similar emission spectrum.
R-PE has rarely been explored as a reagent for single molecule imaging. In one example,
Darrel Irvine et al. used PE to label major histocompatibility complex on the surface of antigen
presenting cells in order to count their copy number (12). We wished to explore other methods of
targeting PE to specific cell surface proteins, and to image them at the single molecule level.
Since PE can only be practically added to cells at low micromolar concentrations, its targeting
requires a method with an extremely high second order rate constant. With its extremely fast
kinetics and cell compatibility, the bis-aryl hydrazone conjugation is ideal for this application.
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Lq NH, W3 LpIA Hyd H HN N
Protein of Interest HO H N' N' NH2
H
Hydrazine (Hyd)
Figure 6-6. Scheme for using lipoic acid ligase (LpIA) to conjugate a hydrazine functional group to
Lp1A acceptor peptide (LAP) fusion proteins.
After ligation, the hydrazine moiety can be chemoselectively derivatized with aryl aldehyde-
functionalized R-phycoerythrin (represented by red circle). The linkage is a hydrazone (highlighted in
yellow) that is stabilized by conjugation to the two neighboring aromatic rings.
Based on the PRIME technique described in Chapter 4, we developed a method that site-
specifically introduce aryl-hydrazine moiety to protein of interest. This method capitalizes on the
W371 mutant of E. coli lipoate protein ligase, LplA, which catalyzes the covalent conjugation of
an aryl hydrazine probe ("Hyd", as shown in Figure 6-6) with LpIA acceptor peptide (LAP), with
a kinetic constant kca, of 0.021 ± 0.003 s-1 (13). Subsequent reaction with PE functionalized with
aryl-aldehyde allows covalent conjugation of the fluorescent probe to the protein target (Figure
6-6). Bis-aryl hydrazone formation is one of the fastest bio-compatible ligation reactions, with a
second order rate constant of ~2000 M-1 s-1 when aniline is used as a catalyst. In the absence of
aniline, the reaction still proceeds at -1 M s-1 (14).
To first evaluate if we could conjugate phycoerythrin selectively, we transfected
HEK293T cells with neurexin-1p, a cell surface protein, fused to LAP and a nuclear-YFP
transfection marker. Cells expressing LAP- neurexin-1p was labeled with the Hyd probe using
W371LplA. After labeling, cells were washed and treated with 20 mM aniline and R-PE modified
with 4-formylbenzamide (PE-Ald). After 45 min the cells were washed and imaged. As shown in
Figure 6-7, clear labeling was observed in transfected cells. No labeling was seen in negative
controls using wild-type LpIA, with ATP omitted, or with an alanine mutation in LAP.
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Nuclear YFP Phycoerythrin
wild-type LpIA
-ATP
LAP-(K-+A)
Figure 6-7. Protein labeling with phycoerythrin on the surface of living HEK293T cells.
This figure was generated by Dr. Justin Cohen. Cells expressing LAP4.2-neurexin-IP were labeled with
W371 LpIA and Hyd substrate for 45 min, washed, then treated with 3 pM phycoerythrin-Ald in the
presence of 10 mM aniline for 45 min, before confocal imaging. Negative controls are shown with wild-
type LpIA, ATP omitted, and an alanine mutation in LAP. Nuclear YFP was a co-transfection marker.
To perform single molecule imaging with PE, we next prepared COS-7 cells that express
LAP-LDLR on the surface. We labeled the LDLR using our Hyd probe, followed by treatment
with 20 mM aniline and PE-Ald. As shown in Figure 6-8, individual labeled LDLR molecules
appeared as single diffraction-limited spots on the cell surface, imaged by total internal reflection
fluorescence (TIRF) microscopy. To confirm that the labeled spots were indeed single receptors
and not aggregates, we compared the intensity distribution of > 2900 spots on cells to individual
PE molecules randomly distributed on glass slides, and observed similar distribution. The labeled
receptors are also dynamic, as shown in time-lapse imaging experiments. The brightness of PE
molecules offers high signal-to-background ratio that is unparalleled by organic fluorophores,
and photobleaching is reduced because of the lower laser intensity required for illumination.
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Phycoerythrin
transfected
untransfected
Figure 6-8. Single-molecule imaging with phycoerythrin on the surface of living COS7 cells.
Left: Cells expressing LAP-LDLR were labeled as in Figure 6-7, except that a lower concentration of
phycoerythrin-Ald (0.3 pM) and 20 mM aniline was used and the cells were imaged in TIRF mode.
Nuclear YFP is a transfection marker. Images of a transfected cell (top) and untransfected cell (bottom)
are shown. Right: enlarged view of the boxed area on left showing individual phycoerythrin particles
conjugated to LAP-LDLR on the COS7 cell surface. Scale bars, 10 pm.
170
6.4 Conclusion
In summary, we have designed, synthesized and tested a novel QD coating ligand. Using
this ligand, we have prepared mSA-conjugated QDs that can be specifically targeted to
biotinylated receptors on the cell surface. Compared to previously published results, this new
ligand fails to improve the stability of QDs after long-term storage; while the information learnt
from this ligand provides the basis for our design of new ligands and new strategies of generating
monovalent QDs. Divalent ligands such as dihydrolipoamine moiety has improved affinity
toward the zinc sulfide shell of QDs, but the interaction is not strong enough to survive for
longer than several days. Tetravalent ligands could potentially solve this problem. In general,
thiol-based ligands tend to get oxidized by 02 over the time, which is another factor for gradual
dissociation from the shell. In future designs, it would be desirable to avoid using thiols as the
chelating moiety. For instance, imidazole also shows strong affinity toward zinc sulfide shell,
and it is resistant to oxidation.
As an alternative probe to QD, R-PE has also been employed as a probe for single-
molecule fluorescence imaging. As a fluorescent protein, R-PE is naturally biocompatible with
the cellular environment, and exhibited minimal stickiness. Our recently developed aryl-
hydrazine ligation technique and the application of bis-aryl hydrozone formation reaction
overcame the challenge of poor kinetics of covalently targeting R-PE to cell surface receptors.
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6.5 Experimental methods
Quantum dot ligand synthesis
5-(1,2-dithiolan-3-yl)pentan- 1-amine
0
i) LiAIH 4, THF NH 2
S-S ii) re-oxidation s Yield = 39%
1.00 g of DL-a-lipoamide was dissolved into 100 mL of anhydrous tetrahydrofuran
(THF). In another round bottom flask, 830 mg of LiAlH 4 power was added into 50 mL of
anhydrous THF, and the mixture was stirred under nitrogen gas. DL-a-lipoamide solution was
slowly added into this LiAlH 4 dispersion, and the reaction mixture was refluxed at 70 'C
overnight. The reaction was worked-up by cooling down to 0 'C, followed by addition of 8 mL
of distilled H20. The solution was stirred at 0 'C for another 30 min. THF solvent was removed
under reduced pressure, and 50 mL of methanol (MeOH) was added to re-dissolve the reaction
product. The insoluble was formed in MeOH solution and filtered away by running the solution
through celite. The methanol solvent was removed from the supernatant on a rotevap. 100 mL of
distilled H20 was added and the pH was adjusted to 6.5 with 1 M HCl (aqueous solution). This
solution was stirred at room temperature overnight. An equal volume of n-butanol was added
into the solution to extract the product. The organic phase was washed with 100 mL of IM
NaOH, dried over anhydrous MgSO 4, and the solvent was removed under reduced pressure.
Yield = 0.36 g (39%).
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Polyethyleneglycol diacid
0 0
HO O O O OH Cr0 3, H2SO 4 N HO h0 O .O OH
acetone
Yield 81%
Jones reagent was prepared by dissolving 14.0 g of Cr0 3 into 100 mL of distilled H20.
The solution was chilled on ice, and then 12 mL of concentrated sulfuric acid was slowly added
in small portions. The solution was warmed slowly to room temperature. 5.0 g (4.5 mL) of
polyethyleneglycol-400 was dissolved into 500 mL of acetone. With stirring, 43 mL of Jones
reagent was added into this solution. The solution was stirred at room temperature overnight. 0.5
g of activated charcoal and 1.0 g of sodium bicarbonate was added into the solution, and the
mixture was stirred for another 2 hours. The mixture was filtered to obtain a clear, colorless
solution. Solvent was removed from the supernatant on a rotevap. Yield = 4.35 g (8 1%).
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Phenacylcarboxyl PEG-acid
0 0
HOKON4 0"1<ONO OH5
I
Br -
Et3 N, THF 5 l =
Yield =19%
0.20 g of phenacyl bromide was dissolved into 5.0 mL of anhydrous THF, and 0.40 g of
polyethyleneglycol diacid and 1.1 mL of triethylamine was added. The solution was stirred at
room temperature overnight. 5 mL of distilled H20 was added and the pH of the solution was
adjusted to ~3 using IM HCL. The aqueous phase was extracted twice with 20 mL of ethyl
acetate (EtOAc), and the combined organic phase was dried over anhydrous MgSO 4. The solvent
was removed under reduced pressure, and the product was purified on a silica column. A
solution of EtOAc:MeOH:H 20= 7:2:1 was used to elute the product. Yield = 0.10 g.
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Phenacylcarboxyl PEG-lipoamide
O 0 i) Et3 N + PFP-TFA, THF
HOA O -O- O OA
0 ii) NH2
s-s
S-S 0
0.10 g of phenacyl polyethyleneglycol diacid was dissolved into 1.0 mL of anhydrous
THF, and into this solution were added 42 tL of anhydrous triethylamine (Et 3N) and 36 p1L of
pentafluorophenyltrifluoroacetate (PFP-TFA). The solution was stirred under nitrogen gas for 30
min. 40 mg of lipoamine was added into another 1.0 mL of anhydrous THF, and this solution
was added drop-wise into the reaction mixture, which was stirred under nitrogen gas overnight.
Solvent was removed in vacuo, the product was dissolved into 5 mL of chloroform (CHCl 3), and
then washed with 5 mL of H20. The organic layer was dried over anhydrous MgSO4. After
filtering, solvent was removed again under vacuum. The product was purified with silica column.
After sample loading, the column was washed with CHCl3, and then the product was eluted with
2% MeOH/CHCl 3. Yield ~ 0.10 g (77%).
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Polyethyleneglycoldiacyl monodihydrolipoamide
0 0
S-S 0
NaBH 4  0 O
0.25 M NaHCO 3, H20 SH SHH
70 mg of phenacylcarboxyl PEG-lipoamide was dissolved into 1.0 mL of 0.25 M
NaHCO 3 aqueous solution. 16 mg of NaBH 4 was slowly added into this solution (divided into
four aliquots, with one aliquot added per 10 min). The reaction mixture was stirred on ice for 2
hours. 5 mL of MeOH was added to help solubilize the reaction mixture. Yellow color faded
away in about 1 hour. The solution was stirred overnight. Solvent was removed under vacuum,
and 5 mL of CHCl3 was added to dissolve the residue. The organic phase was washed by 5 mL
of 1 M HCl and 5 mL brine. The aqueous phase was back-extracted with 5 mL CHCl3. The
combined organic phase was dried over anhydrous MgSO 4, and solvent was removed under
vacuum. Yield = 60 mg (86%).
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Mammalian cell culture and imaging
HEK and COS-7 cells were cultured in growth media consisting of Minimum Essential
Medium (MEM, Cellgro) supplemented with 10% fetal bovine serum (FBS, PAA Laboratories).
Cells were maintained at 37'C under 5% C02. For imaging, HEK cells were grown on glass
coverslips pre-treated with 50 [tg/mL fibronectin (Millipore) to increase their adherence. COS-7
cells were grown in LabTek II chambered coverglass system 8 well plates.
Cells were imaged in Dulbecco's Phosphate Buffered Saline (DPBS) at room temperature.
The images were collected on a Zeiss AxioObserver.ZI microscope equipped with a Yokogawa
spinning disk confocal head containing a Quad-band notch dichroic mirror (405/488/568/647
nm). YFP (491 nm laser excitation, 528/38 emission filter), AlexaFluor568 / Phycoerythrin (561
nm laser excitation, 617/73 emission filter) and DIC images were collected using Slidebook
software (Intelligent Imaging Innovations). Images were acquired for 20 to 500 milliseconds
using a Cascade 11:512 camera. Fluorescence images in each experiment were normalized to the
same intensity range.
TIRF images were acquired using 100x oil-immersion objective. YFP (491 nm laser
excitation, 525/30 emission filter, 502 nm dichroic mirror), AlexaFluor568 / Phycoerythrin (561
nm laser excitation, 605/30 emission filter, 585 nm dichroic mirror) and DIC images were
collected using Slidebook software (Intelligent Imaging Innovations). Digital images (16 bit)
were obtained with a cooled EMCCD camera (QuantEM:512SC, Photometrics) with exposure
times between 50 msec and 200 msec.
Cell surface labeling with R-PE
The amino acid sequence of LAP is GFEIDKVWHDFPA, in which the underscored
lysine residue is covalently conjugated with the aryl hydrazine probe. HEK cells were transfected
at ~70% confluence with 200 ng LAP-Neurexin-1P and 200 ng H2B-YFP co-transfection marker
plasmid (per 48-well) using Lipofectamine 2000 (Invitrogen). 15 hours after transfection, the
growth media was removed, and the cells were washed three times with DPBS with 0.5% casein.
Casein was added to DPBS for all washing and labeling steps as a blocking agent and was
required to reduce non-specific sticking of the probes. The cells were then labeled by applying
100 p.M Hyd probe, 1 p.M w371LpIA, 1 mM ATP, and 5 mM magnesium acetate in DPBS with
0.5% casein at room temperature for 45 minutes. Cells were then washed three times with DPBS
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with 0.5% casein and then treated with 10 mM aniline and 3 pM PE-Ald (4FB-R PE, Solulink)
for 45 min at 4'C. Cells were washed an additional three times and then imaged. Similarly, COS-
7 cells were transfected with 200 ng LAP-LDLR and 100 ng H2B-YFP co-transfection marker,
only 20 jM Hyd probe was used in the initial labeling, and 0.3 IM PE-Ald with 20 mM aniline
for 45 min was used for the fluorophore conjugation.
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